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Chapter 1  
1.1 Principles of hemodialysis 
During hemodialysis treatment, many solutes, such as urea, sodium and potassium, which 
have accumulated as a result of renal failure, have to be removed. Due to reduced diuresis 
approximately 1.5-4.5 liters of water has to be removed during each treatment. During the 
procedure, blood is led through an extracorporeal circuit with an artificial kidney, and then 
returned to the patient, as first reported by Kolff  (Figure 1)[1,2].  
 
 
Figure 1. Hemodialysis block diagram 
 
In the artificial kidney, blood is separated from the dialysate by a semi-permeable membrane. 
This membrane is permeable to solutes up to several thousand Dalton, which allows fluid and 
waste products to pass through, but prevents the exchange of blood components, 
microorganisms and endotoxins. Dialysate, flows on the other side of the membrane and in 
the opposite direction (Figure 2).  
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Figure 2. The Artificial kidney 
 
Four processes control the transmembrane exchange of water and solutes: diffusion, 
ultrafiltration, convection and osmosis. When blood and dialysate flow through the dialyzer a 
transmembrane concentration gradient is formed. As governed by Fick’s law this results in 
diffusion of the accumulated solutes from the intravascular space to the dialysate compartment 
(Figure 3). By controlling the composition of the dialysate, the concentration gradient can be 
altered, resulting in an appropriate transfer of solutes. Excess water is removed by 
ultrafiltration. During this process, a trans-membrane pressure (TMP) gradient is generated 
between the blood and dialysate compartments (Figure 3). This results in the movement of 
plasma water to the dialysate compartment. As water moves across the dialyzer membrane it 
drags along solutes (convection), while solutes with a greater molecule mass, such as proteins 
(colloid solutes), remain within the vascular space [3,4]. The ratio of the amount of solute 
transported to the ultrafiltrate to the amount retained in plasma water is called the sieving 
coefficient. The sieving coefficient depends on the properties of the membrane (diameter of 
membrane pores), and on the molecular size and the chemical properties of the solute. The 
sieving coefficient of urea equals one and that of proteins is zero [5]. Cations, such as sodium, 
have a sieving coefficient slightly lower than one. This is caused by the fact that the 
negatively charged proteins in plasma attract cations, resulting in a decreased trans-membrane 
movement. This is called the Donnan effect [6-8].  
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Ultrafiltration can be performed in combination with hemodialysis, or without concomitant 
diffusive hemodialysis, i.e. isolated ultrafiltration. Osmosis is the net movement of water 
across a selectively permeable membrane, driven by a difference in the concentration of a non 
permeating solute on the two sides of the membrane (Figure 3). The water shift during 
osmosis depends on the overall concentration- and hydrostatic pressure gradients across the 
membrane. When fluid moves to the compartment with the lowest concentration, the 
hydrostatic pressure in this compartment rises, until equilibrium is reached.  The difference in 
hydrostatic pressure between both compartments in equilibrium is called osmotic pressure. 
When osmotic pressure is caused by colloids, it is called colloid osmotic (oncotic) pressure. 
During dialysis, this process does not determine water movement across the dialyzer 
membrane but it is of major importance in the distribution of water between the fluid 
compartments [9]. During hemodialysis, fluid is withdrawn from the intravascular space. 
However, the excess of fluid is distributed over all fluid compartments of the body, e.g. 
plasma volume, interstitial volume, and intracellular volume. During ultrafiltration, plasma 
volume is refilled with fluid from the other compartments, as intravascular colloid osmotic 
pressure increases and hydrostatic pressure decreases. Nevertheless, as the result of a delay in 
plasma refilling, a decrease in plasma volume is inevitable when a substantial amount of fluid 
is rapidly removed from the relatively small intravascular space. Consequently, intermittent 
hemodialysis is often complicated by hypotension, which occurs in one third of the dialysis 
procedures [10-12].  
 
Figure 3. Principles of hemodialysis 
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1.2 Hemodialysis related hypotension 
Dialysis-induced hypotension has been defined as a decrease in systolic blood pressure (SBP) 
to below 100 mmHg and/or a decrease in SBP of 25% or more during the dialysis session 
[13]. Hypotension is a major cause of morbidity such as dizziness, vomiting and 
lightheadedness [14], but also affects the prognosis of the patient through cardiac, cerebral 
and mesenteric ischaemia [15-17]. The decrease in blood volume, caused by ultrafiltration 
and delayed plasma refilling from the interstitial space plays a pivotal role in the pathogenesis 
of dialysis related hypotension [18-21]. Moreover, compensatory mechanisms, such as 
vasoconstriction, that mobilizes blood to the central active blood volume that participates in 
maintaining blood pressure, may be inadequate during hemodialysis [22-25]. As it is desirable 
to minimize the frequency of dialysis associated hypotension, the physiology of these 
compensatory mechanisms during dialysis and ultrafiltration needs to be studied and 
strategies to improve blood volume preservation and the cardiovascular response during 
dialysis needs to be devised.  
 
1.3 Blood and plasma volume during hemodialysis 
Plasma Volume 
During ultrafiltration, the driving forces for plasma refilling (J ref) are the decrease in 
hydrostatic pressure and the increase in colloid osmotic pressure gradients over the capillary 
membrane, as given by the formula of Starling: 
J ref = Lp (- p) [26,27]. 
Thus, plasma refilling is determined by the water filtration coefficient (Lp), which depends on 
the total membrane surface area and the permeability of the capillary membrane. The colloid 
osmotic pressure gradient () and the hydrostatic pressure gradient (p) also determine  
capillary refilling.  
 
Active blood volume   
During hypovolemia, the compensatory response to maintain Mean Arterial blood Pressure 
(MAP) must act on total peripheral resistance (TPR) or on cardiac output (CO = Stroke 
Volume (SV) x Heart Rate (HR)) as:    
MAP = TPR x SV x HR   
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A substantial percentage of the total blood volume is located in the venous system and its 
capacity can change markedly. This blood volume is “inactive” and does not contribute to 
blood pressure. During hypovolemic hypotension, venoconstriction mobilizes blood towards 
the central circulation. This increases stroke volume and helps to maintain blood pressure 
[28]. Both vasoactive hormones and the sympathetic nervous system regulate venous tone. 
However, venous tone also interacts with arterial pressure by means of the de Jager Krogh 
phenomenon. As arteriolar vasoconstriction decreases filling and reduces blood flow of the 
vascular bed, venous recoil of the compliant venous system reduces venous capacity and 
venous blood is translocated to the heart [29,30]. Arteriolar vasoconstriction, like venous 
vasoconstriction, results from sympathetic activation. An afferent signal to the medulla 
oblongata is given by the cardiopulmonary receptors (located in the atria and the pulmonary 
veins) and the baropressor receptors (located in the aorta and in the carotid artery) [31]. 
Norepinephrine (NE) is then released by the efferent nerves and causes vasoconstriction [32]. 
During sympathetic activation cardiac contractility (systolic function) and heart rate are 
increased [31,32]. However, from animal studies and studies using beta blockade and cardiac 
denervation, it can be concluded that during hypovolemia cardiac output is predominantly 
determined by cardiac filling [33,34]. Therefore, diastolic left ventricular function is of major 
importance in maintaining adequate cardiac output during hypovolemia. Diastolic function is 
the capacity of the ventricles to relax and to accept blood without a disproportionate change in 
ventricular pressure. When diastolic function is inadequate, stroke volume decreases rapidly 
during an ultrafiltration-induced reduction in cardiac filling [35]. 
 
1.4  Patient related factors affecting the blood pressure response to hemodialysis  
The incidence of hypotension is not uniform in all patients on hemodialysis. Some patients 
appear to be hypotension prone, whereas others are hypotension-resistant. In the hypotension 
prone patients, not all dialysis sessions lead to hypotension. 
 
Fluid status  
In hypervolemic patients hydrostatic interstitial pressure is high. This will induce a rapid fluid 
shift from the interstitial intravascular compartment during ultrafiltration. Conversely, when 
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the patient is near normovolemia, or at hypovolemia, refilling is diminished, as fluid in the 
interstitial space is depleted and interstitial hydrostatic pressure is low [36-39]. 
It is important to determine the fluid status of the individual patient. Normovolemia is 
difficult to determine and clinically normovolemia is defined as the lowest possible body 
weight after dialysis (dry weight) without the occurrence of intradialytic symptoms. However, 
as some patients need antihypertensive drugs to control interdialytic hypertension a more 
objective measure of normovolemic weight is required. The diameter of the inferior caval 
vein has been proposed as a more objective measure of dry weight. Underhydration is defined 
as a vena cava diameter < 8 mm/m2 body surface area, and overhydration as an inferior caval 
diameter >11.4 mm/m2 body surface area [40]. In some patients, increasing the target weight 
to clearly hypervolemic levels may be the only way to provide a therapy without recurrent 
dialysis hypotension. However, overhydration has unfavorable cardiovascular effects, such as 
left ventricular hypertrophy leading to diastolic dysfunction. 
 
Autonomic function 
Renal failure often results from diabetes and/or hypertension, which lead to cardiovascular 
abnormalities, such as heart failure [41,42]. Moreover, an increasing proportion of the  
dialysis patients are elderly. In diabetics [43], in patients with congestive heart failure [44,45], 
and the elderly [46,47] cardiopulmonary and pressoreflex function are often impaired, leading 
to inadequate vasoconstriction and cardiac contractility. Renal failure per se could also lead to 
autonomic insufficiency due to accumulation of metabolic waste products [48-51]. Impaired 
vasoconstriction could directly affect plasma volume preservation by a change in  hydraulic 
pressure (p) the total surface area (Lp) in Starling’s formula. However, in most studies, a 
causal relation between a diminished baroreceptor function and dialysis related hypotension 
could not be shown [52-55]. 
 
Systolic and diastolic left ventricular function  
The volume and pressure overload caused by overhydration, anemia and arterio-venous 
shunts lead to arterial stiffness and left ventricular hypertrophy. Both will affect the 
cardiovascular response during hypovolemia [56-59]. Structural abnormalities of the cardiac 
wall such as left ventricular hypertrophy or coronary ischaemia could lead to impaired cardiac 
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relaxation, which in turn results in a reduction of the compliance of the left ventricle (diastolic 
dysfunction) [60-61]. In clinical studies it has been shown that dialysis patients with an 
impaired left ventricular relaxation are particularly sensitive to hemodialysis induced 
hypotension [62]. ACE inhibitors or calcium antagonists may improve diastolic function in 
the long term, but these drugs may also induce hypotension. The most important strategy 
remains the prevention of left ventricular hypertrophy through timely and adequate treatment 
of hypertension, anemia and overhydration in the pre-dialysis phase. 
 
1.5  Dialysis related factors affecting the blood pressure response to hemodialysis  
Ultrafiltration 
The total ultrafiltration volume required during a dialysis treatment is determined by the 
patient’s interdialytic weight gain, which is related to the interdialytic sodium intake. High 
ultrafiltration rates will exceed the plasma refilling capacity [63-66]. Hypotensive episodes 
during dialysis are generally treated by stopping ultrafiltration and/or administering 
intravenous fluids. However, this will lead to a less than adequate treatment with 
overhydration and consequently cardiac failure. Cardiovascular morbidity is the major cause 
of death in dialysis patients [67-68]. The problem of sustained fluid overload can be solved by 
increasing treatment time, but this increases the infringement on the normal lifestyle of the 
patient, as generally three sessions a week are needed with a total treatment time of 12 to 15 
hours. Frequent nocturnal dialysis could improve the tolerability of frequent fluid removal. 
 
Dialysate sodium concentration 
Lower dialysate sodium concentrations are associated with an increased incidence of 
hypotensive periods as compared to higher sodium concentrations [69-71]. This could be 
explained by the fact that high dialysate sodium concentrations increase plasma osmolarity. 
The increased plasma osmolarity improves plasma refilling, by inducing an osmotic fluid shift 
(change in ) from the intracellular to the extracellular space [71-75]. The extent to which 
plasma volume changes at a given dialysate sodium concentration depends on the trans-
membrane sodium gradient, which is also determined by the plasma sodium concentration 
and the plasma concentration of anionic proteins (Donnan effect). [76,77]. On the other hand, 
the effect of a positive sodium gradient on hemodynamic stability could also be due to a direct 
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effect of sodium on vascular resistance [78]. Moreover, it is reported that dialysate sodium 
could increase stroke volume without any effect on total blood volume [79].  
However, a positive sodium gradient increases sodium load and thereby thirst and increased 
inter dialytic weight gain. This results in fluid overload and consequently left ventricular 
hypertrophy [80]. A positive sodium gradient can therefore be applied during a limited time 
only. Moreover, in order to avoid a positive sodium balance, a low dialysate sodium 
concentration must be applied at other phases of the dialysis session.  
 
Diffusive dialysis  
It has been shown by Bergström that ultrafiltration is better tolerated when dialysis is not 
performed simultaneously [81-83]. Several mechanisms could explain the improved 
hemodynamic stability during isolated ultrafiltration, such as an increased refilling, improved 
cardiac function and increased vasoconstriction. During diffusive dialysis, the decrease in 
plasma osmolarity, due to the removal of accumulated solutes, such as urea, influences the 
intercompartmental fluid shifts and could delay refilling. However, urea rapidly equilibrates 
between the intracellular and extracellular compartments and some studies failed to observe 
significant differences in plasma volume preservation between ultrafiltration and 
ultrafiltration combined with hemodialysis [84-85]. Diffusive dialysis could worsen 
hemodynamic stability in hypovolemic state, as a result of a diminished ability to increase 
vascular tone. A change in calcium concentration due to calcium shifts could impair either 
myocardial contraction and relaxation [86]. Hypokalemia may also impair protective 
circulatory reflexes needed to avoid hypotension [87]. Moreover, diffusive dialysis impairs 
the ability to increase vascular tone by an increase in body temperature.  
 
Regional blood flow  
Regional blood flow affects both the distribution of blood between pooled and active blood 
volumes and plasma refilling. The two vascular beds that are of particular importance in the 
regulation of the active blood volume are the splanchnic and cutaneous circulation [88]. 
During ultrafiltration, the perfusion of these vascular beds is decreased by sympathical 
vasoconstriction. This maintains blood pressure, either directly or through the de Jager Krogh 
phenomenon. When having a meal, blood is pooled in the splanchnic vascular bed, and active 
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blood volume is consequently decreased [89]. For that reason, ingestion of food should be 
avoided during dialysis in patients prone to hypotension.  
Blood pressure can be stabilized by cold dialysate, as this induced cutaneous vasoconstriction 
and blood is pooled from the cutaneous to the central active blood volume [90-94]. Therefore, 
an active control of body temperature can significantly improve intradialytic tolerance in 
hypotension prone patients [95]. 
A change in regional blood flow during dialysis may also affect vascular refilling by a change 
in both Lp and p in Starling’s formula. Peripheral pooling could decrease vascular refilling, 
which could contribute to the pathogenesis of hypotension during hemodialysis.  
 
Vasodilators 
During dialysis, vasodilatory substances could be released as a result of the interaction of 
blood with the membrane of the artificial kidney [96]. During these interactions complement 
activation takes place resulting in production of interleukin-1 and tumor necrosis factor in 
monocytes [97-101]. These cytokines stimulate the NO synthesis from l-arginine [102,103]. 
NO produces cyclic guanosine 3’5’ monophosphate (cGMP) in smooth muscle cells, which 
results in relaxation. Moreover, Endothelin-1, which has a potent vasoconstriction action, is 
decreased by NO [104]. L-arginine and NO synthesis are higher in uremic patients [105]. 
Increased NO production also directly decreases sympathetic tone [106]. However, there is no 
evidence that, with the exception of anaphylactic reactions, blood pressure is affected by the 
type of dialyzer used [98]. Apart from the direct effects of Nitric Oxide on blood pressure, the 
impaired vasoconstriction could also affect plasma volume by a change in hydraulic pressure 
and the total capillary surface area. 
 
1.6  Strategies to improve blood pressure stability during hemodialysis 
The absolute change in blood volume depends on the amount of ultrafiltration and the 
compensatory plasma refilling. Relative changes in total blood volume can be estimated from 
changes in hematocrit or total plasma protein concentration measurements, which can be 
measured continuously during hemodialysis [107,108]. 
Monitoring relative blood volume during hemodialysis and discontinuing ultrafiltration when 
a critical level of relative blood volume reduction is reached, has been advocated in order to 
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improve hemodynamic stability during dialysis [109,110]. In order to prevent hypotensive 
episodes, the reduction in blood volume during dialysis to critical levels can be prevented by 
deliberately changing the dialysate sodium concentration in order to combine an efficient 
ultrafiltration with a balanced sodium handling [111-118].  
Blood returning from the extracorporeal circuit to the patient is cooled by the ambient 
temperature. This cooling of the blood is prevented by the contact of blood with heated 
dialysate [119,120]. The cooling effect of the extracorporeal circulation on blood temperature 
during isolated ultrafiltration could prevent cutaneous vasodilatation. Cooling of blood could 
also increase systolic left ventricular function [121]. Differences in hemodynamic stability 
between combined ultrafiltration/dialysis and isolated ultrafiltration disappear when treatment 
modalities are matched for the extracorporeal energy transfer, suggesting that this is the most 
important factor for the divergent vascular response [122,123]. 
 
Current limitations of blood volume modeling 
At present, blood volume modeling lacks an adequate basis for several reasons.  An absolute 
and objectively critical level of Relative Blood Volume at which hypotension occurs does not 
exist. Any change in patients serum osmolarity, protein concentrations or hydration status can 
modify the critical level. Each patient should therefore be studied several times in order to 
assess his or her own critical threshold. Moreover, the critical level of Relative Blood Volume 
depends on the cardiovascular status of the patient. During blood volume modeling an 
increase in relative blood volume does not prevent dialysis related hypotension when it does 
not result in an increase of the central active blood volume. An increase in relative blood 
volume during blood volume modeling could be induced by sodium profiling, and this would 
prevent the relative blood volume to reach the critical level at which hypotension occurs. 
However, the increase in relative blood volume by sodium profiling is relatively small as 
compared to the decrease in blood volume by ultrafiltration [124,125]. Alternatively, the 
effect of sodium profiling on hemodynamic stability could also result from an improved 
cardiovascular response. Thus, sodium profiling could lower the critical blood volume level, 
rather than increasing relative blood volume. Also other factors during dialysis could induce a 
change in critical blood level, such as temperature and changes in splanchnic blood 
sequestration following meals [95-101]. Therefore, for adequate blood volume modeling, it 
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must be known in what way these factors affect both blood volume and the critical level of 
relative blood volume at which hypotension occurs. Changes in vascular resistance could also 
alter the whole body filtration coefficient, as well as the hydrostatic capillary pressure. The 
direct relation between vasoconstriction and plasma refilling has previously received little 
attention. 
 
1.7 Aim of the thesis 
The blood pressure response during dialysis depends on blood volume preservation and/on 
changes in vascular tone. However, these two are not independent. In order to delineate the 
role of blood volume profiling in the prevention of intradialytic hypotension, more 
information is needed on the relationship between these physiological defense mechanisms. 
Therefore, we performed several studies to clarify this relationship and to improve the 
understanding of dialysis related hypotension. Such understanding is desperately needed 
before preventive measures can be initiated. 
 
In Chapter 2, a mathematical model is constructed that simulates the intercompartmental fluid 
shifts during combined hemodialysis, diffusive hemodialysis, and isolated ultrafiltration. The 
relative theoretical effect of hydration status, dialysate sodium concentration, initial plasma 
concentrations of sodium and urea, and the tissue permeation capacity (change in regional 
blood flow) on changes in relative blood volume are analyzed.  
 
In Chapter 3, the reproducibility of the measurement of relative blood volume during standard 
hemodialysis sessions, with a standard dialysate sodium concentration, and in which the 
decrease in relative blood volume was corrected for the amount of ultrafiltration volume, is 
analyzed. This study is unique in its setting, as both intra- and inter-individual differences are 
studied. As it is essential for blood volume modeling that the critical level of reduction in 
relative blood volume can be predicted in individual cases, the relationship between the 
occurrence of  hypotension and the decrease in relative blood volume is studied.  
 
In Chapter 4, the change in relative blood volume during diffusive dialysis without 
ultrafiltration is analyzed and compared with the predictions from the mathematical model. It 
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is unclear whether the negative effect of diffusive dialysis on hemodynamic stability results 
from reduced blood volume preservation or from reduced vascular reactivity. The 
mathematical model does not account for a decrease in vascular tone during diffusive dialysis.  
 
In Chapter 5, the effect of isotonic saline (0.9 %), isotonic glucose (5%), hypertonic saline 
(3%), mannitol (20%) and glucose (20%) on relative blood volume are compared. The effect 
of changes in osmolarity on hemodynamic stability could be related to an effect on vascular 
refilling and/or changes in cardiovascular reactivity.  
 
In Chapter 6, the pathophysiology of hemodialysis related hypotension is studied. 
Hypotension can be due to dialysis-related factors such as changes in osmolarity and diffusive 
dialysis, but also to patient related factors such as diastolic and autonomic dysfunction. In 
order to distinguish between dialysis related and patient related factors hypotensive dialysis 
sessions are compared with Lower Body Negative Pressure experiments.  
 
In Chapter 7, we study the relationship between changes total peripheral resistance, and 
relative blood volume following pharmacological intervention. Some studies indicate that, 
vasoconstriction can increase relative blood volume, whereas other studies suggest a decrease 
in plasma volume during vasoconstriction. 
 
In Chapter 8, we attempt to answer the question why some patients are hypotension prone in 
hypovolemic state and why others are hypotension resistant. In order to study the isolated 
effect of a reduction in cardiac filling, we compared the hemodynamic response to Lower 
Body Negative Pressure (LBNP) in hypotensive prone and hypotensive resistant patients.  
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Abstract 
Hypotension is the most frequent complication during hemodialysis. An important cause of 
hypotension is the decrease in the intravascular volume. In addition, a decrease in plasma  
osmolarity may be a contributing factor. Modeling of sodium and ultrafiltration (UF) may 
help in the understanding of underlying relationships. We therefore simulated in a 
mathematical model the intercompartmental fluid shifts during standard hemodialysis (SHD), 
diffusive hemodialysis (DHD), and isolated ultrafiltration (IU). We analyzed the relative 
theoretical effect of hydration status, dialysate sodium concentration, the initial plasma 
concentrations of sodium and urea, and the tissue permeation to solutes on the magnitude and 
direction of intracellular and intravascular volume changes. 
This theoretical analysis show that the transcellular fluid shifts taking place during 
hemodialysis treatment are for a great part due to an inhomogeneous distribution of regional 
blood flow and tissue fluid volumes. During hemodialysis treatment, the cellular fluid shift in 
tissue group with a relative high perfusion of blood and a small volume fraction occurs from 
the intra- to the extracellular spaces. However, the fluid shift in the tissue group with a 
relative low perfusion of blood and a great volume fraction takes place in the opposite 
direction. The UF volume and rates, and the size of sodium (Na+) gradient between the 
dialysate and blood side of the dialyzer membrane are the most important factors influencing 
the fluid shifts. Higher UF volumes and flow rates cause an increasing decline in the plasma 
volume in both SHD and IU. High dialysate sodium concentration (150 mEq L-1) helps 
plasma refilling slightly when compared with a normal dialysate sodium concentration (140 
mEq L-1). However, a high dialysate sodium concentration is associated with a high plasma 
sodium rebound, which in turn lead to interdialytic water intake resulting from thirst and may 
cause increased weight gain and hypertension. 
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Introduction  
The most frequent complication of hemodialysis is hypotension [1]. An important cause of 
hypotension is the decrease in intravascular volume resulting from ultrafiltration (UF). 
Moreover, the changes in plasma osmolarity induced by dialysis may result in 
intercompartmental fluid shifts [2-5]. Mathematical models were proposed to predict such 
volume changes by considering a 2-pool kinetic of water, urea and sodium [6-8]. More 
comprehensive mathematical models, including a 3-pool water kinetic have also been 
proposed [9-11]. These models, which differ from each other in assumptions and parametric 
details, have led the to conclusion that the transcellular fluid shifts caused by a rapid fall in 
the plasma osmolarity are relatively small and not significant as compared with the 
transcapillary volume shifts caused by ultrafiltration. In contrast, others [12,13] have 
suggested that, even with low or moderate UF, dialysis might cause severe hypovolemia by 
inducing a significant water shift from the plasma volume toward the intracellular space. 
We simulated the intercompartmental fluid shifts during standard hemodialysis (SHD), 
diffusive hemodialysis (DHD) without ultrafiltration, and during isolated ultrafiltration (IU). 
Furthermore the relative importance of ultrafiltration volume (and flow rate), dialysate Na+ 
concentration, the initial plasma concentrations of Na+ and urea, and the tissue permeation 
capacity were determined. 
Our mathematical model is based on the concept of regional blood flow [14], in which the 
body tissues have been categorized according to their fractions of fluid volume and blood 
perfusion. The tissue group (internal organs) with a relative small volume and high blood 
perfusion is called as the high flow system (HFS). The tissue group (skin, muscle, etc.) with a 
relative great volume and low blood perfusion is called as the low flow system (LFS) [14]. In 
each tissue group, a 2-pool model of both urea and non-urea (Na+, K+, and their 
accompanying anions) kinetics is combined with a 3-pool model of water kinetic. This model 
differs from previous classical models in that the classical two-compartment model of solute 
kinetic has been combined with the model of regional blood flow [14,15]. The effect of 
cardiopulmonary and blood access re-circulation on the dialyzer clearance has been taken into 
account.  The present model is suitable for profiled hemodialysis.  
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Mathematical Model 
Model description and assumptions 
The model incorporates differential equations describing solute and water kinetics as a 
function of time (t) during hemodialysis. All symbols and units are summarized in the 
Appendix. The model equations and the initial values of variables are based on the following 
assumptions: 
1. The initial volume fraction of HFS tissue group (fvH) equals 20% of the total body water. 
The volume fraction of LFS tissue group equals 1-fvH. The volume fraction equals the 
ratio of tissue volume to that of total body water. The HFS blood perfusion fraction (fqH) 
equals 80% of the systemic arterial blood, whereas the LFS tissue group equals 1-fqH 
[14,15]. The perfusion fraction equals the ratio of flow rate of arterial blood, that enters 
the HFS tissue group, to that of the systemic arterial blood (minus the flow of blood 
entering the arterial blood access). 
2. During hemodialysis with or without ultrafiltration, solute mass and excess water are 
removed from circulating arterial blood; e.g., blood is accessed through an arterio-venous 
device (fistula). At a flow rate of 0.3 L min-1, the access re-circulation ratio equals 
approximately 3% of the blood flow entering the dialyzer. However, the access re-
circulation depends on the flow rate of blood entering the dialyzer and the functionality of 
the access device.  
3. The solute concentrations in arterial blood entering the tissue groups and blood access are 
equal. Urea, Na+, K+ and other unspecified non-urea blood enter the extracellular space 
directly. The solute mass transfer from tissue EC space to the circulating venous blood 
takes place by convection and diffusion. The tissue permeation coefficient (product of 
permeability and surface area) is constant during the whole dialysis session. However, it is 
likely that the tissue permeation alters during hemodialysis sessions. 
4. Within each tissue group, the solute exchange through the capillary wall is neglected 
because of rapid diffusive exchange of small substances and high permeability of the 
capillary wall [10]. Consequently, small solutes are evenly distributed over both the 
interstitial and plasma spaces. One exception is that for charged substances the interstitial 
concentration is corrected for the Gibbs-Donnan effect. On calculating the solute 
concentrations in plasma water, the plasma water concentrations of both Na+ and K+ 
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become very close to those in interstitial space. This is a result of the fact that the ratio of 
Donnan factor to the free water fraction is very close to1. The only barrier to solute mass 
exchange within each tissue group is the cell membrane. Therefore, the solute kinetic 
within each tissue group is described by means of a 2-pool compartment model [11]. 
5. The changes in osmolarity are based on the transcellular exchange and removal rates of 
water, urea, Na+, K+ and unspecified osmotically active solutes. For modeling, all 
unspecified solutes are lumped together as a single solute. K+, Na+, their accompanying 
anions (Cl-) and other unspecified substances (such as Mg2+, PO4-) are called non-urea. 
6. Transvascular water exchanges according to the Starling forces. The hydraulic 
permeability and the compliance of intra- and extravascular spaces are constant 
parameters. However, it is likely that they might vary with the hydration status of the 
patient. They may also depend on  vasoconstriction or vasodilatation. Transvascular 
protein mass exchange is neglected; e.g., the plasma together with interstitial space forms 
one single compartment for indiffusable proteins. Proteins, which enter to the interstitium 
by capillary filtration, return to the venous blood through the lymphatic circulation.  
7. Initial hematocrit (Ht) in both tissue group is equal. The water volume of red blood cells 
(RBC) varies only because of the volume change of intracellular space. This is a 
consequence of 2-pool compartment model [10]. 
8. The relative change in the plasma volume represents the relative change in both the 
arterial and venous plasma volumes. The ratio of the arterial to the venous plasma volume 
is 1:4 [16]. The initial ratio of IC to EC volumes is 5:3 [16] and the initial plasma volume 
is 24% of the initial EC volume [17]. The initial value of total body water is 58% of the 
sum of patients dry weight and the weight gain [16,17]. These assumptions are true for 
non-overhydrated patients only. 
9. The residual renal function is considered negligible. 
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Solute Kinetics 
Intracellular solute kinetics 
Whole body intracellular mass (Mi,j) of solute j consists of the sum of solute masses in each 
tissue groups intracellular spaces. The mass transfer rates of intracellular substances of both 
tissue groups (Jti,j) are equal to the sum of mass transfer rate by diffusion and convection: 
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Here, the tissue groups are distinguished by the superscript t that refers to H representing the 
HFS-tissue group or to L representing the LFS-tissue group. The subscripts i and j represent 
respectively the intracellular space and the solute standing for Na (sodium), K (potassium), u 
(urea), X (other unspecified solutes) or n (non-urea). The first term on the right-hand side of 
Equation 1 stands for the mass transfer rate by convection from the IC to the EC space, and 
the second term for the diffusive mass transfer rate. Convective transport takes place by 
solvent drag with a volume flow rate (Qti), which equals the exchange rate of intracellular 
fluid volume. Solute sieving (j) determines the rate of convective mass transport. We 
consider the sieving coefficient for urea (u) to be one and those for K+, Na+ and other 
unspecified substances to be zero. The diffusive mass transfer rate across the cell membrane is 
equal to the product of the diffusive mass exchange coefficient (Dj) and the concentration 
gradient between both spaces. The whole body cellular mass exchange coefficient represents 
the product of diffusive permeability and the whole body cell surface area. The whole body 
mass transfer coefficients of urea, Na+ and K+ are 0.8 L min-1 [8], 1.5 L min-1 and 4.02x10-3 L 
min-1, [11] respectively. The solute concentration in extracellular space (Ce,j) is corrected by a 
factor (Fw) as a result of the time-dependent change in the free water fraction of blood plasma 
during hemodialysis, and by a factor (Zj) representing the solute distribution coefficient at 
equilibrium between IC and EC spaces. Both passive electro-diffusive and active transport via 
ATP-ase pumps affect the dynamic of Na+ and K+ transport through cellular membrane. 
Because Na+ is actively transported from IC to the EC space, the equilibrium distribution 
coefficient ZNa (= 0.0713) is less than 1. For K+ the coefficient ZK (= 28.2) is greater than one 
because K+ is counter transported from EC into the IC space. In contrast, the IC urea depends 
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upon the passive transport by diffusion and convection and it is not affected by active 
transport. At equilibrium, the IC urea concentration equals the EC urea concentration. 
Therefore, the urea distribution coefficient (Zu) equals 1. 
 
Extracellular solute kinetics 
Whole body mass (Me,j) of solute j in EC space consists of the sum of solute masses in each 
tissue group’s  EC space. The solute concentration (Cte,j) in EC volume (Vte) is considered to 
be distributed in blood plasma, in red blood cells, and in tissue interstitial spaces. The 
interstitial solute concentration differs slightly from that in blood plasma (Ctp,j) because of the 
Gibbs-Donnan ratio between plasma and interstitium, which is assumed 0.95 for Na+, K+, and 
1.0 for urea and for other unspecified substance [11]. For the sake of simplicity, the RBC 
concentration gradients of Na+, K+, urea, and other unspecified substances are considered 0. 
Consequently, the EC solute mass is taken as the solute mass in blood plasma plus that in the 
interstitium. During hemodialysis, the mass transfer rates of substances in the EC spaces (Jte,j) 
of both tissue groups vary according to the following relationship: 
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The first term on the right-hand side of Equation 2 represents the IC mass transfer (Jti,j), the 
second term represents the mass transfer rate of solute from tissues’ extracellular space to the 
venous blood (Jtav,j), and the third term is the rate of the generation or intake (Gj). In this 
simulation work, we stipulate that urea is produced in the liver and directly enters the EC 
space (the whole body Gu = 0.083 mmol min-1 [8]. Also is considered that neither sodium nor 
potassium is taken (enteral or parenteral) in the EC space (GNa=GK=0 mEq min-1). The 
following relationship gives the mass transfer rate of solute from tissue extracellular space to 
the venous blood: 
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Equation 3 expresses the rate of solute mass gain in venous blood from the tissues EC spaces. 
The flow rate (Qtv) of blood leaving the tissue group equals the blood flow rate (Qta) entering 
the tissue group increased by the ultrafiltration flow rate (Qf): 
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The flow rate of systemic arterial blood (Qa) equals the cardiac output (CO) minus the flow 
rate of blood entering the blood access (QaAC). The solute concentration in blood leaving the 
tissue group (Ctv,j) is assumed to relate to the tissue EC solute concentration (Cte,j) according 
to the following relationship [14]: 
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In Equation 5, the term mtj represents the coefficient of concentration equilibration between 
arterial and venous sides of tissue bed. The mtj depends upon the Péclet number, which is the 
ratio of the tissue permeation coefficient (PSj) to the flow rate of blood (Qtv) leaving the tissue 
bed. PS stands for the product of permeability and tissue surface area. Solute transport from 
tissue bed to the venous blood is flow limited if the mtj equals 1.0. The solute concentration in 
arterial blood (Ca,j) follows from the overall mass balance: 
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with QvAC and CvAC denoting respectively the flow rate of and the solute concentration in 
blood that returns to the venous limb. 
 
Solute kinetics in blood access and dialyzer 
Solute mass in blood entering the arterio-venous access exchanges through the dialyzer 
membrane with the solute mass in the dialysate compartment. The rate of mass transfer 
between arterial and venous limbs of the blood access device equals the rate of solute mass 
 38
Mathematthical  Study of Blood  Volume Changes during  Hemodialysis  
 
exchange (Jdial,j) through the dialyzer membrane, which occurs by combined diffusion and 
convection [7]: 
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The second term on the right-hand side of Equation 7 stands for the mass transfer rate by 
convection combined with diffusion, in which Qwi,j denotes the flow rate of blood water 
entering the dialyzer. The solute concentration in blood entering the dialyzer is corrected for 
the Gibbs-Donnan ratio (RD,j) for charged solutes between the blood and dialysate sides of the 
dialyzer membrane, for the time-dependent change in the free water fraction of blood plasma 
(Fw), and for the cardiopulmonary re-circulation (kjCP). The first term on the right-hand side 
(Jdif,j) represents the rate of mass transfer through the dialyzer membrane by diffusion without 
ultrafiltration (Qf = 0) as: 
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with CLj the solute dialysance by diffusion and Cd, j the solute concentration in the dialysate 
fluid entering the dialysate compartment of the dialyzer. 
 
Water Kinetics 
During hemodialysis with ultrafiltration, the EC fluid volume of both tissue groups changes 
because of isotonic volume loss (Vtuf) by ultrafiltration (UF) and the transcellular fluid shifts: 
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The second term on the right-hand side of Equation 9 stands for the exchange rate of the 
intracellular volume (Qti) and the first term for the ultrafiltration flow rate (Qf): 
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The rate of change in the EC volume equals also the sum of rate of change in interstitial 
volume (Vtis), in water volume of RBC (Vtrc), and in plasma volume (Vtp): 
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The first term on the right-hand side of Equation 11, representing the rate of change in the 
plasma volume, depends upon both the rate of volume gain (Vtpr) from interstitial space and 
the rate of volume loss by ultrafiltration: 
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The second term on the right-hand side of Equation 11, representing the rate of change in the 
water volume of RBC, varies as a result of the change in the intracellular volume [10]: 
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Vi(0) and Vrc(0) stand, respectively, for the initial IC volume and the initial water volume of 
red blood cells. The initial water volume of RBC is related to the initial plasma volume, 
Vp(0), and the initial arterial hematocrit, Ht(0): 
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According to Equation 12, during dialysis with ultrafiltration the decline in plasma volume 
resulting from the volume loss by ultrafiltration is partially compensated for by the volume 
gain from the interstitial space. 
  
Transcellular fluid shifts 
The volume of fluid entering or leaving the IC compartment is referred to as the transcellular 
fluid shift. The rate of change (Qti) in the intracellular volume (Vti), which equals the rate at 
which the transcellular fluid shift takes place, is taken to be proportional to the net osmotic 
pressure gradient between both EC and IC spaces: 
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where, kc (= 19.66x10-5 L mmHg-1 min-1 [8]) is the whole body cellular water exchange 
coefficient, R (= 62.364x10-3 L mmHg K-1 mmol-1) is the gas constant, T (= 310 K) is the 
temperature. Osmt stands for the net osmolality difference due to the difference between the 
osmolality of urea (Osmu) and that of non-urea (Osmn) on both sides of the cell membrane: 
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The intra- and extracellular osmolality difference of urea is due to the difference between the 
IC urea (Cti,u) and EC urea (Cte,u) concentration: 
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with  (=0.95) [8] representing the cellular urea reflection coefficient. In fact, urea causes no 
osmolality difference at equilibrium. Depending on the removal rate of other osmotically 
effective substances from EC spaces, there may be regional differences in the urea gradients 
between IC and EC spaces. The intra- and extracellular osmolality difference of non-urea is 
due to the non-urea concentration difference between the IC (Cti,n) and EC (Cte,n) spaces: 
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where  (=1.846) [8] is the factor (osmotic coefficient) that converts the molar concentration 
(free plus bound) of non-urea into its osmotically equivalent osmolar concentration 
(osmolality). For the sake of simplicity, the osmotic coefficients of Na+, K+ and other 
unspecified non-urea solutes are taken to be equal. The molar concentration of urea is the 
same (=1) as the osmolar concentration because it is uncharged. The EC non-urea is 
considered to be Na+ (Ce,Na), K+ (Ce,K) and other unspecified electrolytes X (Ce,X). The IC 
non-urea is considered to be K+ (Ci,K), Na+ (Ci,Na) and other unspecified electrolytes X (Ci,X). 
At equilibrium, the osmolality on both side of the cell membrane is the same, and therefore 
there is no fluid exchange between intra- and extracellular spaces. 
 
Transvascular fluid shifts 
The volume (Vtpr) of fluid exchanging between plasma and interstitial spaces is referred to as 
the transvascular fluid shift. The net rate (Qtpr) at which the transvascular fluid exchange takes 
place depends on the rate of water filtration (Qtwf) at the capillary end and the water 
reabsorption  (Qtwr) at the venous capillary end: 
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Qtpr is known as the plasma-refilling rate (PRR) when the shift takes place from interstitial to 
the plasma space. According to Starling concept, water filtration rate from the arterial 
capillaries into the interstitial space is due to the transcapillary hydraulic and oncotic pressure 
gradients: 
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with Lf (=6x10-4 L mmHg-1 min-1) [9] representing the whole body hydraulic permeability 
coefficient of the arterial capillary wall, Pta the hydraulic pressure in the arterial capillaries, 
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Ptis the hydraulic pressure in the interstitial space. The hydraulic pressure in the capillary end 
varies due to changes in the plasma volume (Vtp): 
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where Pa(0) (= 35 mmHg) is the Pa at the start (at t=0) of hemodialysis treatment, Vp(0) the 
initial Vp, and a (=0.012×venous compliance) [18] is the arterial compliance. The interstitial 
hydraulic pressure varies due to the change in the interstitial fluid volume: 
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with Pis(0) (=1 mmHg) is the initial Pis, Vis(0) the initial Vis, and is (=0.10 per unit interstitial 
hydraulic pressure) [9] the interstitial volume compliance. The oncotic pressures (p) and 
(is) in Equation 20, exerted respectively by the plasma and interstitial proteins, can be 
estimated from the following empirical relationships [19]: 
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in which the plasma (Ctp) and interstitial (Ctis) protein concentrations in gram per liters are 
determined from the protein mass balance between plasma and interstitial space.  The water 
reabsorption rate depends on the hydraulic permeability coefficient (Lr =3.7x10-3 L mmHg-1 
min-1) [9] of the venous capillary wall and on the net pressure gradient across the venous 
capillary wall: 
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The hydraulic pressure in the venous plasma space (Pv) varies due to the change in the plasma 
volume: 
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in which Pv(0) (=15 mmHg) is the initial hydraulic pressure in the venous plasma, and v 
(=0.15 per unit hydraulic pressure) [9] is the venous compliance. 
 
Methods 
Predicting the diffusive clearance of K+, Na+ and urea 
The urea dialysance equals the urea clearance since the urea concentration at the dialyzer inlet 
of the dialyzer is considered to be zero. However, both Na+ and K+ dialysance depends on 
their dialysate concentrations. In hemodialysis without UF the dialyzer solute clearance (CLj) 
can be estimated from the following equation [20]: 
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with KSj the overall (diffusive) permeability coefficient of solute j, which is the total 
membrane surface area times the diffusive mass transfer coefficient of the dialyzer, and Qdi 
the dialysate inlet flow rate that is assumed to be constant during hemodialysis. The overall 
permeability coefficient (KSj) of solute j is related to the permeability coefficient of urea 
(KSu) and that of creatinine (KSc) [21]: 
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with MWj the molecular weight (23 D for Na+, and 39.1 D for K+) and MWc the molecular 
weight of creatinine (113 D). The ratio of KSu to KSc has been experimentally proven to be 
1.32 [21]. The relationship given in Equation 28 might also be used to estimate the tissue 
permeation coefficient (PSj) in Equation 5 for Na+, K+ and other unspecified solutes when the 
tissue permeation for urea (PSu = 28 L min-1) is known. 
 
Cardiopulmonary and access re-circulation 
The correction factor for cardiopulmonary re-circulation follows from the following 
relationship[14]: 
 
)()(
)(
)(
tCLtkQ
tQQ
tk
j
AC
ja
faCP
j 
         (29) 
 
where kjAC is the correction factor for the solute clearance due to the AV- access recirculation 
flow rate (QR,jAC) as given by the following expression [14]: 
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The access re-circulation flow is corrected for the blood water fraction. We consider that it is 
equal for all solutes during hemodialysis. 
 
Blood water flow rate 
The blood water flow rate (at the blood inlet) (Qwi j) differs from the blood flow rate entering 
the dialyzer (Qbi) because of the time dependent changes in arterial hematocrit (Ht) and in 
arterial plasma protein concentration (Cp) [22]: 
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where 1-Cp(0) is the initial free water fraction of blood plasma with  = 0.00107 Lg-1 
representing a factor to calculate the protocrit from the plasma protein concentration, fj is the 
fractional volume distribution of solute j in blood cells (fu = 0.8 for urea and fNa = fK = 0 for 
sodium and potassium [22]. The first term on the right-hand side of Equation 31 represents 
the plasma water flow rate and the second term the flow rate of water in red blood cells. The 
correction factor (Fw) is the free water fraction of blood during hemodialysis with respect to 
the initial water fraction: 
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At the start of hemodialysis, where the water fraction of blood with a plasma protein 
concentration of Cp(0) = 70 g L-1 equals 0.925, the correction factor equals 1.0. The arterial 
hematocrit (Ht) varies in time according to the following relationship: 
 





t
t
b
t
t
p
t
t
b
t
t
rc
tV
tV
 
tV
tV
 Ht(t)
)(
)(
1
)(
)(
       (33) 
 
where the blood volume (Vb) equals the sum of plasma volume (Vp) and the volume of red 
blood cells (Vrc). 
 
The Gibbs-Donnan ratio 
The Gibbs-Donnan ratio (RD,j) between the blood and dialysate compartments of the dialyzer 
equals 1 for urea (because it is uncharged) and approximately 0.942 for Na+ and K+ [7,8], but 
also varies due to changes in the plasma protein concentration (Cp) [23]: 
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where the protein concentration at the dialyzer blood outlet (Cpo) differs from that at the blood 
inlet (Cp = Cpi) when UF takes place: 
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Without ultrafiltration (and pre-dilution), the arterial hematocrit and plasma protein 
concentration in blood leaving the dialyzer equal the hematocrit and plasma protein 
concentration in blood entering the dialyzer. 
 
Initial solute composition of extra- and intracellular spaces 
The whole body initial concentrations of the IC Na+, K+ and urea are calculated from their 
initial plasma concentrations (Cp, Na(0) = 140 mEq L-1, Cp, K(0) = 5 mEq L-1 and Cp, u(0) = 30 
mmol L-1 respectively): 
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The initial non-urea plasma osmolarity (Osmp, n) is considered mainly due to plasma Na+ (Cp, 
Na) and to a minor extend due to plasma K+ (Cp, K) and other unspecified substances (Cp, X): 
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The initial EC non-urea osmolarity equals the initial non-urea plasma osmolarity divided by 
the free water fraction: 
 
 47
Chapter 2  
)0(1
)0(
)]0()0()0([ ,,,
p
n  p,
XeKeNae C 
OsmCCC        (40) 
 
Because the normal initial plasma osmolarity due to osmotically active non-urea, which is 
considered to be 285 mosmol L-1, and the initial plasma Na+ and K+ concentrations are given, 
the unspecified EC non-urea concentration can be calculated as: 
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The IC non-urea is considered to be mainly K+ (Ci, K) and to a minor extent Na+ (Ci, Na) and 
other unspecified substances (Ci, X). The initial unspecified IC non-urea concentration can be 
calculated from the following relationship: 
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At equilibrium, the total initial plasma osmolality is equal to 290 mosmol L-1 with a normal 
initial urea concentration of 5 mmol L-1. 
 
Computational methods for solute and protein concentrations 
Calling t a time element on which all variables are considered to be constant, all the first 
order differential equations governing the changes in volumes and solute masses are 
numerically solved in the commercially available spreadsheet MS Excel 97  
For each tissue group, the time-dependent changes in both intracellular mass (Mti, j) and 
extracellular mass (Mte, j) of Na+, K+ and urea are computed from the following difference 
equations: 
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The initial value of Mti, j equals ftvVi(0)Ci, j(0) and that of Mte, j equals ftvVe(0)Ce, j(0). Jti,j and 
Jte,j are given by Equation 1 and Equation 2 respectively. Given the exchange rate of 
intracellular fluid (Qti) as in Equation 15 and the exchange rate of intracellular fluid (Qte) as in 
Equation 9, the time-dependent changes in both intra- and extracellular volumes can be 
computed from the following difference equations: 
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The initial values of Vti and Vte equal ftvVi(0) and ftvVe(0) respectively. The time-dependent 
change in the transcellular fluid shift is calculated as Vti(t)=Vti(0)-Vti(t). The starting value 
of whole body Vi (Ve) is estimated as 5/8 (3/8) times the sum of the total body water and the 
weight gain (excess water volume).  
The total body water volume is estimated as 58% of the dry body weight. The time-dependent 
changes in plasma volume (Vtp) are calculated as the difference between the plasma refilling 
rate (Qtpr) from Equation 19 and the cumulative volume loss (Vtuf) by UF: 
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The initial plasma volume, Vtp(0) = ftvVp(0), is estimated as 24% of the initial EC volume. 
The cumulative volume gain by plasma refilling from the interstitial space and the volume 
loss from the plasma volume by ultrafiltration are computed as follows: 
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The initial values of Vtpr and Vtuf equal zero. At the end of dialysis session (t=Td), Equation 48 
results in the total plasma water volume gain (loss) from (to) the interstitial space. At t=Td, 
Equation 49 results in the total volume loss by ultrafiltration that equals the initially 
determined weight gain (excess water volume). The ultrafiltration flow rate can be profiled as 
desired. In this simulation work, we utilize a constant ultrafiltration flow rate during 
hemodialysis and calculate it by dividing the excess water volume by the duration of dialysis 
session. We calculate the relative time-dependent change in the plasma volume as RVtp (t) = 
[Vtp(t)/Vtp(0)] –1. The time-dependent changes in the water volume of RBC are calculated as: 
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where the initial value of Vtrc(0)=ftvVrc(0), and Qtrc is calculated from Equation 13. The 
interstitial volume is calculated as the EC volume minus the blood volume: 
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On dividing the solute mass by the volume, the intra- and extracellular concentrations of Na+, 
K+ and urea are calculated: 
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The unspecified substances are not removed across the dialyzer membrane. Consequently, 
their time-dependent changes in both intra- and extracellular spaces are due to changes in 
volumes: 
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Total plasma protein and interstitial protein concentrations can be computed as: 
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in which the initial plasma and interstitial protein concentration are considered respectively as 
Cp(0) = 70 g L-1 and Cis(0) = 19.2 g L-1 to obtain a zero plasma refilling rate at t = 0. 
 
 Adequacy of dialysis treatment 
To evaluate the adequacy of hemodialysis sessions we calculate the dialysis dose (Dd), which 
is known as KT/V-value in the literature [24]. An adequate dialysis treatment for urea is 
achieved if the total urea clearance per treatment is higher than the post-dialysis volume of 
urea distribution (Vi+Ve) in patients who have negligible residual renal function. This 
statement is characterized by dialysis dose. We calculate the cumulative dialysis dose during 
hemodialysis by making use of Equation 7: 
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At t=0 the dialysis dose equals zero. At t=Td (the end of dialysis session), Equation 55 results 
in the value of dialysis dose. In general, a dialysis dose of 1.2 to 1.4 achieved at the end of a 
dialysis session lasting Td = 4 hours on a trice weekly basis has been shown to be associated 
with decreased mortality [24]. 
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Results  
Simulations 
We simulated diffusive hemodialysis (DHD) session with zero UF rate (Qf = 0) to correct 
uremia with a dialysis dose of 1.2, isolated ultrafiltration (IU) treatment (CLu = CLNa = CLK = 
0) to correct excess water, and standard hemodialysis (SHD) session to correct uremia with a 
dialysis dose of 1.25 and to withdraw excess water simultaneously.  All simulated sessions, 
each lasting 4 hr, were calculated for an adult of 72 Kg dry-weight with an excess water 
volume of 3.2 L, and with an initial plasma urea concentration of 30 mmol L-1 indicating the 
initial uremic state. The dialysate Na+ and K+ concentrations were 140 and 2 mEq L-1 
respectively. The initial diffusive clearance values of urea, Na+ and K+ were calculated as 
0.225, 0.19 and 0.186 L min-1 respectively from Qbi = 0.3 L min-1, Qdi = 0.5 L min-1 and SKu = 
0.72 L min-1. The tissue permeation coefficients of Na+ and K+ were calculated from that of 
urea (PSu = 28 L min-1) according to Equation 28. The cardiac output and the arterial blood 
access flow rate were 6.3 and 0.8 L min-1 respectively. The access flow recirculation ratio was 
assumed 0.03. The fractions of tissue volume and blood perfusion were fHv = 0.2, fHq = 0.8, 
for HFS, and fLv = 0.8, fLq = 0.2 for the LFS, corresponding to mH = 0.98 and mL = 0.64 for 
urea.  
 
Transcellular fluid shifts 
Figure 1 shows time courses (bold thick lines) of the exchange rates of IC fluid (Qi) and the 
resulting fluid shifts (Vi) in HFS, LFS and HFS+LFS during DHD. Both tissue groups are 
assumed to have equal fractions of volumes (fLv = fHv = 0.5) and equal fractions of blood 
perfusion (fLq = fHq = 0.5), corresponding to mL = mH = 0.92.  During early hours of DHD, the 
sum of transcellular osmolar gradients in both tissue groups due to changes in urea and non-
urea concentrations result in a negative net osmolar gradient (Qi <0). This causes a fluid shift 
from the EC to the IC space. Note that the magnitude of fluid shift equals the area under the 
net Qi-curve. After that an equilibrium state (Qi = 0) is reached, the net osmolar gradients 
become positive (Qi >0) and increase gradually to the end of treatment, causing a decrease in 
the fluid shift from EC to the IC spaces. The osmolar gradients in both tissue groups develop 
equally. 
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Figure 1 
Simulated time changes in the exchange rate of intracellular fluid (Qi) during diffusive hemodialysis, and the 
resultant transcellular fluid shifts (Vi). The HFS and LFS tissue groups have different fractions of volume (fLv = 
0.8, fHv = 0.2) and blood perfusion (fLq = 0.2, fHq = 0.8). The HFS+LFS represents the overall tissue. The bold 
thick lines represent the changes in Qi and Vi when the tissue groups are assumed to have equal fractions of 
volume (fLv = fHv = 0.5) and blood perfusion (fLq = fHq = 0.5).   
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Figure 2 . 
Simulated time courses of Qi during diffusive hemodialysis (DHD), isolated ultrafiltration (IU) and standard 
hemodialysis (SHD), and the resultant fluid shifts (Vi). The HFS and LFS tissue groups have different fractions 
of volume (fLv = 0.8, fHv = 0.2) and blood perfusion (fLq = 0.2, fHq = 0.8). 
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Consequently, the fluid shifts in both tissue groups are equal (0.027 L in HFS, 0.027 L in 
LFS, accounting for an overall fluid shift of 0.054 L). After the end of treatment, the net 
osmolar gradients in both tissue groups tend to disappear, causing the fluid eventually to shift 
out of the cells. Figure 1 (thin lines) shows the time-dependent changes in Qi and Vi during 
DHD in the tissue groups with different fractions of volume and blood perfusion. The 
transcellular fluid in the HFS tissues shifts from IC to the EC space, while that in the LFS 
tissues takes place in the opposite direction. The overall fluid shift at the end of treatment 
accounts for 0.45 L out of the cells (0.77 L out of cells in HFS, and of 0.33 L into cells in 
LFS). This indicates that the transcellular fluid shifts taking place during DHD are, to a great 
part, due to an inhomogeneous distribution of regional blood flow and tissue fluid volumes. 
 
In Figure 2, the net osmolar gradients and the resulting transcellular fluid shifts during IU and 
SHD sessions are compared with those during DHD sessions. The magnitudes of net osmolar 
gradients in HFS during both DHD and SHD sessions are almost equal, indicating that the 
effect of ultrafiltration on the fluid shift in HFS is relatively small. The magnitudes of net 
osmolar gradients in LFS during both IU and DHD sessions are almost equal, indicating that 
the effect of diffusive solute exchange on the fluid shift in LFS is, once again, relatively 
small. The overall fluid shift at the end of session accounts for –0.29 L (-0.63 L in HFS, 0.34 
L in LFS) with IU. Note that Vi<0 indicates a fluid shift from intra- to the extracellular 
space. With SHD, the overall fluid shift is –0.97 L (-0.85 L in HFL, -0.11 L in LFS). 
 
Plasma refilling rate and depletion of plasma volume 
The time courses of the transvascular fluid exchange (Qpr) and the relative changes in the 
plasma volume (RVp) during the modeled sessions of IU, DHD and SHD are depicted in 
Figure 3. Although excess water is withdrawn with constant UF flow rates, the plasma 
volumes of both HFS and LFS tissues groups decrease the fastest within the first hour of UF 
treatment. One half of the total depletion of plasma volumes occurs in this early hour, as the 
response of Starling forces to refill the plasma volume is lacking. After reaching its maximum 
value within the first hour, the Qpr in HFS tissue group decreases slightly during the later 
treatment, leading to a gradual decline of plasma volume.  
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Figure 3 
Simulated time changes in the plasma refilling rate (Qpr) and the relative changes in the plasma volumes (RVp) 
during DHD, IU and SHD. The HFS and LFS tissue groups have different fractions of volume (fLv = 0.8, fHv = 
0.2) and blood perfusion (fLq = 0.2, fHq = 0.8).  
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The Qpr in LFS tissue group reaches its maximum slower than that in the LFS tissue group 
and remains unchanged during the later treatment, leading to a linear decrease in plasma 
volume. The difference between the area (Vuf) under the line representing the UF flow rate 
and the area (Vpr) under the theoretical Qpr-curve corresponds to the depletion of the initial 
plasma volume due to insufficient refilling from the interstitial space. The smaller the 
difference between Vuf and Vpr ,the higher the plasma refilling capacity. The depletion of 
plasma volume in the HFS tissue group accounts for 7% while that in LFS tissue group is 
almost two times more (15.6%). After stopping the treatment, the Qpr decreases and returns to 
0. During this period, the fluid shift from interstitial space causes the plasma volume to 
increase. When the same amount of excess water is withdrawn by performing SHD, the 
degree of depletion of the plasma volume in both tissue groups is slightly smaller (1.7%) than 
with IU, emphasizing the fact that the diffusive solute removal only has a minor influence on 
plasma volume depletion. When dialysis is performed without UF, the plasma volume of the 
HFS tissue group increases up by 7.5% due to the plasma refilling from the interstitial space. 
In contrary, the plasma volume of the LFS tissue group decreases by 1.4% as a result of 
volume loss to the interstitial space. Note that the relative depletion of the overall (total) 
plasma volume is not equal to the linear sum of the relative depletions of plasma volumes of 
both tissue groups. When both tissue groups are assumed to have equal fractions of volume 
and blood perfusion, the time-dependent changes in Qpr in both systems develop equally. 
Consequently, both tissue groups contribute equally to the depletion of the overall plasma 
volume. 
 
Sensitivity Analysis  
We investigated the relative importance of variables such as ultrafiltration flow rate and 
volume, dialysate Na+ concentration, initial plasma Na+ and urea concentrations, and the 
tissue perfusion (PS) on the exchange rate of intracellular fluid (Qi) and the plasma refilling 
rate (Qpr) during SHD, by performing a sensitivity analysis (one variable changes while all 
others are held unchanged). 
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Ultrafiltration flow rate and volume.  
An UF volume equal to the excess water (several liters of fluid) is removed during the course 
of a SHD session or by IU with constant or profiled ultrafiltration flow rates. Figure 4 shows 
the effect of removing the same amount of excess water (2.4 L) with different (constant) 
ultrafiltration rates, and the effect of removing different amount of excess water (2.4 L, 4.8 L) 
within the same duration of SHD (4h) on the transcellular and transvascular fluid shifts during 
SHD. Withdrawal of an excess volume of 2.4 L in a short (Td = 2h) and fast (Qf = 20 mL min-
1) hemodialysis causes a fluid shift of –0.49 L (-0.73 L in HFS, 0.24 L in LFS). The same 
amount of excess water in a long (Td= 4h) and slow (Qf = 10 mL min-1) hemodialysis results 
in a fluid shift of –0.83 L (-0.82 L in HFS, -0.01 L in LFS). It is evident that the shorter the 
session (thus the higher the UF flow rate) the harder the net osmolar gradient develops, and 
consequently the greatest the amount of fluid shift to the EC space. However, due to diffuison 
a higher amount of solute (urea, Na+, K+) is removed in longer than in shorter hemodialysis, 
leading to a greater fluid shift at the end of a longer session than that with a shorter session. 
At the end of session lasting 4 h, the slow UF together with the fluid shift to the EC space 
improves the plasma refilling capacity by 4.7% (6.2% in HFS, 4.4% in LFS). By prolonging 
the duration of treatment session with a high UF flow rate (Qf = 20 mL min-1) 2 hours longer, 
an excess volume of 4.8 L is withdrawn, causing an increased fluid shift to the EC space (–
1.25 L, -0.92 L in HFS, -0.33 L in LFS). Nevertheless, despite this increased fluid shift to the 
EC space, the capacity to refill the plasma volume decreases by 3.6% (2% in HFS, 4% in 
LFS). The response of Starling forces to refill the plasma volume decreases with the 
increasing volume of ultrafiltration. 
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Figure 4 
Simulated time courses of the net Qi (a), the resultant Vi (b), the Qpr (c), and the RVp (d) in the HFS+LFS 
during SHD for three cases of ultrafiltration. 1) An excess water volume of 2.4 L is withdrawn in a short (2 h) 
and rapid (Qf = 20 mL min-1) hemodialysis (bold thick lines). 2) The same volume of excess water (2.4 L) is 
withdrawn in a relative long (4 h) and slow (Qf = 10 mL min-1) hemodialysis. 3) The rapid (Qf = 20 mL min-1) 
hemodialysis is prolonged to 4 h to withdraw an excess water volume of 4.8 L. 
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Dialysate sodium concentration.  
Figure 5 shows the time courses of Qi and Qpr during SHD with different dialysate Na+ 
concentrations and with an initial plasma Na+ concentration of 140 mEq L-1. At the low (120 
mEq L-1) dialysate Na+ concentration, the plasma Na+ concentration at the end of session is 
changed by 3.6% (17.4% in HFS, -0.9% in LFS). The net osmolar gradient reaches an 
equilibrium state almost at the end of the session, causing a fluid shift of 0.82 L (-0.47 L in 
HFS, 1.29 L in LFS). The plasma refilling is 5% (3% in HFS, 5.4% in LFS) less than when a 
dialysate Na+ concentration of 140 mEq L-1 (normal) is used. At the high (150 mEq L-1) 
dialysate Na+ concentration, the overall plasma Na+ concentration at the end of the session of 
SHD is changed by 8.1% (22.7% in HFS, 3.4% in LFS). The net osmolar gradient at the end 
of the session causes a fluid shift of -1.81 L (-1.03 L in HFS, -0.78 L in LFS). Due to the fluid 
shift to the EC space, the plasma refilling is improved by 2.1% (1.3% in HFS, 2.4% in LFS), 
when compared to the normal dialysate Na+ concentration. 
 
 
 
Figure 5 
Simulated time changes in the net Qi (a), the resultant Vi (b), the Qpr (c), and the changes in RVp (d) in the 
HFS+LFS during SHD. Initial plasma Na+ concentration (140 mEq L-1) is fixed and dialysate Na+ concentration 
is varied from 120 mEq L-1 to 150 mEq L-1. 
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Initial plasma sodium concentration 
The changes in Qi and RVp due to different initial plasma Na+ concentrations during SHD 
(with CdNa = 140 mEq L-1) are shown in Figure 6. The initial plasma Na+ concentration was 
varied by 3.6% from 140 mEq L-1. Hereby, the initial IC Na+ concentration was calculated 
so that at the start of each session the osmolality on both sides of the cell membrane is equal. 
At 135 mEq L-1, a fluid shift of 1.44 L (0.9 L in HFS, 0.54 L in LFS) takes place out of the 
cells due to an increased plasma Na+ concentration. The plasma refilling is 1.6% (0.4% in 
HFS and 1.9% in LHF) more than at a normal plasma Na+ concentration (140 mEq L-1). 
However, at 145 mEq L-1 the fluid shift accounts for -0.46 L (-0.81 L in HFS, +0.35 L in 
LFS). The plasma refilling is 1.8% (0.4% in HFS, 2.1% in LFS) less than at a normal plasma 
Na+ concentration. 
 
Initial urea concentration 
The changes in Qi and RVp due to different initial urea concentrations during SHD are also 
shown in Figure 6. The initial plasma urea concentrations (both in the intra- and extracellular 
space) were varied by 10 mmol L-1 from 30 mmol L-1. In all cases the fluid shift from EC to 
the IC space occurs in the first hour of treatment. The fluid shift to the EC space decreases 
slightly with the increasing urea concentration. It varies from 1 L (0.86 L in HFS, 0.14 L in 
LFS) at 20 mmol L-1 to 0.93 L (0.85 L in HFS, 0.08 L in LFS) at 40 mmol L-1. A variation in 
the initial urea concentration by 10 mmol L-1 from 30 mmol L-1 has no remarkable effect on 
the plasma refilling capacity. 
 
Tissue permeation capacity 
An averaged value of 20 L min-1 for the tissue urea permeation coefficient was reported in the 
literature [14]. It is very likely that this quantity might vary from patient to patient, and even 
during treatment in one patient. The higher the tissue permeation coefficient, the faster the 
concentration in tissue equilibrates with that in venous blood (flow-limited transport). Figures 
7 and 8 show respectively the time-dependent changes in the transcellular and transvascular 
fluid shifts during SHD, when the tissue permeation coefficient is varied by 50% from 28 L 
min-1. The lower the tissue permeation capacity the higher the amount of fluid shift out of the 
cells in the HFS tissue group, and the higher the plasma refilling capacity. In the LFS tissue 
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group, a decreased tissue permeation coefficient causes the fluid to move in the cell. The 
lower the tissue permeation capacity the lower the plasma refilling capacity in the LFS tissue 
groups. A higher value of the tissue permeation coefficient than 28 L min-1 does not affect the 
overall plasma refilling. 
 
 
 
Figure 6 
Simulated time courses of the net Qi (a) and the RVp (b) in the HFS+LFS during SHD. Dialysate Na+ 
concentration (140 mEq L-1) is fixed and initial plasma Na+ concentration is varied from 135 mEq L-1 to 145 
mEq L-1.  Time courses of the net Qi (c) and the changes in RVp (d) when the initial concentration of plasma urea 
is varied from 20 mmol L-1 to 40 mmol L-1.  
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Figure 7 
The simulated time changes in the net exchange rate of intracellular fluid (Qi) and the resultant transcellular fluid 
shifts (Vi) during SHD. All other parameters are fixed and the tissue permeation coefficient for urea is varied 
from 14 L min-1 to 56 L min-1. Since the HFS and LFS tissue groups have different fractions of volume (fLv = 
0.8, fHv = 0.2), their tissue permeation coefficients for urea are also different.  
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Figure 8.  
The simulated time changes in the plasma refilling rate (Qpr) and the relative changes in the plasma volume 
(RVp) during SHD. See also Figure 7. All other parameters are fixed and the tissue permeation coefficient for 
urea is varied from 14 L min-1 to 56 L min-1 
 
Discussion 
We describe a mathematical model of intercompartmental fluid and solute kinetics during 
hemodialysis. This model differs from previous models in that the IC and EC solute masses, 
IC and EC osmolarities, dialysis dose, urea clearance, Na+ and K+ dialysance, blood water 
flow rate, erythrocyte water content, and Donnan factor are all taken as variable in time. Thus, 
this model may predict changes in solute and water transport throughout the profiled dialysis 
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session. Further, a regional blood flow model is combined with the classical two-compartment 
model. Correction factors for the dialyzer performance due to cardiopulmonary and access 
recirculation, are included. Using a sensitivity analysis we assessed the relative importance of 
ultrafiltration flow rate and volume, dialysate Na+ concentration, initial plasma Na+ 
concentration and initial urea concentrations, and the tissue permeation capacity on dialysis 
induced intercompartmental fluid shifts in both HFS and LFS tissue groups. 
The greater the amount of UF the greater the amount of fluid shift to the EC space. This fluid 
shift to the EC space is not sufficient to refill the plasma volume loss by ultrafiltration. In 
addition, the higher the rates of ultrafiltration flow, the higher the decline of plasma volume. 
High dialysate Na+ concentration (150 mEq L-1) causes the cellular fluid (1.8 L) to move to 
the EC space, enhances the plasma refilling (2.2%) and, therefore, helps the plasma volume 
preservation during standard hemodialysis when performed with a normal (140 mEq L-1) 
dialysate Na+ concentration. A variation in the initial plasma Na+ concentration by  5 mEq L-
1 from normal plasma Na+ concentration causes a variation of 0.45 L in the fluid shift. A 
variation in the initial plasma urea concentration by 10 mmol L-1 from 30 mmol L-1 causes a 
variation of 0.03 L in the fluid shift, and it has no remarkable effect on the refilling rate 
capacity. Low tissue permeation in the LFS tissue group leads to an increase of the fluid shift 
in the cells, especially in the early hour of treatment, causing a delay in the plasma refilling. 
In the HFS tissue group, this has a contrary effect on the plasma refilling due to the increased 
fluid shift from intra- to the extracellular space. 
Other factors influencing the transcellular and transvascular fluid shifts, such as solute and 
fluid distributions, transvascular protein transport, volume compliance, the solute and fluid 
permeation coefficients, which we cannot measure directly, are given at the start of treatment 
as parameters. Some factors such as flow rates, dialysate Na+ and K+ concentrations, length of 
dialysis session, and urea clearance are either given at the start of treatment or can be 
measured directly. However, some other parameters such as the permeability coefficients, 
compliance and initial ratios of different volume compartments were taken from literature, are 
likely to change during dialysis therapy, and can only be estimated in vivo. However, 
differences between this mathematical model and the in vivo situation enable us to compare 
the changes in the fluid and electrolyte fluxes that are predicted, to those observed during 
actual treatment. This is bound to improve our understanding of such variables, which is 
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especially relevant, as we must assume that the dialysis treatment itself induces changes in 
these variables. 
We conclude that the magnitudes and direction of fluid shifts induced by hemodialysis 
treatment are not equal in tissue groups with different fractions of volumes and blood 
perfusion. The UF volume and flow rate, and the size of Na+ gradient between the dialysate 
and blood (EC) side of the dialyzer membrane are the most important factors influencing the 
magnitude (up to 1.8 L) and direction of transcellular fluid shifts. High dialysate Na+ 
concentration helps plasma refilling (by 2.5%). However, a high dialysate Na+ concentration 
is associated with a high EC Na+ rebound, which in turn may lead to interdialytic water intake 
resulting from thirst and may cause increased weight gain and hypertension.  
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Appendix: list of symbols and units 
Symbol   Explanation [units] 
 <ga>   a factor to calculate protocrit from plasma protein concentration [Lg-1] 
j <gg>   solute cellular sieving coefficient 
Osm   magnitude of the net transcellular osmolar driving force [mosmol L-1] 
Osmn   magnitude of osmolar gradient due to non-urea [mosmol L-1] 
Osmu   magnitude of osmolar gradient due to urea [mosmol L-1] 
t   a discrete time interval [min(utes)] 
Vi   magnitude of transcellular fluid shift [L(iters)] 
 <gk>   conversion factor from molar to equivalent osmolar concentration 
is, p <gP>  oncotic pressure in intersitial and plasma compartment [mmHg] 
u <gs>  transcellular urea reflection coefficient 
a, v, is  compliance of arterial, venous plasma and interstitial space [% mmHg-1] 
Cd, j   inlet dialysate solute concentration [mEq L-1] 
Ce, j, Ci, j, Cp, j  EC, IC and plasma solute concentration [mEq L-1, mmol L-1] 
Ca, j, Cv, j  arterial and venous concentration of solute j [mEq L-1, mmol L-1] 
Cis, Cp   interstitial and plasma protein concentration [g L-1] 
CLj   solute clearance or dialysance by diffusion [L min-1 or Lh-1] 
CO   cardiac output [L min-1] 
Dd    dialysis dose 
Dj   whole body cellular diffusion coefficient of solute [L min-1] 
fj   volume distribution of solute in red blood cell volume 
fvt   volume fraction of tissue group t 
fqt   blood perfusion fraction of tissue group t 
Fw   correction factor for the free water fraction of EC space 
Gj   generation or intake rate [mEq min-1, mmol min-1] 
Ht   hematocrit 
Jdial,j, Jdif,j  total and diffusive transport rate through dialyzer [mEq min-1, mmol min-1] 
Ji, j, Je, j   mass exchange rate of IC and EC solute [mEq min-1, mmol min-1] 
Jav,j   mass transfer rate from tissue to venous blood [mEq min-1, mmol min-1] 
kc   transcellular whole body water exchange coefficient [L min-1 mmHg-1] 
kCP   correction factor for cardiopulmonary recirculation 
 69
Chapter 2  
 70
kAC   correction factor for arterial access blood recirculation 
Lf, Lr   arterial and venous capillary hydraulic permeability [L mmHg-1 min-1] 
mt   concentration equilibration coefficient in tissue group t  
Mi, j, Me, j  IC and EC solute mass [mEq, mmol] 
MWj   molecular weight of solute j [Dalton] 
Osmp, n   plasma non-urea osmolality [mosmol L-1] 
Pa, Pv, Pis  hydraulic pressure in arterial, venous plasma, interstitium [mmHg] 
PSj   whole body tissue permeation coefficient for solute j [L min-1] 
Qa   systemic arterial blood flow rate [L min-1] 
QaAC, QvAC  flow rate of blood entering and leaving the dialyzer [L min-1] 
Qat, Qvt   flow rate of blood entering and leaving the tissue group t [L min-1] 
Qbi, Qwi, j  flow rate of blood and blood water that enters the dialyzer [L min-1] 
Qdi, Qf   dialysate inlet and ultrafiltration flow rates [L min-1] 
Qwf, Qwr  vascular water filtration and reabsorption rate [L min-1] 
Qi, Qpr, Qrc  exchange rate of IC, transvascular and red blood cell volume [L min-1] 
QRAC   access recirculation blood (water) flow rate [L min-1] 
R   gas constant [L mmHg K-1 mmol-1] 
RcD, RD,j  capillary wall and dialyzer membrane Gibbs-Donnan ratio 
RVp   relative change in plasma volume with respect to its initial value [%] 
SKj   dialyzer membrane solute permeation coefficient [L min-1] 
T, Td   temperature [K(elvin)], duration of treatment session [min, hour] 
Ve, Vi, Vis  volume of EC, IC and interstitial compartment [L] 
Vp, Vb   plasma, blood volume [L] 
Vuf   excess water (weight gain) or ultrafiltration volume [L] 
Vrc,Vpr   volume of red blood cells and plasma refilling [L] 
Zj   solute distribution coefficient between EC and IC space at equilibrium 
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Abstract 
A decrease in blood volume is thought to play a role in dialysis-related hypotension. Changes 
in relative blood volume (RBV) can be assessed by means of continuous haematocrit 
measurement. We studied the variability of RBV changes, and the relation between RBV and 
ultrafiltration volume (UV), blood pressure, heart rate, and inferior caval vein (ICV) diameter.  
In 10 patients on chronic hemodialysis, RBV measurement was performed during a total of 
one hundred 4-h hemodialysis sessions. Blood pressure and heart rate were measured at 5-min 
intervals. ICV diameter was assessed at the start and at the end of dialysis using 
ultrasonography.  
The changes in RBV showed considerable inter-individual variability. The average change in 
RBV ranged from -0.5 to -8.2% at 60 min and from -3.7 to -14.5% at 240 min (coefficient of 
variation (CV) 0.66 and 0.35 respectively). Intra-individual variability was also high (CV at 
60 min 0.93; CV at 240 min 0.33). Inter-individual as well as intra-individual variability 
showed only minor improvement when RBV was corrected for UV. We found a significant 
correlation between RBV and UV at 60 (r= -0.69; P<0.001) and at 240 min (r= -0.63; 
P<0.001). There was a significant correlation between RBV and heart rate (r= -0.39; 
P<0.001), but not between RBV or UV and blood pressure. The level of RBV reduction at 
which hypotension occurred was also highly variable. ICV diameter decreased from 10.3±1.7 
mm/m2 to 7.3±1.5 mm/m2. There was only a slight, although significant, correlation between 
ICV diameter and RBV (r= -0.23; P<0.05). The change in ICV-diameter showed a wide 
variation.  
RBV changes during hemodialysis showed a considerable intra- and inter-individual 
variability that could not be explained by differences in UV. No correlation was observed 
between UV or changes in RBV and either blood pressure or the incidence of hypotension. 
Heart rate, however, was significantly correlated with RBV. Moreover, IVC diameter was 
only poorly correlated with RBV, suggesting a redistribution of blood towards the central 
venous compartment. These data indicate that RBV monitoring is of limited use in the 
prevention of dialysis-related hypotension, and that the critical level of reduction in RBV at 
which hypotension occurs depends on cardiovascular defense mechanisms such as 
sympathetic drive.  
 
 72
Variability of  Relative Blood Volume during  Hemodialysis 
Introduction 
Intradialytic hypotension is a common complication in patients on chronic hemodialysis. 
Many factors have been implicated in its pathogenesis, including autonomic dysfunction, 
cardiac dysfunction and a reduction in effective blood volume [1,2]. Changes in effective 
blood volume can be measured by radioisotope dilution techniques [3], but these methods are 
complicated and not easily applied on a routine basis. Changes in relative blood volume 
(RBV), however, can be estimated by means of continuous haematocrit measurement [4-6]. 
Monitoring RBV during hemodialysis and discontinuing ultrafiltration when a critical level of 
RBV reduction is reached has been advocated in order to improve haemodynamic stability 
during dialysis [7,8]. For this it is essential that the critical level of RBV reduction can be 
predicted in individual cases. Therefore we studied the intra- and inter-individual variability of 
RBV measurement and the correlation of RBV with blood pressure (BP), heart rate (HR), and 
inferior caval vein (ICV) diameter.  
 
Subjects and methods  
Patients and hemodialysis treatments 
Ten patients on regular hemodialysis were asked to participate in this study. This study was 
approved by the ethical committee of the University Hospital Rotterdam–Dijkzigt, and 
informed consent was obtained from all patients. Age, sex, and dialysis data are given in Table 
1. Hemodialysis treatments were performed using bicarbonate buffered dialysate (sodium 138 
mmol/l, potassium 2.0 mmol/l, bicarbonate 34 mmol/l), polysulphone membranes (F60, 
Fresenius, Bad Homburg, Germany) and Fresenius 4008 E hemodialysis monitors. Blood flow 
ranged from 200 to 250 ml/min, and dialysate flow was 500 ml/min. Treatments were 
performed on a thrice-weekly basis for 4 h. Only subjects requiring at least 1000 ml of 
ultrafiltration volume (UV) during each treatment were included.  
         
Table 1. Characteristics of the patient 
     
 Age (yrs) 65.5 ± 11.9 
 male/female  5/5  
 dry weight (kg) 63.8 ± 11.8 
 time on dialysis (yrs) 5.3 ± 2.5 
 Cardiac index (L/m2) 2.3 ± 1.1 
 EA ratio 0.9 ± 0.3 
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Food and fluid intake was withheld prior to each investigative dialysis sessions. One hour 
after starting, one cup of tea and a snack were served. One hour later, another cup of tea was 
provided.  
 
Blood pressure, inferior caval vein diameter, and cardiac output measurements 
During dialysis, BP and HR was measured at 5-min intervals by means of the Accutor 3 
oscillometric device (Datascope Co., Montreal NJ, USA). Hypotension was defined as a 
systolic blood pressure 90 mm Hg. To estimate hydration status before and after dialysis., 
ICV measurements were performed using ultrasonography (Aloka SDD 1100, 3.75 MHz 
probe, Aloka Co., Tokyo, Japan). Real-time, two-dimensional ultrasonography was used, with 
simultaneous ECG monitoring. The longitudinal axis of the ICV was used to measure its 
diameter at inspiration and at end-expiration, exactly 2 cm below the diaphragm. Using a cine 
loop memory containing 10 images, an image just before the P wave on the ECG tracing was 
taken for measurement. In all patients, cardiac function was previously analyzed using 
precordial ultrasonography. Cardiac output was determined by calculating the stroke volume 
using the bi-plane discs method. Diastolic left ventricular function was assessed by Doppler 
evaluation of left ventricular filling. After measuring early (E) and atrial (A) flow over the 
mitral valve, the E/A ratio was calculated. Diastolic dysfunction was present in all patients.  
 
Relative blood volume measurement 
RBV measurement was performed by continuous optical measurement of the haematocrit 
using the Crit-line device (In-line Diagnostics Co., Riverdale, Utah, USA). Patients were 
placed in a supine position 30 min before starting RBV measurements, and this position was 
maintained throughout the investigative dialysis sessions. To ensure an adequate baseline 
haematocrit without mixture of rinsing saline, RBV measurement was started 5 min after the 
onset of hemodialysis. RBV measurement was performed during 10 consecutive weeks on the 
same weekday.  
 
Data collection 
Data from the Crit-line device and the Accutor 3 were sent to a personal computer and 
recorded by a data acquisition program. During the data collection, the occurrence of 
symptoms and/or changes in the dialysis treatment parameters was instantly recorded.  
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Statistics 
For RBV, means of 10-min periods at 60, 120, 180, and 240 min were used for comparison. 
Similarly, means of RBV values over a range of 10 ml at 500, 1000, and 1500 ml 
ultrafiltration volumes were taken. Differences in BP, HR, ICV diameter, and RBV were 
analyzed using ANOVA for repeated measurements followed by the Newman–Keuls test for 
multiple comparisons. Differences between patients were analyzed using two-way ANOVA. 
Variability was assessed by calculating the coefficient of variance. Correlation was assessed 
using linear correlation by calculating Pearson's correlation coefficient. All data are presented 
as mean±standard deviation. A P value of <0.05 was assumed to indicate statistical 
significance.  
 
Results 
Ultrafiltration volume 
Measurements were performed in 100 hemodialysis sessions. UV after 4 h was 2438±457 ml. 
With a mean body weight of 65.9±9.3 kg; this represents 3.7% of the total body weight. The 
mean UV corrected for body surface area (BSA) was 1428±311 ml/m2 (Table 2. In 19 
sessions, ultrafiltration was temporarily stopped because of hypotension or other symptoms.  
 
time (minutes) start 60 120 180 240 F P 
UV (ml/m2)   386 ± 118 746 ± 184 1098 ± 254 1428 ± 311   
ICVD-exp. (mm/m2) 10.3 ± 1.7        7.3 ± 1.5  <0.001
SAP (mm Hg) 151.4 ± 20.6 151.1 ± 14.1 150.5 ± 18.6 148.1 ± 18.9 140.0 ± 17.3 2.4 <0.05 
DAP (mm Hg) 84.0 ± 7.1 82.7 ± 7.7 83.8 ± 6.5 83.6 ± 7.9 79.8 ± 7.7 6.2 <0.001
HR (bpm) 73.9 ± 7.9 74.9 ± 10.1 76.9 ± 9.2 80.0 ± 9.2 81.3 ± 10.2 33.7 <0.001
 
Table 2. Weight gain, ICV measurement, blood pressure, RBV, and ultrafiltration volume (mean of all sessions) 
 
Mean systolic blood pressure (SAP) decreased from 151.4±20.6 mmHg at the start of 
hemodialysis to 140.0±17.3 mmHg at the end (P<0.05; Figure 1.) Diastolic blood pressure 
(DAP) decreased from 84.0±7.1 to 79.8±7.7 mmHg (P<0.001), while the heart rate increased 
from 73.9±7.9 to 81.3±10.2 b.p.m. (P<0.001).  
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Fig. 1.  
Systolic and diastolic blood pressure during 4 h of hemodialysis in 10 patients (thick lines, mean of all patients; 
thin lines, ±standard deviation). 
 
ICV measurement 
At the start of dialysis, mean ICV diameter at end-expiration and at inspiration were 10.3±1.7 
mm/m2 and 8.2±2.2 mm/m2 respectively. At the end of dialysis, mean ICV diameters had 
decreased to 7.3±1.5 mm/m2 at end-expiration and 5.3±1.5 mm/m2 at inspiration (P<0.001; 
Table 2).  
 
Blood volume monitoring 
Changes in RBV showed marked inter-individual variability (Figure 2a. For all patients, the 
change in RBV was -3.8±2.5% at 60 min and -10.3±3.6% at the end of dialysis (Table 2. At 
60 min, mean RBV of 10 single patients varied between -0.51% and -8.17% (P<0.001), and at 
the end of dialysis, RBV varied between -3.71% and -14.55% (P<0.001; Table 3). The 
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coefficients of variability demonstrate a wide variation in RBV after 60, 120, 180, and 240 
min between different patients (CV 0.66, 0.52, 0.41, and 0.35 respectively; Table 3.  
Within individual patients, changes in RBV were also highly variable. Mean coefficients of 
intra-individual variability ranged from 0.66 after 60 min to 0.35 at the end of dialysis (Table 
3) 
 
Figure 2.  
Mean changes in relative blood volume of 10 patients in 10 hemodialysis sessions (thin lines), and mean of all 
patients (thick line), plotted (a) against time and (b) against ultrafiltration volume 
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 RBV at CV RBV at CV RBV at CV RBV at CV 
 60 minutes  120 minutes  180 minutes  240 minutes  
Patient 1 -4.24 0.57 -6.70 0.32 -10.15 0.33 -13.71 0.19 
Patient 2 -2.43 0.67 -3.00 0.74 -5.35 0.33 -6.98 0.30 
Patient 3 -2.27 0.68 -5.20 0.46 -7.96 0.38 -9.99 0.31 
Patient 4 -0.51 3.65 -0.52 6.41 -1.20 2.83 -3.71 0.87 
Patient 5 -1.37 1.58 -3.51 0.76 -6.12 0.55 -8.23 0.37 
Patient 6 -4.12 0.43 -7.13 0.35 -11.23 0.22 -14.55 0.23 
Patient 7 -8.17 0.29 -10.05 0.27 -10.94 0.25 -8.64 0.42 
Patient 8 -7.48 0.29 -8.68 0.27 -11.27 0.16 -12.84 0.17 
Patient 9 -2.77 0.70 -3.89 0.74 -6.44 0.59 -9.73 0.20 
Patient 10 -4.51 0.40 -5.41 0.59 -9.02 0.37 -14.51 0.22 
Mean -3.79 0.66 -5.41 0.52 -7.97 0.41 -10.29 0.35 
Inter- 
individual CV 0.93  1.09  0.60  0.33  
 
Table 3. Relative blood volume of 10 patients (mean of 10 hemodialysis sessions) at 60, 120, 180, and 240 min 
of dialysis 
 
 
When changes in RBV were plotted against UV corrected for BSA, inter-individual variability 
remained considerable (Figure 2b). Coefficients of variation ranged from 0.48 to 0.23 (Table 
4). Intra-individual variability was also marked (mean intra-individual CV 0.95 to 0.37; Table 
4).  
 
Correlation between relative blood volume, ultrafiltration volume, heart rate, blood pressure, 
and inferior caval vein measurement 
The change in RBV was highly correlated with ultrafiltration volume both at 60 min (r= -
0.69; P<0.001), and at 240 min (r= -0.63; P<0.0001; Figure 3a). Interestingly, there was no 
significant correlation between the change in RBV and either systolic or diastolic blood 
pressure, at 60 min and at 240 min (Figure 3b). Ultrafiltration volume was not correlated with 
either systolic or diastolic blood pressure. The change in heart rate was correlated with change 
in RBV at 240 min (r=-0.39; P<0.0001; Figure 3c), but not with ultrafiltration volume. 
Although there was a marginally significant correlation between the change in RBV and ICV 
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diameter (r=-0.23; P<005), there was a considerable variation in the decrease in ICV diameter 
(Figure 3d).  
 
          
  RBV at CV  RBV at CV  RBV at CV 
  500 ml UV   1000 ml UV   1500 ml UV  
Patient 1  -4.40 0.60  -7.57 0.36  -11.56 0.24 
Patient 2  -2.15 0.80  -5.59 0.55  - - 
Patient 3  -3.22 0.64  -7.36 0.30  -10.16 0.29 
Patient 4  -0.60 5.24  -3.03 0.98  -3.96 1.34 
Patient 5  -3.52 0.52  -8.95 0.30  - - 
Patient 6  -6.76 0.22  -9.39 0.12  -12.38 0.08 
Patient 7  -5.04 0.27  -10.04 0.24  -14.63 0.17 
Patient 8  -8.20 0.28  -10.27 0.26  - - 
Patient 9  -3.31 0.47  -5.15 0.32  -8.58 0.29 
Patient 10  -4.86 0.48  -8.40 0.23  -14.47 0.08 
Mean  -4.20 0.95  -7.57 0.37  -10.81 0.37 
Inter-individual CV  0.48   0.31   0.23 
 
Table 4. Relative blood volume of 10 patients (mean of 10 hemodialysis sessions) at 500, 1000, and 1500 ml of 
ultrafiltration volume/m2 of body surface area 
 
Incidence of hypotension, and corresponding relative blood volume and haematocrit 
The incidence of hypotensive episodes was relatively low. Hypotension occurred in seven 
hemodialysis sessions, all in two patients. Systolic blood pressure ranged from 63 to 89 
mmHg in patient 1 (four sessions), and from 84 to 89 in patient 7 (three sessions). In six 
sessions, hypotension was accompanied by a heart rate of 60 b.p.m. or less. In both patients, 
RBV at which hypotension occurred, varied markedly (patient 1, -9.2 to -16.0%; patient 7, -
1.4 to -16.5%). In addition, the corresponding haematocrit values showed considerable 
variation (patient 1, 0.27 to 0.31; patient 7, 0.32 to 0.37). Change in ICV diameter was not 
significantly different from sessions without hypotensive episodes.  
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Figure 3.  
(a) RBV (%) vs ultrafiltration volume after 240 min of hemodialysis. (b) RBV (%) vs change in systolic blood 
pressure after 240 min of hemodialysis. (c) RBV (%) vs change in heart rate (%) after 240 min of hemodialysis. 
(d) RBV (%) vs decrease in ICV diameter (end-expiration; mm/m2) after 240 min of hemodialysis. 
 
 
Discussion 
In this paper, the variability of RBV changes during hemodialysis is reported for the first time. 
We observed a considerable inter-and intra-individual variability of RBV changes during 
hemodialysis, even when corrected for UV. Although there was a significant correlation 
between RBV and ultrafiltration volume, a correlation between RBV and blood pressure was 
not found. Ultrafiltration volume was not correlated with blood pressure or heart rate. There 
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was, however, a significant correlation between RBV and heart rate, and a slight correlation 
between RBV and ICV-diameter.  
It is not surprising that we observed high inter-individual variability of RBV changes as 
differences in body composition, hydration state, and the cardiovascular status are known to 
affect the course of RBV during dialysis [1,2,9]. However, we found that the intra-individual 
variability was equally high. In our study, this variability could not be explained by 
differences in food and fluid intake during dialysis, as these were restricted according to a 
standardized time and quantity schedule. Also, medication was not changed during the 10-
week trial period, and intercurrent changes in the cardiovascular status such as the occurrence 
of myocardial ischaemia or systemic infection were not observed.  
It is tempting to assume that the observed intra-individual variability in RBV changes was 
caused by differences in ultrafiltration volume, as there was a significant correlation between 
UV and RBV. However, when the RBV curves were plotted against UV instead of time, we 
found only a minor improvement of the variation coefficients. Thus, differences in 
ultrafiltration rate are unlikely to account for the day-to-day variation of the blood volume 
response to hemodialysis, and other factors must be involved.  
There was no correlation between RBV and blood pressure, which is contrary to other 
observations [6,10,11]. However, a discrepancy between blood pressure and blood volume has 
been reported before [12]. Blood pressure was also not dependent on UV. There was, 
however, a significant correlation between RBV and heart rate. This suggests that a reduction 
in RBV, through ultrafiltration, stimulates the autonomic nervous system, which prevents a 
decrease in blood pressure by an increase in heart rate. In patients who did develop 
hypotension during dialysis, we were unable to determine a critical level of RBV reduction. 
Moreover, in six out of seven hypotensive dialysis sessions, patients were bradycardic instead 
of tachycardic, indicating that in these patients hypotension was caused rather by a failing 
cardiovascular response than by critical level of blood volume reduction.  
In our study, ICV diameter decreased significantly during dialysis. However, when we studied 
the relation between the change in ICV diameter and the change in RBV during dialysis, the 
correlation proved to be poor. This means that filling of the central venous compartment, 
which is assumed to be represented by the ICV diameter [13], does not change in parallel to 
changes in RBV. Therefore a redistribution of blood within the vascular compartment must be 
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assumed. This most probably results from cardiovascular defense mechanisms such as 
peripheral and/or venous vasoconstriction, or a change in cardiac output.  
We conclude that RBV changes have a considerable intra- and inter-individual variability, not 
only in time but also when plotted against UV. No correlation was observed between UV or 
changes in RBV and either blood pressure or the incidence of hypotension. Heart rate, 
however, was significantly correlated with RBV. Moreover, IVC diameter was only poorly 
correlated with RBV, suggesting a redistribution of blood towards the central venous 
compartment. These data indicate that RBV monitoring is of limited use in the prevention of 
dialysis-associated hypotension. The critical level of reduction in RBV at which hypotension 
occurs may depend more on cardiovascular defense mechanisms such as sympathetic drive, 
than on the reduction in RBV.  
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 Relative Blood Volume during Hemodialysis Without Ultrafiltration 
 
 
 
Chapter 4: Increase in Blood Volume during Dialysis without Ultrafiltration. 
 
 
 
 85
Chapter 4 
 
Abstract  
Combined dialysis and ultrafiltration leads to more frequent episodes of hypotension than 
isolated ultrafiltration. It has been suggested that decreased plasma volume preservation could 
be responsible for this phenomenon. The present study evaluates the effects of diffusive 
dialysis on the changes in relative blood volume. Six stable hemodialysis patients, without the 
need for ultrafiltration, were studied during ten sessions of diffusive dialysis (bicarbonate) 
lasting four hours. Relative blood volume (RBV) was monitored continuously by 
measurement of hematocrit. During the first and second hour RBV increased by 2.4 ± 1.4 and 
2.5 ± 0.8 % respectively, returning to baseline levels at the end of dialysis. No changes in 
blood pressure or heart rate were noted. We conclude that during diffusive dialysis without 
ultrafiltration relative blood volume is increased. A decrease in vascular resistance, or 
changes in regional blood distribution could explain the findings. 
 
Introduction 
Hypotension is a major complication of hemodialysis, which occurs in approximately one 
third of the patients [1]. It has been shown that isolated ultrafiltration without simultaneous 
dialysis is better-tolerated [2]. This could suggest that the hemodynamic instability that occurs 
during dialysis results from changes in osmolality [3-5]. Using kinetic modelling, the rapid 
fall in the urea concentration of the extracellular compartment, is predicted to induce a 
volume shift from the extracellular to the intracellular compartment [6,7,8]. On the other 
hand, some studies failed to observe differences in plasma volume preservation between 
ultrafiltration and ultrafiltration combined with hemodialysis [9,10,11]. However, differences 
between blood volume decrement during isolated ultrafiltration and ultrafiltration combined 
with dialysis could be masked in these studies, as there is an intra-individual variability in 
change of blood volume during ultrafiltration, which is relatively large as compared to the 
expected change in blood volume during diffusive dialysis [12,13]. To avoid these problems, 
the effect of blood volume can best be studied during dialysis without net ultrafiltration 
(diffusive dialysis). The effect of diffusive dialysis on changes in blood volume has been only 
reported by Fleming et al. [14]. However, this study was set up to investigate the effect of 
different dialysate sodium concentrations on blood volume, rather than the effect of diffusive 
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dialysis on blood volume.  At present, it is therefore unclear whether the negative effect of 
diffusive dialysis on hemodynamic stability results from reduced blood volume preservation 
or from altered vascular reactivity. The present study evaluates the effects of diffusive dialysis 
on blood volume preservation by continuously measuring the change in relative blood 
volume. In order to correct for intra-individual variability, all subjects were studied during ten 
dialysis treatments.  
 
Subjects and Methods  
Patients 
 We studied 6 patients, 4 men and 2 women, requiring chronic hemodialysis (time on dialysis 
2 months - 5 years) with such a residual diuresis (900ml - 2000 ml/24 hr) that ultrafiltration is 
not necessary. None of these patients suffered from diabetes mellitus. As there were no 
further exclusion criteria all six patients were studied. Mean age of the subjects was 59  20 
years. Their mean weight was 72 16 kg. The local ethics committee approved the study and 
informed consent was obtained in all subjects. Medication was changed during the 
experiments. 
 
Dialysis prescription 
In this study we examined 10 sessions for each patient. All dialysis sessions were performed 
on the same day of the week. Dialysis was performed three times a week for four hours using 
bicarbonate dialysate. Dialysate contained a sodium concentration of 138 mEq/L. Fresenius F-
60 high-flux dialyzers (Fresenius AG, Bad Homburg, Germany) and Fresenius 4008E 
hemodialysis monitors were used to perform the treatments. Patients were connected to the 
circuit after the priming volume of saline was discarded. Blood and dialysate flow rates were 
200-300 ml/min and 500 ml/min respectively. Delivered Kt/V ranged between 1.1 and 1.3 on 
a trice weekly basis, including residual renal function. All patients remained supine starting 
from 30 minutes before being connected to the dialysis circuit till the end of the treatment. No 
intravenous infusions were given during the treatment and the intake of fluids and food was 
withheld during the treatment.  
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Measurements 
Blood volume was measured optically by means of the CRIT-LINE device (In-line 
Diagnostics Co., Riverdale Utah). Before dialysis a sterile plastic disposable blood chamber 
was placed between arterial bloodline and the dialyzer. The CRIT-LINE uses a transmissive 
photometric technique to determine the hematocrit with a 95 % confidence interval from + 
2.32 to – 2.31 hematocrit % and a repeatability 95 % interval from + 0.56 to - 0.55 hematocrit 
% [15]. The CRIT-LINE device calculates relative blood volumes (RBV) from initial 
hematocrit and the subsequent changes in wavelength as the erythrocytes pass the through the 
blood chamber. For each patient, we calculated a mean relative blood volume and standard 
deviation at 60, 120, and 180 minutes, and at the end of treatment. From all the mean relative 
blood volumes of each patient, we calculated a grand mean relative blood volume. Blood 
pressure was measured by means of an oscillometric device (Accutor 3, Datascope Co., 
Montreal, NY) at 5-minute intervals. Blood pressure and heart rate were calculated as the 
average of three consecutive measurements. Hypotension was defined as decrease in systolic 
blood pressure (SBP) of more than 30%. Blood samples were taken before and after the 
dialysis session for measurement of the sodium and urea concentrations and for the mean 
corpuscular volume (MCV) of the erythrocytes. We used the ionometric method for 
determination of the sodium concentrations, because this method refers to the activity of the 
sodium capable of crossing the membranes of the dialyzer [16].  
 
Statistical analysis 
All data are presented as mean  standard deviation (SD). For changes in relative blood 
volume 95 % confidence intervals were calculated. Differences between study periods were 
assessed by means of ANOVA with repeated measures. All calculations were performed 
using the SPSS statistical software package.  
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Results 
Relative blood volume 
RBV increased significantly during the first (+ 2.4  1.4 %; p< 0.05) and second hour (+2.5  
0.8 %; p< 0.05) of the treatment (fig 1.). After reaching a plateau, RBV tended to decrease at 
the end of the treatment. We observed no correlation between the changes in RBV and plasma 
urea or sodium concentrations prior to dialysis (table 1). The observed increase in RBV did 
not result from a change in MCV (91 ± 3.7 vs. 92 ± 2.8 fL). There was a similar pattern of 
increase in all patients studied. However, there were considerable inter- and intra- individual 
differences (table 2). 
 
Patient  AHT* [Na]  SD [Urea]  SD RBV120  SD BP120 ± SD 
1 A, C, E 142  1 27.4  0.3 0.51 2.71 1  12 
2 None 138  2 28.5  3.6 4.35  4.2 10 ± 12 
3 B, D 142  1 26.5  0.7 6.90  1.74 -9 ± 28 
4 None 141  2 26.4  14 3.70  0.35 2 ± 10 
5 D 140  1 31.5  0.7 1.90  0.99 0 ± 9 
6 None 134  2 32.1  0.2 0.73  2.16 5 ± 11 
Mean  140  3 28.4  3 2.45  1.62 0.55 ± 15.4 
 
Table 1. Relationship between the use of anti-hypertensive drugs, osmolarity, blood pressure and blood volume  
Abbreviations are : aHT = antihypertensive drugs, [Na] = mean plasma sodium concentration  (mmol/l) , [Urea] 
= mean plasma urea concentration (mmol/l), SD = standard deviation, BP120 = % increase in systolic blood 
pressure in the first two hours, RBV120 = % increase in relative blood volume in the first two hours.  
A = Nitates, B =  blocker, C = Calcium antagonist, D = ACE inhibitor, E =  1 blocker 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Relative Blood Volume Changes in 6 patients during diffusive dialysis. Each curve represents the 
avarage of 10 dialysis sessions. The bold curve represents the avarage of all 6 patients. 
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 60 minutes 120 minutes 180 minutes 240 minutes 
 RBV 
(%) 
95% conf. 
Interval 
RBV
(%)
95% conf. 
Interval 
RBV 
(%)
95% conf. 
Interval 
RBV 
(%) 
95% conf.  
Interval 
Patient 1  2.71  (0.36-5.06) 0.51 (-2.2-3.22) -1.36 (-5.07-2.35) -2.41 (-6.89-2.01) 
Patient 2 2.42  (0.84-4.00) 4.35 (0.15-8.55)  3.45  (0.00-6.90)  3.02  (1.04-7.08) 
Patient 3 4.40  (3.21-5.59) 6.90 (5.16-8.64)  5.77  (3.45-8.10)  7.51  (5.07-9.93) 
Patient 4  1.33  (0.27-2.39) 3.70 (3.35-4.05)  4.17  (2.17-6.17)  2.23  (0.01-4.45) 
Patient 5  3.00  (1.69-4.39) 1.90 (0.91-2.89)  0.44  (-1.40-2.28) -0.29 (-2.07-1.48) 
Patient 6 0.48 (-0.43-1.39) 0.73 (-0.26-2.89)  0.80 (-0.78-2.38)  0.32 (-2.21-2.93) 
Mean 2.39  (1.03-3.75) 2.45 (1.64-3.26)  2.21 (- 0.46-4.89)  1.73 (-1.69-5.15) 
Table 2: Relative blood volume measurements and 95% confidence intervals during four hour 
 
Blood pressure 
SBP and heart rate remained unchanged during the procedure (141 ± 35 vs. 148 ± 39 mmHg 
and 84 ± 9.8 vs. 87 ± 8.8 bpm respectively (table 3). No episodes of symptomatic hypotension 
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were noted. We observed no relationship between changes in RBV and usage of anti-
hypertensive drugs (table 1). There was also no association between serum sodium 
concentration prior to dialysis and pre- dialysis SBP or change in SBP, although blood 
pressure tended to increase when initial serum sodium was low (table 1). 
 
  Systolic blood pressure (mmHg) 
  0 min. 60 min. 120 min. 180 min. 240 min. Significance 
 Patient 1 179 7 177 6 18010 184 3 193 5 n.s 
 Patient 2 15740 15741 16730 16830 16831 n.s 
 Patient 3 17327 15412 16612 16517 17718 n.s. 
 Patient 4 1122 112 6 11313 108 7 105 4 n.s 
 Patient 5 135 7 13110 134 7 136 8 14411 n.s 
 Patient 6 90 7 96 4 97 7 95 3 98 5 n.s. 
 Total 14135 138 30 14333 n.s. 14336 14839 
   
    Table 3: Blood pressure measurement 
 
 
Discussion 
This study demonstrates that a decrease in plasma osmolality by diffusive dialysis (regular 
dialysis without ultrafiltration) is associated with a significant increase in RBV.  
This finding is contrary to predictions derived from mathematical modeling in which RBV is 
predicted to decrease [6-8] (Figure 2).  
 
-1 .4  
-1  
-0 .6  
-0 .2  
0  60  120  180  240  300  
 
Figure 2. Change in Relative Blood Volume during diffusive dialysis according our Mathematical model  
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Diffusive dialysis leads to a decreased extracellular osmolarity, as there is an efflux of urea 
from the extracellular space. Theoretically, such a decrease in extracellular osmolarity would 
lead to a decreased tonicity of the extracellular space, and this would result in an osmotic fluid 
shift towards the intracellular space. This fluid shift would in turn lead to a decrease in blood 
volume [6-8]. As we find an increase in blood volume, the decrease in osmolarity by 
decreased plasma urea concentrations does not result in a volume shift towards the 
intracellular compartment. These findings are in accordance with those of Fleming et al, who 
previously observed that changes in blood volume are not correlated with urea efflux [14].  
However, in this study there was a positive correlation between changes in blood volume and 
the extra cellular sodium concentration. As sodium penetrates the cells much less rapidly than 
urea it has a far greater impact on tonicity. A small increase in the extracellular sodium 
concentration during dialysis would thus favor an increase in plasma volume, even when a 
concomitant efflux of urea exists, that leads to a net decrease in osmolarity. 
In our study, the average effective sodium concentration in the blood compartment of the 
dialyzer accounting for both plasma-water concentration and the Donnan-Gibbs ratio, was 
145 mmol/l [7,8]. Using a dialysate sodium concentration of 138 mmol/l would therefore 
result in a sodium transport towards the dialysate compartment, even if backfiltration were to 
occur. The observed changes in blood volume can therefore not result from sodium kinetics.  
Several other mechanisms could explain the observed blood volume patterns by such as: an 
increase in the volume of the erythrocytes, an increase in the total amount of intravascular 
protein, and changes in vascular resistance, especially when the patients are overhydrated. 
Blood volume measurements by CRIT-LINE assume the constancy of erythrocyte mass and 
volume. In theory, the observed decrease in hematocrit could be explained by a fluid shift 
from the erythrocyte to the intravascular space, thereby reducing erythrocyte volume. 
However, we observed no differences between MCV measured before and after dialysis, 
findings that are similar to previous reports [17,18]. Moreover, such a fluid shift from the 
erythrocyte to the intravascular space is unlikely to occur under these circumstances as the 
changes in osmolality during dialysis favor a water flux towards the intracellular compartment 
[8,18].  
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An increase in the total amount of protein in the intravascular space would also result in an 
increase in plasma volume. As the total fluid shift between intra- and extra-vascular 
compartments is determined by the transmural oncotic pressure gradient. The interstitial fluid 
pressure determines lymph drainage, which increases the back-flow of proteins. However, 
during dialysis there is a decrease in osmolality in the interstitial space. As this will decrease 
rather than increase the interstitial volume, it is unlikely that such a backflow of protein would 
occur.  
According to Starlings law, the fluid shift between the vascular and interstitial compartments 
depends on changes in hydrostatic and oncotic capillary pressure and on the filtration 
coefficient of the capillary basement membrane [19]. This filtration coefficient varies 
considerably from one tissue to the other. The whole body filtration coefficient represents the 
mean value of filtration coefficients of all segments of the regional micro-vascular system, 
each segment weighted for its fraction in capillary surface area. A change in vascular 
resistance will alter the blood flow distribution to different sections of the micro-vascular 
system and could therefore influence the whole body filtration coefficient, as well as 
hydrostatic capillary pressure. This would result in a different Starling equilibrium between 
the interstitial and intravascular space. 
Wehle et al. [20] observed that diffusive dialysis, using acetate buffered dialysate reduces 
peripheral resistance. Moreover, several other investigators observed that the increase in 
peripheral resistance and venous tone during isolated ultrafiltration was significantly reduced 
by concurrent diffusive bicarbonate dialysis [21, 22].  These results suggest that bicarbonate 
dialysis reduces peripheral resistance. Wehle et al also observed that, when a dialysate sodium 
concentration of 140 mmol/L is used, the observed decrease in peripheral resistance during 
diffusive dialysis is counterbalanced by an increase in cardiac output [23]. This is in 
accordance with our results that showed no change in blood pressure during diffusive dialysis.  
Moreover, Wehle et al. found that at a low dialysate sodium concentration, which decreases 
extracellular sodium concentration, the increase in stroke volume was much smaller and blood 
pressure dropped [23]. Indeed, in those patients that had a low baseline serum sodium 
concentration (2 and 6) and hence a relatively high dialysate concentration, we observed a 
tendency for an increase in blood pressure as compared to the other patients. 
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When diffusive dialysis without ultrafiltration is performed in overhydrated patients, the 
decrease in vascular resistance would induce an even greater increase in RBV than in 
normohydrated patients. It has been shown that during ultrafiltration in overhydrated patients 
plasma volume preservation is better than in normohydrated patients [24, 25].  As the 
compliance of the interstitium is high in overhydrated patients a decrease in intra-vascular 
hydrostatic pressure resulting from ultrafiltration will not lead to a decreased interstitial 
pressure hence reabsorption of fluid into the capillaries. In our study ultrafiltration was not 
performed, but a decrease in vascular resistance could also result in a decreased intravascular 
hydrostatic pressure. Consequently, the high compliance of the interstitial space in 
overhydrated persons will thus lead to increased absorption of fluid from the capillaries and a 
greater increase in RBV. Despite the considerable diuresis in our patient group, some patients 
might have been fluid overloaded, as two patients had elevated systolic blood pressure and 
several patients used anti-hypertensive medication. In our study, we found no correlation 
between initial blood pressure or usage of anti hypertensive drugs and RBV during dialysis.  
However, this does not exclude a relationship between initial fluid overload and the observed 
increase in RBV.  
The relationship between vascular tone and plasma volume expansion was directly assessed 
by several investigators, who found a plasma volume expansion, following the administration 
of a vasodilator agent [26,27,28]. Many factors could alter vascular tone during diffusive 
dialysis, such as induction of cytokine production in the presence of dialysate-derived 
contaminants or a change in body temperature [29,30]. Cold dialysis results in a greater 
decrease in relative blood volume, compared to standard treatment [31]. We did not measure 
body temperature. However, others have shown that body temperature rises during diffusive 
dialysis and ultrafiltration with a dialysate temperature of 37 C [32].  
The changes in blood volume in this study are small compared to those measured during 
routine hemodialysis with substantial ultrafiltration rates. Previous studies, in which RBV was 
studied during dialysis with ultrafiltration and during isolated ultrafiltration showed a 
tendency for a less pronounced fall in RBV during ultrafiltration combined with dialysis, 
although this difference was not significant [7,8,9]. However, the relatively large decrement 
in RBV during ultrafiltration could easily mask the relatively small increase in RBV during 
diffusive dialysis, as there is a considerable intra-individual variability in RBV during 
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ultrafiltration [12]. This could explain why these previous studies failed to observe significant 
differences. Fleming et al [14] studied blood volume changes during diffusive dialysis, and 
found no significant change in blood volume. However, in this study only twelve sessions 
with standard sodium concentration were studied, and only 1 or 2 (17 in total) blood volume 
measurements were done, while in our experiment relative blood volume was measured 
continuously during 60 sessions.  
We conclude that during diffusive dialysis without ultrafiltration relative blood volume is 
increased. A decrease in vascular resistance or changes in regional blood distribution could 
explain these findings.  
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Effect of Infusions on Relative Blood Volume 
 
 
 
Chapter 5 : Specific Effect of the Infusion of Glucose on Blood Volume 
during Hemodialysis. 
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Abstract  
Intradialytic morbid events, such as hypotension and cramps during hemodialysis are 
generally treated by infusion of iso-or hyper-tonic solutions. However, differences may exist 
between solutions with respect to plasma refilling and vascular reactivity.  
We compared the effect of no infusion (NI), with iso-volumetric infusion of isotonic saline 
0.9% (IS), saline 3% (HS), isotonic glucose 5% (IG), glucose 20% (HG) and mannitol 20% 
(HM), in 6 patients during the first hour of 6 standardized hemodialysis sessions with 
ultrafiltration. Relative blood volume was monitored continuously by measurement of the 
intravascular amount of protein. Blood pressure was measured by an oscillometric method, 
while cardiac output was measured by a thoracic impedance technique.  
At baseline no differences in serum urea, sodium, potassium, glucose and osmolarity were 
found between the various infusion experiments. The maximum increase in relative blood 
volume directly after infusion was significantly greater with HG (5.1±0.7%) than with all 
other infusions (p 0.05). Stroke volume increased (21.019.2 %, p 0.05) and total 
peripheral resistance decreased significantly (15.4  16.4 %, p 0.05) after HG infusions.  
Infusion of hypertonic glucose during dialysis results in a greater increase in relative blood 
volume than equal volumes of other solutions. As mannitol has the same osmolarity, molecule 
mass and charge, the greater increase in RBV following hypertonic glucose appears to be a 
specific effect, possibly related to a decline in vascular tone. It is therefore uncertain whether 
the observed increase in plasma volume during hypertonic glucose infusions will be of 
clinical benefit.  
 
Introduction 
Hemodialysis is frequently accompanied by acute symptoms or complications, such as 
hypotension, severe muscle cramps, dizziness, and lightheadedness [1]. An important 
contributing factor for these intradialytic morbid events (IME) is hypovolemia due to removal 
of fluid from the intravascular space by ultrafiltration and inadequate refilling from the 
extravascular compartment [2]. Inadequate constriction of both arterial and venous vascular 
beds may also be of importance in the pathogenesis of IME, especially during hypotension 
[3]. Infusion of fluids to increase blood volume has been advocated to prevent IME. 
Increasing plasma osmolarity during dialysis has also been shown to reduce IME [4]. The 
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reduction of symptoms may result from improved refill of the intravascular compartment by 
the induction of an osmotic gradient between the vascular and the extravascular compartment 
[4,5], but may also be related to a direct effect of osmolarity on cardiovascular reactivity [6]. 
In clinical practice isotonic saline (0.9 %) or hypertonic (3%) saline infusions are most 
frequently used in order to prevent IME. However, increasing the sodium load during dialysis 
has been shown to increase interdialytic thirst and weight gain [7]. Alternatively, glucose or 
mannitol solutions can be given. The acute and specific effects of these solutions and their 
osmolarities on vascular refilling and reactivity are largely unknown. Clear insight into the 
exact effects of the solutions on hemodynamics and osmolarity is pivotal for the 
determination which solution should be given during dialysis associated morbidity. We 
therefore compared the effects of saline 0.9 and 3 %, glucose 5 and 20 %, and mannitol 20 % 
on vascular refilling and vascular reactivity during combined hemodialysis and ultrafiltration 
(HD+UF). In order to obtain optimal reproducibility, the dialysis sessions as well as the 
infusions were standardized. Moreover, the infusions were given during the first hour of the 
treatment, when variability in blood volume decrement between dialysis sessions is relatively 
low [8]. 
 
Subjects and Methods  
Patients  
Six clinically stable patients, 3 men and 3 women, requiring chronic hemodialysis were 
studied. The patients had a mean age of 48  5.9 years and time on hemodialysis averaged 
18.5 ± 12.5 months. Renal failure resulted from polycystic kidney disease (2), nephrosclerosis 
(2), renal artery stenosis (1) and antiglomerular basement membrane nephritis (1). Exclusion 
criteria were acute infectious diseases, diabetes, severe coronary or valvular heart disease and 
compromised left ventricular function. The patients did not use anti-hypertensive drugs, 
except for one patient who used nifedipine. This drug was stopped one week prior to entry in 
the study. The local ethics committee approved the study and informed consent was obtained 
from each patient. Dry weight was considered when patients remained without symptoms of 
dyspnea or edema during the interdialytic period. Moreover, inferior caval vein diameter 
(VCD) measurements were performed at intervals of three weeks. Overhydration was defined 
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as a VCD of more than 11.4 and underhydration was defined as a VCD of less than 8 mm/m2 
body surface area [9].  
 
Dialysis prescription 
Dialysis was performed three times a week with the procedure normally used at our 
institution, using bicarbonate dialysate (32 meq/L). Dialysate further contained sodium 138 
mmol/L, potassium 2 mmol/L, calcium 1.75mmol/L, glucose 5.5 mmol/L with a total 
osmolarity of 292 mosm/L, a conductivity of 11.7 mS/cm (Fresenius SK-F213, Fresenius AG, 
Bad Homburg, Germany) and a temperature of 37 ºC.  Fresenius F-60 high flux dialyzers and 
Fresenius 4008E hemodialysis monitors were used to perform the treatments. Blood and 
dialysate flow rates were 200-300 ml/min and 500 ml/min respectively. Delivered Kt/V 
ranged between 1.1 and 1.3, including residual renal function. Patients were connected to the 
circuit after the priming volume of saline was discarded.  
 
Study protocol 
All sessions were performed on the same day of the week during six consecutive weeks. The 
patients remained supine throughout the experiments and no food or beverages were provided. 
The investigations were performed during the first hour of six hemodialysis sessions. The 
ultrafiltration rate was standardized at 20 ml/kg/hr. The study was started after the patients 
had had a supine rest for 30 min, after which the needles were inserted (t=0). After exactly 10 
minutes of UF one of the test solutions was infused by an infusion pump for ten minutes (t=10 
to t=20) at the same rate as the ultrafiltration rate (20 ml/kg/hr), so that no net fluid was 
extracted from the body during the infusion period. In each patient, the effects of no infusion 
(NI), isotonic saline 0.9%  (IS), hypertonic saline 3% (HS), isotonic glucose 5% (IG), 
hypertonic glucose 20% (HG), and mannitol 20% (HM) (Baxter BV, Utrecht, The 
Netherlands) were compared. The order in which the solutions were infused was random. The 
osmolarity of HS (900 mOsmol/L) was roughly comparable to the HM and HG solutions. The 
HM and HG solutions were iso-osmolar (both 1098 mOsmol/L).  
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Measurements  
Relative Blood Volume (RBV) was measured by means of a blood volume monitor (BVM, 
Fresenius, Bad Homburg, Germany), which measures the total protein concentration, the sum 
of hemoglobin and plasma proteins in the vascular space. Changes in total protein 
concentration during dialysis are used to estimate changes in plasma volume. This method has 
a very good agreement with a standard reference method involving calculation of RBV from 
serial measurements of hemoglobin levels (SD 1.7%, r > 0.96) and allows precise and reliable 
measurement of RBV [10].  Moreover, these measurements showed no sensitivity to changes 
in blood components such as sodium and glucose. Systolic, diastolic and mean arterial blood 
pressures (SAP, DAP, MAP) and heart rate (HR) were measured in triplicate at 10-minute 
intervals by means of an oscillometric device (Accutor 3, Datascope Co., Paramus, NJ). The 
average of three consecutive measurements was used for analysis. Stroke volume (SV) was 
measured every 10 minutes using electrical impedance cardiography (Cardioscreen Medis, 
Ilmenau, Germany). Impedance cardiography is based on the fact that when blood is pumped 
into the aorta from the electrically well isolated heart, the electrical impedance of the thorax 
changes. SV can be subsequently calculated on the basis of this pulse synchronous change in 
impedance.  This method has proven to give reliable information about the changes in stroke 
volume during hemodialysis [11]. Moreover, the results of impedance cardiography are highly 
reproducible (SD 0.36 l/min) [12].  One pair of electrodes was placed on each side of the 
neck. A third and fourth pair were placed on the lateral thorax at the xiphisternal level. Of 
each pair one electrode was placed exactly 5 cm above the other. The upper neck and lower 
xiphisternal electrodes were stimulated by a 60 kHz sinusoidal current and the resulting 
voltage was monitored from the inner recording electrodes. Two separate electrodes were 
placed in order to obtain the ECG signal. Stroke volume was calculated with the equation of 
Bernstein [13]:    
SV= VEPT x LVET x (dZ/dtmax)/TFI (ml), where VEPT is the volume of electrically 
participating tissue, which depends on height and weight of the patient. The weight of the 
patient at the moment of the measurement was considered as the predialysis weight minus the 
weight of the net ultrafiltrationvolume. LVET is the left ventricular ejection time (ms), 
dZ/dtmax (Ώ /ms) is the magnitude of the peak value of the impedance derivative and TFI (Ώ) 
is the thoracic fluid index, which is given by the basic impedance. At 10- minute intervals the 
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patients were asked to keep perfectly still and during 20 heart cycles in the course of the 
examination the impedance curves were transported into a cardioscreen trend 
softwarepackage (version 3.1) and recorded on a PC screen. A mean impedance curve was 
calculated by the software program and the curves that varied more than 5% from average 
were discarded manually. When no more than five curves were discarded stroke volume was 
calculated from the remaining heart cycles. Total peripheral resistance (TPR) was calculated 
from, SV, HR and MAP using the following formula: TPR = (MAP/(SV x HR)) x 80 (dyn/sec 
/cm-5 ). Before (t=0) and after one hour of treatment (t=60) blood samples were taken for the 
determination of urea, sodium, potassium, glucose, and osmolarity.  
Sodium concentration was measured by ionometry. Osmolalarity was measured by determing 
the crystallizing temperature of the sample by freezing point depression then using the 
temperature and calibration curve to determine the osmotic pressure. 
 
Statistical analysis  
All data and values are presented as mean ± standard deviation. 
Differences in body weight, hemodynamic parameters and laboratory between the procedures 
were analyzed by one way ANOVA with the post hoc LSD test using the SPSS statistical 
software package (SPSS version 8.0).  Changes in hemodynamic and laboratory parameters 
compared to baseline were analyzed with a paired t-test. 
 
 
Results  
Body Weight  
The average dry weight was 53.8  13.5 kg, while the mean interdialytic weight gain was 4.6 
 2.0 % of body weight (Table 1). During the 6 weeks period dry weight remained stable in 
all patients. The average interdialytic weight gain was comparable for all infusion 
experiments. 
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However, patient 2 and 3 showed an intra-individual variability in interdialytic weight gain.  
 
Patient Dry weight (kg) NI (%) IS (%) HS (%) IG (%) HG (%) HM (%)  
1 56.5 6.9 7.6 6.4 6.7 6.5 8.4  
2 32.0 2.5 4.1 8.4 6.2 7.1 4.7  
3 70.0 3.8 3.3 3.2 1.6 1.7 1.6  
4 49.5 4.8 3.2 4.6 3.6 4.4 3.6  
5 65.5 2.4 2.9 2.4 3.5 2.7 2.1  
6 49.5 6.6 6.5 5.6 6.6 4.2 6.5  
Mean 53.8 13.5 4.5 1.9 4.6 1.9 5.1 2.1 4.7 2.1 4.42.1 4.52.6 n.s. 
 
   Table 1: Dry weight and interdialytic weight gain. Means are given  standard deviation   n.s.= not significant 
 
 
 
RBV(%) 
t=20 min 
RBV(%) 
t=30 min 
RBV(%) 
t=40 min 
RBV(%) 
t=50 min 
RBV(%) 
t=60 min 
No Infusion -1.5±0.8 b -1.9±1.1 -3.4±1.9 -4.6±2.3 -6.0±2.3 
Isotonic Saline (0.9%) 0.5±1.0 -1.1±1.4 -2.4±2.0 -3.6±2.4 -4.9±2.7 
Hypertonic Saline (3%) 1.5±0.8 a -0.8±2.3 -2.4±1.2 -3.6±1.2 5.0±2.2 
Isotonic Glucose (5%) 1.6±1.0 a -0.3±2.4 -1.8±3.5 -3.3±3.9 -4.3±4.7 
Hypertonic Glucose (20%) 4.6±0.6 a b 2.6±1.4 a b -0.7±2.2 -2.7±1.6 -4.6±3.8 
Hypertonic Mannitol (20%) 2.6±1.2 a 0.8±1.9 -1.1±1.9 -2.6±2.6 -3.8±3.1 
  
Table 2.Changes in relative blood volume (RBV) compared to the start 
of the infusions (t= 10 min.) All values are given as mean  standard deviation  
  a =P < 0.05 increase compared to baseline,  b =P < 0.05 compared to all other infusions. 
.   
 
Relative blood volume 
During ultrafiltration, at a rate of 20 ml/kg/hr, RBV fell by 0.13 %  in the first 10 minutes in 
all patients (Fig 1). A 10-minute infusion at a rate equal to the rate of ultrafiltration prevented 
a further decrease in RBV, as RBV at the end of the infusion (t=20) was significantly 
different from the control experiment for all solutions infused (Table 2). With infusion of HG 
the increase in RBV was significantly greater than the increase observed with all other 
infusions (Fig 1, Table 2). Moreover, the time at which RBV reached the same level as the 
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level at which the infusion was started was 18  2 min for HG, which was significantly longer 
than all other infusion experiments (p<0.05, Fig 1). In patient 2,  the interdialytic weight gain 
during the HG and HS infusion session were comparable and RBV increased by 4.8% during 
the HG infusions whereas RBV increased only 1.8% during the HS infusions (from t=10 to 
t=20 min). Moreover, RBV increased only by 2.3% during the HM session, despite the fact 
that interdialytic weight gain was relatively low. The interdialytic weight gain for patient 3 
during the HG and HM sessions were comparable. During the HG infusions the increase in 
blood volume was larger than during the HM infusion (4.1% by HG and 2.3% during HM).  
  
 
 
 
Figure 1: Mean changes in relative blood volume (RBV; %) for all patients during combined dialysis and 
ultrafiltration (20 ml/kg/hr) following the infusion of different solutions. The increase in RBV is significantly 
greater during infusion of hypertonic glucose (5). 1= No infusion, 2 = isotonic sodium 3= hypertonic sodium 4= 
isotonic glucose 5= hypertonic glucose 6= hypertonic glucose 
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Blood pressure, heart rate and stroke volume. 
Blood pressure and heart rate remained unchanged during all experiments (Table 3). No IME 
events were noted. After infusion of HG blood pressure tended to increase but these changes 
did not show statistical significance. No episodes of symptomatic hypotension were noted. 
Stroke volume increased and TPR decreased significantly after the HG infusion. 
 
  SAP (%) HR (%) SV (%) TPR (%) 
 No Infusion  -0.3  5.0 +2.2  5.6 -6.8  10.6 +9.7   12.6 
 Isotonic Saline (0.9%) -1.0  3.6 -1.6  3.7    +4.2  13.4  -1.4  14.6 
 Hypertonic Saline (3%) -0.5  4.8  0.0  2.3 +6.0  23.6    0.0  27.0 
 Isotonic Glucose (5 %) -1.0  8.1   +3.0  5.0 +6.9  18.4   -1.2  18.2 
 Hypertonic Glucose (20%) +7.4 10.8 0.4  5.4 +21.0  19.2 a b  -15.4  16.4 ab 
 Hypertonic Mannitol (20%) +1.3   4.5    -3.8  4.1 +9.3   18.0   -6.1 17.6 
 
Table 3: Changes in systolic arterial pressure (SAP, %) heart rate  (HR, %), stroke volume (SV, %), and 
total peripheral resistance  (TPR, %) between beginning (t=10) and end (t=20) of the infusion period. All 
values are given as mean ± standard deviation.  a =P < 0.05 compared to baseline. b  =P < 0.05 compared to no 
infusions  
 
 
Laboratory parameters 
At baseline no differences in serum urea, glucose, sodium, potassium, and osmolarity were 
found between the various infusion experiments (27.9 6.8 mmol/l, 6.7  1.7 mmol/l, 137 
2.9 meq/l, 5.370.72 meq/l, and 3078 mOsmol/l respectively). After one hour of dialysis, 
serum urea concentration was decreased by a similar extent in all experiments (Table 4). Not 
surprisingly, serum sodium increased significantly after HS (from 137 ± 2.9 to 140.3 ± 3.0 
meq/L; p<0.05) and sodium decreased after the HM compared to the most other solutes (136 
±2.5 to 135 ±2.0 meq/l). Serum potassium was lowered significantly during all experiments. 
The decrease was significantly greater after HG compared to NI, HM and IS experiments (5.4 
± 0.7 to 4.1 ± 0.6 meq/l; p<0.05). Glucose increased significantly after HG infusion only 
(6.3± 0.9 to 8.2 ±1.2 mmol/L; p<0.05). Plasma osmolarity decreased during NI and IG and 
tended to decrease in all infusion experiments, but this decrease did not reach statistical 
significance.  
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 Urea Na+ K+ Glucose Osmol 
 (mmol/l)  (mmol/l)  (mmol/l)  (mmol/l)  (mosmol/l) 
No Infusion -11.9  6.5 a 2.53.2 -0.85  0.29 a -1.35  2.02 -10.4  5.8 a 
Isotonic Saline (0.9%) -11.5  7.9 a 2.84.8 -0.83  0.41 a -1.12  1.31 -3.8  9.5 
Hypertonic Saline (3%) -11.0  5.3 a   3.0 1.1 a   -0.95  0.11 a -1.07  0.83 a -5.8  7.0 
Isotonic Glucose (5%) -9.4   2.4 a 1.32.0 -0.98  0.26 a -0.13  1.18 b -8.2  7.2 a 
Hypertonic Glucose (20%) -10.1 3.4 a 0.51.8   -1.30   0.57 abce 1.93  1.22 a f -6.9  7.4  
Hypertonic Mannitol (20%) -7.7  1.4 a   -1.21.5 bcd -0.86  0.40 a -0.17  1.18 -2.2  5.0 
 
Table 4: Changes in laboratory parameters between the start of the dialysis session (t=0) and one hour of dialysis 
(t=60). All values are given as mean ± standard deviation. a =P < 0.05 compared to baseline 
b =P < 0.05 compared to no infusions c =P < 0.05 compared to isotonic saline,  d =P < 0.05 compared to 
hypertonic saline  e =P < 0.05 compared to mannitol,  f =P < 0.05 compared to all other infusions. 
 
Discussion: 
The results of our study demonstrate that during hemodialysis with ultrafiltration, infusion of 
hypertonic glucose solution (20%) results in a greater preservation of RBV than isovolumetric 
infusions of either normotonic or hypertonic saline or mannitol. Compared to the other 
infusion experiments, the increased RBV during hypertonic glucose infusion was associated 
with an increase in stroke volume and a decrease in vascular resistance. In our study, the 
finding that infusion of hypertonic glucose is more effective in increasing RBV than infusion 
of mannitol 20% is remarkable. Van der Sande et al. [14] compared colloids, such as albumin 
and or hydroxyethylstarch (HES) with saline and found a much greater increase in blood 
volume and blood pressure after the infusion of colloids. These differences were attributed to 
an increase in oncotic pressure during the colloid infusions. However, comparing the osmotic 
agents used in our study, mannitol closely resembles glucose in that it has the same molecular 
mass and charge and both solutions do not increase the oncotic pressure. Unlike glucose, 
which is rapidly transported from the extracellular to the intracellular space by insulin, 
mannitol is slowly eliminated from plasma [15,16]. Thus compared to infusion of mannitol, 
infusion of glucose is associated with a shorter lasting increase in plasma osmolarity. Indeed, 
in the present study, osmolarity, 40 minutes after infusions were discontinued, tended to be 
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slightly higher after administration of mannitol than after administration of glucose.  As 
changes in osmolarity, hence oncotic pressure, do not provide an explanation for the greater 
increase in RBV after infusion of hypertonic glucose, it is tempting to speculate that glucose-
induced vasodilatation accounts for the observed increase in RBV. Compared to other 
infusions or no infusion at all, infusion of hypertonic glucose was associated with a 
vasodilator response reflected by a decrease in vascular resistance and an increase in stroke 
volume. One could argue that the changes in electrolyte composition of the plasma induced by 
the sudden infusion of hypertonic salt or water directly affect impedance and might cause 
errors in the estimation of stroke volume and the subsequent calculation of vascular 
resistance. However, this change will not alter the magnitude of the peak value, as a 
correction for the baseline impedance is made. Therefore we don’t expect problems with the 
adequacy of the impedance cardiography. Moreover, hypertonic glucose infusion will give a 
much higher electrical resistance than the infusion of hypertonic saline, which is an 
electrically active compound. As electrical resistance is inversely related to impedance and 
stroke volume, changes in stroke volume during hypertonic glucose infusion would be 
underestimated and those during saline would be overestimated.  It has been shown that 
infusion of hypertonic glucose, but not of normotonic glucose or hypertonic mannitol into the 
brachial artery, is associated with a forearm vasodilator response [17].  A Study using 
vasodilator agents demonstrated that vasodilatation is associated with an increase in plasma 
volume without a concomitant increase in body weight, indicating that redistribution of the 
extracellular volume between the intravascular and extravascular compartments underlies this 
increase in plasma volume [18]. Recruitment of capillaries leading to an expansion of the 
vascular area could explain the vasodilatation- induced increase in RBV. Such a mechanism 
would be especially favorable for the action of glucose, as it can increase the disposal of 
glucose to the intracellular compartment [19].   
It is uncertain whether the observed increase in RBV is of clinical benefit, as a change in 
peripheral resistance could induce a change in the critical value of blood volume at which 
IME occurs. The relatively small increase in blood volume during hypertonic sodium infusion 
could therefore lead to a more effective RBV and cardiac filling pressure. Previous studies 
showed that hypertonic saline infusion during hypotension is effective in raising blood 
pressure and cardiac filling pressure [5.6].  A dissociation between blood volume and vascular 
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tone would also change the algorithms for those clinical settings, in which RBV 
measurements are performed with a feed back control in order to prevent IME 
We conclude that infusion of hypertonic glucose during dialysis results in a greater increase in 
RBV than equal volumes of other solutions. As mannitol has the same osmolarity, molecule 
mass and charge, the greater increase in RBV following hypertonic glucose appears to be a 
specific effect, possibly related to a decline in vascular tone. It is therefore uncertain whether 
the observed increase in RBV will be of clinical benefit during IME.  
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Abstract  
Hypotensive episodes are a major complication of hemodialysis. Hypotension during dialysis 
could be directly related to a reduction in blood volume or to a decrease in cardiovascular 
activation as a response to decreased cardiac filling. A decreased cardiovascular activation 
could be due to patient-related or to dialysis-related factors. In order to study the isolated 
effect of a reduction in filling pressure, lower body negative pressure (LBNP) causes 
activation of the cardiovascular reactivity with a decrease in cardiac filling, but without the 
influence of the dialysis procedure that could affect cardiovascular reactivity. 
We studied the relationship between Relative Blood Volume (RBV), Central Venous Pressure 
(CVP), Systolic Arterial Pressure, Heart Rate, Stroke volume Index (SI), and Total Peripheral 
Resistance Index (TPRI) during a combined dialysis/ ultrafiltration and during LBNP to –40 
mmHg in 21 hemodialysis patients with a high incidence of hypotension. Systolic arterial 
pressure, heart rate, SI, and TPRI were measured by Finapres. CVP was measured after 
cannulation of the jugular vein. During dialysis RBV was measured by a blood volume 
monitor (BVM). In order to study the conditions in which hypotension occurred after the 
dialysis, we divided the patients into two groups: Hypotensive (H) and non-Hypotensive (NH) 
during dialysis.  
Baseline levels did not show any significant differences. During dialysis systolic arterial 
pressure declined gradually in the H group from 30 minutes before the onset of hypotension. 
There was a similar decrease of RBV and increase of heart rate in both groups with a large 
inter-individual variation. At hypotension, H patients showed a significantly smaller increase 
in TPRI, as compared to NH patients. The reduction in SI tended to be greater at hypotension, 
while CVP decreased to a similar extent in both groups.  
Moreover, during LBNP, a similar reduction in CVP resulted in a much smaller decrease in 
SI.   
Systolic arterial pressure was only slightly lowered due to a much greater increase in TPRI. 
We conclude that dialysis related hypotension in our patient group did not result from an 
inability to maintain blood volume or from decreased cardiac filling. Hypotension appeared to 
result from the inability to adequately increase arteriolar tone and a reduction in left 
ventricular function. 
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Both vascular tone and left ventricular function appeared to be impaired by the dialysis 
procedure. 
 
Introduction 
Hypotensive episodes are a major complication of hemodialysis [1]. Hypovolemia resulting in 
a decrease in preload has been implicated as a major causative factor. Hypovolemia results 
from fluid withdrawal from the intravascular space during ultrafiltration and inadequate 
refilling from the extravascular space [2]. Whether hypovolemia leads to hypotension is 
dependent on the increase in systemic vascular resistance and maintenance of cardiac output. 
In response to the decrease in filling pressure adequate cardiac filling and stroke volume (SV) 
will especially depend on the diastolic function of the left ventricle (LV). Dialysis related 
hypotension is generally believed to have a multifactorial genesis, involving patient related 
factors such as sympathetic responsiveness [3], cardiac function [4], age [5] as well as dialysis 
associated factors such as body heating, [6,7], release of vasodilator agents [8,9], osmolar [10] 
and electrolyte changes [11].  
We studied the relationship between Relative Blood Volume (RBV), Central Venous Pressure 
(CVP), Stroke volume Index (SI), Heart Rate, Systolic Arterial Pressure, and Total Peripheral 
Resistance Index (TPRI) during combined dialysis/ ultrafiltration in 21 hemodialysis patients 
with a high incidence of hypotension. Depending on the blood pressure response during the 
dialysis session after the dialysis the patients were divided into two groups; those that became 
hypotensive during dialysis (H) and those that did not (non-hypotensive; NH). However, 
given the multifactorial genesis, it is difficult to study the contribution of separate factors 
within the setting of hemodialysis.  
The application of negative pressure to the lower part of the body can be used to decrease 
venous return, thereby simulating hypovolemia. In order to study the isolated effect of a 
reduction in filling pressure, we compared the hemodynamic circumstances under which 
hypotension occurred during dialysis with the response to Lower Body Negative Pressure 
(LBNP) in H patients. During LBNP, we measured the same parameters except for relative 
blood volume. Moreover, LBNP was performed under identical conditions at the same 
hydration status.  
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Methods  
Twenty-one patients on chronic hemodialysis with a high incidence of hypotension during 
dialysis (i.e more than 30 % of their sessions) were studied during a combined 
dialysis/ultrafiltration session and a LBNP session. The LBNP sessions were performed on 
the same day as the dialysis session. Following LBNP, patients were allowed to rest for 60 
minutes but refrained from fluid intake before the start of dialysis. The ethical committee of 
the Erasmus Medical Centre Rotterdam had approved the study, and all participants had given 
written informed consent.  
 
Dialysis procedure  
The dialysis procedure was performed with the procedure generally used at our institution, 
using bicarbonate dialysate (32 mmol/L) and a sodium concentration of 138 mmol/L 
(Fresenius SK-F213, Fresenius AG, Bad Homburg, Germany) and a temperature of  of 37 ºC.   
The dialysate contained lesser than 50 CFU/ml water and the limulus amoebycyte lysate test 
was negative.  Fresenius 4008H hemodialysis monitors and biocompatible hemophane (MA-
12; Kawasumi, Tokyo, Japan) or polysulphone (F-60S; Fresenius MC, Bad Homburg, 
Germany) hemodialyzers were used to perform the treatments. Blood and dialysate flow rates 
were 200 ml/min and 500 ml/min respectively. All patients were ultrafiltrated with a constant 
ultrafiltration rate until dry weight in a 4-hour session. Inferior caval vein measurements were 
done at intervals of one month and dry weight was adjusted accordingly. Dry weight was 
considered optimal when patients remained without symptoms of dyspnea or edema during 
the interdialytic period. Overhydration was defined as a caval vein diameter of more than 11.4 
and underhydration as a caval vein diameter of less than 8-mm/m2 body surface area [12,13]. 
All patients remained supine starting 30 minutes before being connected to the dialysis circuit 
until the end of the treatment. No intravenous infusions were given during the treatment and 
intake of fluids and food was withheld during treatment, unless hypotension occurred. 
Hypotension was defined as a decline in systolic arterial blood pressure by more than 30 %. 
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LBNP procedure  
During the LBNP procedure, the patients were placed in a box up to the iliac crest, and an 
airtight connection was attached to the patient’s waist.  Evacuating air from the box created a 
lower body negative pressure. After an equilibration period, LBNP of –20 mmHg was applied 
for 15 minutes. LBNP was subsequently increased to –40 mmHg for 15 minutes. 
Measurements were taken at the end of each 15 minutes of LBNP. 
 
Measurements 
During the LBNP and combined dialysis/ultrafiltration sessions systolic arterial pressure and 
heart rate were measured continuously by the Finapres device (Ohmeda 2300, Englewood, 
CO), using the middle finger of the nonfistula arm. This apparatus measures the blood volume 
under an infrared plethysmograph. When blood volume is kept constant at a set point value by 
controlling the cuff pressure, Systolic arterial pressure and heart rate can be calculated from 
these changes in cuff pressure. This method has been validated in many studies against 
invasive blood pressure measurements [14]. Changes in stroke volume and total peripheral 
resistance were derived on a beat-to-beat basis from the pulse pressure curve of the Finapres 
and computed by the Modelflow program (TNO, Amsterdam, the Netherlands) [15]. These 
parameters have been validated even in patients with shock [16].  However, for highest 
accuracy and precision a calibration of the model parameters is required [14]. Therefore, 
before the Finapres measurements were started, all patients underwent an echocardiographic 
measurement of stroke volume to calibrate the model. The volume of the left ventricle was 
calculated from the apical two- and four chamber views using a modification of Simpson’s 
rule [17]. The principle of Simpson’s rule is to divide the left ventricle into known slices of 
thickness. The volume of the ventricle is then equal to the sum of the volume of the slices. 
The endocardial borders of these views were digitally traced at end diastole and end systole. 
Stroke volume was calculated as the difference between end-diastolic and end-systolic 
volume. Measurement of CVP was performed continuously with a small bore catheter with a 
diameter of 0.6 mm, which was inserted in the right jugular vein using the Seldinger 
technique. 
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Statistical analysis  
Hemodynamic data are given as mean ± standard deviation. SI and TPRI are given per m2 
body surface. Differences in baseline hemodynamics between H and NH were tested with the 
unpaired two-tailed Student’s t-test. Differences in medication were tested with the Fischer’s 
exact test. All changes are given as percentages, except for the changes in CVP, which are 
given in mmHg. Differences between the groups (H and NH) and procedures (LBNP vs. 
dialysis) and changes versus baseline were analysed using ANOVA for repeated 
measurements, and followed by the SNK test for multiple comparisons if appropriate. The 
level of significance was defined at 0.05.   
 
Results  
Baseline characteristics  
Eleven of the 21 patients experienced a hypotensive period (H group) during dialysis, while 
the remaining 10 patients had no such event (NH group). Age, dry weight, time on dialysis, 
interdialytic weight gain, ultrafiltration rate/kg dry weight, and medication were comparable 
between the two groups (Table 1). Before dialysis systolic arterial pressure appeared to be 
lower in the H group, although this was not significant (127±26 vs.151±46 mmHg; Table 2). 
Baseline values in both groups for heart rate, SI, TPRI and CVP also did not show any 
significant differences.  
 
Dialysis procedure  
During dialysis, hypotension occurred on average 150 minutes after the start of the dialysis 
session. We therefore compared the 150-min measurements in the NH group with the moment 
of hypotension in the H group (Table 3). Most hypotensive patients developed severe 
symptoms, which necessitated intervention. Therefore, as we wanted to make a reliable 
comparison with the NH group, all data after the occurrence of hypotension were not 
analyzed.  
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Table 1. Patient characteristics 
 
   Hypotensive (H) Non Hypotensive (NH)  p 
Number   11 10   
Age (yr.)   60.6 ± 13.3 53.4 ± 12.0 n.s. 
M/F   6/5 8/2  n.s. 
Time on dialysis (yr.)  2.5 ± 2.1 2.4 ± 1.5 n.s. 
Dry weight (kg)  65.7 ± 6.9 67.3 ± 10.4 n.s. 
Interdialytic weight gain (kg) 3.0 ± 1.4 3.0 ± 2.5 n.s. 
Ultrafiltration rate/ kg dry weight 
(ml/min/kg) 
10.3 ± 2.6 9.0 ± 2.9 n.s. 
Medication     
Beta-adrenergic blockers 3 5  n.s. 
ACE- inhibitors   1 2  n.s. 
Calcium antagonists  3 4  n.s. 
Values are mean ± SD   n.s. = not significant  
 
 
Table 2. Baseline hemodynamic data in Hypotensive and Non Hypotensive patients 
 
  Hypotensive Non Hypotensive p  
       
SAP (mmHg) 127 ± 26 151 ± 46 n.s.  
HR (bpm)  70 ± 10 67 ± 10 n.s.  
SI (ml /m2 ) 33 ± 8 34 ± 11 n.s.  
TPRI (dyne/sec/cm-5)/ m2) 1225 ± 483 1277 ± 529 n.s.  
CVP (mmHg) 11.0 ± 7.0 10.2 ± 4.8 n.s.  
Hemodynamic data are mean ± SD   n.s. = not significant SAP= Systolic Arterial Pressure; HR= Heart Rate;  
SI= Stroke volume Index; TPRI= Total Peripheral Resistance Index; CVP= Central Venous Pressure 
 
 
In most patients systolic arterial pressure declined gradually, starting twenty minutes before 
the onset of hypotension (Figure 1). Ten minutes before the onset of hypotension blood 
pressure had already declined significantly compared both to baseline and the NH group (-9 ± 
12 vs. +3±6; Table 3). In two patients systolic arterial pressure had dropped by up to 20 % at 
thirty minutes before the onset of hypotension, whereas in two other patients the drop in 
systolic arterial pressure occurred in only five minutes (Figure 1). Heart rate increased to a 
similar extent in both groups (Table 3). During or before hypotension no episodes of 
bradycardia were observed (Figure 1).  During the hypotensive episode SI tended to be lower 
than at the corresponding time in the NH group (-41±20 vs.-28±18%; Table 3). At 
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hypotension this difference did not reach statistical significance. However, in the H group, SI 
had already declined within the first hour of the dialysis session (-20± 15 vs.-4±15%; Table 
3). CVP tended to decrease comparable in both groups (Table 3). 
 
 
Table 3: Hemodynamic changes (%) at each hour, at 30 and 10 minutes before hypotension and at Hypotension 
(H) or the corresponding moments (NH). 
   
 Non Hypotensive group (n=10)        
Time (min) SAP (%) HR (%) SI (%) TPRI (%) CVP (mmHg) RBV (%) 
60  2 ± 14 0 ± 7 -4 ± 15 11 ± 32 -1.3 ± 1.3 a -1.5 ± 2.4 
120  3 ± 8 5 ± 8 -17 ± 14 a 51 ± 71a -1.5 ± 3.4  -4.1 ± 2.9 a
150  3 ± 6 9 ± 14 -28 ± 18 a 82 ± 83 a -1.7 ± 2.7  -6.5 ± 3.5 a
180  -2 ± 8 11 ± 9 a -28 ± 15 a 64 ± 75 a -1.7 ± 3.0  -7.6 ± 4.3 a
240  -4 ± 9 13 ± 14 a -40 ± 11 a 81 ± 76 a -2.8 ± 2.5 a -9.6 ± 5.3 a
Hypotensive group (n=11)            
Time (min)  SAP (%)    HR (%) SI (%) TPRI (%) CVP(mmHg) RBV (%) 
60  2 ± 16 4 ± 9 -20 ± 15 a, b 25 ± 31 a -1.5 ± 2.3a -3.6 ± 2.9 a
H-30   (120 ± 60 min)  -4 ± 17 10 ± 16 -27 ± 19 a 34 ± 27 a -2.6 ± 2.1a -6.5 ± 5.2 a
H-10   (140 ± 60 min) -9 ± 12 a,b 13 ± 17  -35 ± 13 a 35 ± 26 a -2.8 ± 3.0 a -8.5 ± 5.0 a
H        (150 ± 60 min) -31 ± 1  16 ± 16 a -41 ± 20 a 25 ± 28 b -3.0 ± 2.3 a -8.5 ± 5.3 a
240 -22 ± 17 18
. 
± 20 -35 ± 30 a  18 ± 43 -3.3 ± 2.1 -10.5 ± 5.0 
All values are expressed as Mean ±  Standard Deviation;  H= time of hypotension  SAP= Systolic Arterial  
Pressure ;HR = Heart Rate SI=Stroke volume Index; TPRI=Total Peripheral Resistance Index; CVP=Central  
Venous Pressure; RBV= Relative Blood Volume. a: p < 0.05 compared to baseline.  b: p<  0.05 compared to  
NH at the corresponding moment (H and H-10 are both compared to 150  min) 
 
 
In the H group, the increase in TPRI at the moment of hypotension was significantly smaller 
when compared with NH patients at 150 minutes (25±28 vs. 82±83 %; Table 3).  
At the onset of hypotension RBV had dropped by 8.5 % (Table 3). At this point, the 
ultrafiltration volume was 920 ml/m2. Mean RBV and ultrafiltration volume for NH at 150 
min was not significantly different  (-6.5 ±3.5 % and 870 ml/m2 respectively). At 
hypotension, there was a huge variation in decline of RBV (Figure1).  
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Figure 1 :  Hemodynamic changes in hypotensive dialysis sessions from 30 minutes before the onset of 
hypotension. SAP= Systolic arterial Pressure ; HR = heart rate; SI = Stroke Volume Index; TPRI = Total 
Peripheral Resistance Index; CVP = Central Venous Pressure, RBV= Relative Blood  Volume. 
 
LBNP compared to dialysis procedure 
In the patients in which hypotension occurred during dialysis, we compared the 
hemodynamics with those during the LBNP experiment. The reduction in CVP at which 
hypotension occurred was achieved by –20 mmHg of LBNP. However, the reduction in 
systolic arterial pressure at this level of LBNP was markedly lower than during dialysis (4±5 
vs. 31±1 % ; Table 4). Moreover, the reduction in SI was significantly less during LBNP (-
22±12 vs -41±20%). At –40 mmHg LBNP the reduction in SI was comparable with that 
during hypotension. However, the systolic arterial pressure was still significantly higher, as 
TPRI  as compared to baseline (Table 4). 
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Table 4: Changes in hemodynamics in hypotensive patients at moment of hypotension and during LBNP.  
 
Hypotensive group 
 
 Dialysis Hypotension LBNP -20 mmHg LBNP -40 mmHg 
Hemodynamics       
SAP (%) -31 ± 1  -4 ± 5a,b -15 ± 16 a,b 
HR (%) 16 ± 16 a  2 ± 5 6 ± 16 
SI (%) -41 ± 20 a  -22 ± 12a,b -37 ± 16a 
TPRI   (%) 25 ± 28  27 ± 19 a 53 ± 53a 
CVP  (mmHg) -3.0 ± 2.3a  -3.3 ± 2.1a -5.2 ± 4.3a 
 
All values are expressed as  Mean ±  Standard Deviation  SAP=Systolic Arterial Pressure; HR=Heart Rate; SI= 
Stroke Volume index; TPRI =Total Peripheral Resistance;  CVP=Central Venous Pressure; a: p < 0.05 compared 
to baseline  b: p<  0.05  compared to dialysis hypotension 
 
 
Discussion 
Hypovolemia is generally thought to play an important role in the pathogenesis of 
intradialytic hypotension [2]. However, in our study hypovolemia did not seem to play a 
pivotal role in the pathogenesis of hypotension, as the change in blood pressure was not 
related to the decline in RBV.  Moreover, at the onset of hypotension there was a huge 
variation in decline of RBV. These results are in agreement with our previous results, in 
which RBV and blood pressure varied significantly during 100 dialysis sessions, even when 
corrected for ultrafiltration volume [18]. We also found that the change in RBV at the 
moment of hypotension varied markedly, even within the same patient.  
It is known that two essentially different patterns of dialysis related hypotension can be 
distinguished. One of these has a more or less gradual decrease in blood pressure, whereas the 
other is characterized by a sudden onset of bradycardia. The bradycardia associated 
hypertension is presumed to result from a Bezold-Jarish reflex, i.e. paradoxical 
symphaticoinhibition during severe underfilling [19]. All hypotensive episodes observed in 
our study were preceded by a gradual increase in heart rate. These findings suggest that the 
hypotensive episodes did not result from severe underfilling or an inability to increase heart 
rate, but rather from an incapability to maintain SI and/or to increase vascular tone. 
In hypotensive subjects SI was decreased within one hour of the start of dialysis. The 
reduction in SI also tended to be greater at the moment of hypotension  than the 
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corresponding moment in the non-hypotensive patients. This reduction in SI occurred at a 
similar reduction in filling pressure, as estimated by CVP. Moreover, when the hypotensive 
patients were subjected to LBNP, a similar reduction in CVP resulted in a much smaller 
decrease in SI. Thus the inability to maintain cardiac output appears to be related to the 
dialysis procedure.  
Dialysis may impair either systolic or diastolic left ventricular function. We previously 
observed a decreased myocardial contractile reserve in hypotension prone patients [20]. 
Further, previous studies have shown that the dialysis procedure appears to interfere with the 
systolic left ventricular function [10,11]. However, there is evidence to suggest that increases 
in cardiac inotropy are not very important during hypovolemic conditions [21,22].  
Alternatively diastolic function, can be reduced by the reduction in filling pressure, as a 
decreased pressure difference between left atrium and ventricle results into a reduced early 
left ventricular filling [23]. Moreover, diastolic dysfunction during dialysis has been 
suggested to result from shifts in ionized calcium [24]. Decreased availability of calcium to 
the myocardium could impair both myocardial contraction and relaxation. Diastolic 
dysfunction is a complex process that may also be influenced by ventricular interaction. 
The observed episodes of hypotension may also have resulted from the inability to adequately 
increase vascular tone. The increase in vascular resistance at hypotension in the H group, was 
smaller than the corresponding time in the NH group. During LBNP, the hypotensive subjects 
were able to increase arteriolar tone and thereby maintain blood pressure despite a similar fall 
in SI.  Therefore, the dialysis procedure appears to interfere with arteriolar tone.  
An inadequate increase in arteriolar tone during dialysis is either due to decreased 
sympathetic activation or to decreased vascular responsiveness.  Many previous studies 
showed that dialysis normally stimulates sympathetic nerve activity during gradual 
hypotension [25, 26]. On the other hand, it has also been suggested that sympathetic function 
detoriates during dialysis as plasma norepinephrine levels do not rise appropriately. [27]. 
Analysis with heart rate variability with spectral analysis also failed to show an increase in 
sympathetic tone during hemodialysis in hypotensive patients [3,28].  
The dialysis sessions in our study lasted for four hours. It is possible that prolonging the 
dialysis session, as described in the Tassin study, would have resulted in an improved blood 
pressure profiles during hemodialysis [29]. 
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A decreased vascular response during dialysis could result from a positive thermal balance, 
due to an inability to dissipate the excess of heat [6,7].  Further, a change in the Nitric Oxide–
Endothelin–1 balance as a result of mechanical and chemical stimuli may also be involved in 
the pathogenesis of dialysis induced hypotension [8,9]. Other dialysis related factors that 
could cause an impaired vascular response include changes in plasma sodium, potassium, acid 
base composition and use of anti hypertensive drugs [21].   
As the decrease in CVP was comparable in both groups, a decrease in venous tone was 
unlikely responsible for the occurrence of the hypotensive episodes in our study. This is in 
agreement with previous study that showed a decreased venoconstriction in stable sessions as 
well [30,31].  
We conclude that dialysis related hypotension in our patient group did not result from an 
inability to maintain blood volume or from decreased cardiac filling. Hypotension appeared to 
result from the inability to adequately increase arteriolar tone and a reduction in left 
ventricular function. Both vascular tone and left ventricular function appeared to be impaired 
by the dialysis procedure. 
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Effect of Vasoconstriction on Relative Blood Volume 
 
 
 
Chapter 7: Norepinephrine-Induced Vasoconstriction Results in Decreased 
Blood Volume. 
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Abstract  
Hypotension during hemodialysis is due to an inadequate cardiovascular response to  
ultrafiltration induced hypovolemia.  In some studies, it is suggested that plasma volume 
could decrease by vasoconstriction, whereas several other studies in non dialysis patients 
observed a decrease in plasma volume. We studied the effect of norepinephrine induced 
vasoconstriction, compared to no infusion, on Relative Blood Volume in six dialysis patients. 
During the infusion we measured RBV, blood pressure, Stroke Volume Index, Ejection 
Fraction , Heart Rate, and body temperature.  
At baseline, both groups were comparable. At the end of infusion or at the comparable 
moment, no significant change in SI (-4 ± 21 vs 0 ± 8 %), HR (-5 ± 19 vs –4 ± 5%), EF (7 ± 
14 versus –2 ± 10%)  and CI (-10 ± 21 versus –3 ±  6%), and T body  (0 ± 2 versus –1 ± 1 %) 
were observed. However, a significant increase in SAP (27 ± 12 vs 0 ± 8 %; p<0.01) and 
TPRI (47 ± 47 versus 4 ± 17%; p<0.01) was found. This decrease was concomitant with a 
significant decrease in RBV (-9±.3 vs. 0±1 % p<0.01).  
We conclude that a norepinephrine induced increase in total peripheral resistance results in a 
decrease in RBV. This indicates that the improved hemodynamic stability during 
hemodialysis through vasoconstriction can be accompanied by a decrease in RBV, and part of 
the variability in blood volume may be due to changes in arterial tone.  
 
Introduction 
Hypotension is a major complication during hemodialysis (HD) [1]. Decreased plasma 
volume preservation, due to the fluid withdrawal from the intravascular space and a delay in 
plasma refilling by ultrafiltration, combined with inadequate compensatory vasoconstriction 
are directly responsible for this phenomenon [2,3]. The Relative Blood Volume (RBV) can be 
derived from the measured percentual changes in total protein concentration. Blood volume 
monitoring (BVM) enables us to measure the relative changes in blood volume (RBV) 
continuously during hemodialysis in the arterial bloodline [4]. It has been thought that an 
increase in peripheral arterial resistance during dialysis can increase venous return by means 
of the DeJagher-Krogh phenomenon [5,6,7]. This implies that when arterial resistance is 
increased, flow and intra-capillary pressure are reduced and vascular refilling is increased. 
Moreover, due to passive recoil, venous capacity is decreased and sequestered blood is 
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translocated back to the heart. Consequently it is suggested that arterial vasoconstriction 
increases RBV [8-10].  
However, evidence for a positive correlation between changes in plasma volume and 
peripheral resistance has never been found. Evenmore, there is evidence suggesting an  
inverse relationship. In non-dialysis patients plasma volume decreased as a result of an 
adrenergically induced vasoconstriction. [11-14]. Moreover, both during diffusive dialysis 
and glucose infusion, procedures in which vascular resistance is decreased, we observed a 
concomitant increase in RBV [15,16]. Dialysis, using a lower dialysate temperature, increases 
peripheral resistance but decreases RBV [17].  
In order to clarify the relationship between vascular resistance and plasma volume, we studied 
the effect of norepinephrine induced vasoconstriction, compared to no infusion, on RBV in 
six dialysis patients. During the infusion we measured RBV, Blood Pressure, Stroke Volume 
Index, Ejection Fraction , Heart Rate, and Body Temperature.  
 
Material and methods 
Patients 
We studied six patients requiring chronic hemodialysis.  None of the patients had severe 
valvular heart disease, heart failure (>NYHA class I) or arrhythmia’s. All medication was 
stopped on the day of the investigation. In the patients using ß blockers, this medication was 
withdrawn the day before the experiment. The ethical review committee of our hospital 
approved the study and written informed consent was obtained from all patients.  
 
Study design 
Each patient was studied during two dialysis sessions, which were performed on the same day 
of the week. On arrival, the patients were weighted and were placed in a dialysis chair, where 
they rested for 30 min (t= -30). During the study, the patients remained supine and no food or 
beverages were provided throughout the experiment. The patients were connected to the 
extracorporeal circuit (Fresenius 4008H machines with Fresenius F60-S polysulphone 
artificial kidneys and BVM/BTM arterial and venous lines; Fresenius MC Bad Homburg; 
Germany). During connection to the dialysis circuit, the priming volume of saline was 
discarded. At the start of this procedure blood was drawn from the access for laboratory 
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measurements. Blood flow was set at 250 ml/min. Neither diffusive dialysis nor ultrafiltration 
was performed throughout the investigation. After being connected to the dialysis circuit 
RBV, Systolic, diastolic and mean arterial blood pressures (SAP, DAP, MAP) and heart rate 
(HR) were measured continuously throughout the experiment. At the start of the experiment 
(t=0), echocardiography was performed to obtain Stroke Volume, and Ejection Fraction. 
Directly after these measurements (t=0 min), either Norepinephrine (Nor) was infused or a 
control experiment was performed in which no infusion was given (Cont).  Nor was given at 
an initial dose of  0.02 g/kg/min I.V. This was increased with 0.03 g/kg/min each 5 minutes 
until after 20 minutes a maximum dose of 0.14 g/kg/min was reached or until systolic blood 
pressure was raised by more than 30%. The infusions and control experiments were 
performed in random order and the patient was blinded to the infusion. Ten and thirty minutes 
(t=10 and t=30) after the start of the Nor, or at the comparable moments for the Cont 
experiments, a second and a third echographic measuments were done. Moreover, 
temperature measurements were performed. After these measurements the study was ended. 
For safety reasons dialysis was started at least 10 minutes after the infusion was discontinued.  
 
Measurements 
 RBV was measured continuously throughout the experiment by means of a blood volume 
monitor (BVM, Fresenius, Bad Homburg, Germany). The blood volume monitor measures 
the total protein concentration in the arterial bloodline, which is the sum of hemoglobin and 
plasma proteins in the vascular space. Changes in total protein concentration during dialysis 
are used to estimate changes in plasma volume. This method has a very good agreement with 
a standard reference method involving calculation of RBV from serial measurements of 
hemoglobin levels (SD 1.7%, r > 0.96) and allows precise and reliable measurement of RBV 
[4]. Systolic, diastolic and mean arterial blood pressures (SAP, DAP, MAP) and heart rate 
(HR) were measured continuously throughout the experiment by the Finapres device 
(Ohmeda 2300, Englewood, CO), using the middle finger of the nonfistula arm. This 
apparatus measures the blood volume under an infrared plethysmograph. When blood volume 
is kept constant at a set point value by controlling the cuff pressure, SAP and HR can be 
calculated from these changes in cuff pressure. This method has been validated in many 
studies against invasive blood pressure measurements [18].  Echocardiograms were obtained 
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using a ultrasound machine (Sonos 5500, Hewlett Packard Medical products, Boston, MA). 
The volume of the left ventricle was calculated from a two dimensional parasternal view. 
Endocardial borders of these views were digitally traced at the end of systole and diastole and 
their volume was calculated. Stroke volume was calculated as the difference between end-
diastolic and end-systolic volume. A mean stroke volume of five consecutive beats was taken. 
Stroke Volume Index (SI) was calculated from stroke volume and body surface area, which 
was calculated from length and height, according the Dubois formula [19]. Directly after each 
ultrasonography, SAP, DAP and MAP were also measured by an oscillometric device 
(Accutor 3, Datascope Co., Paramus, NJ). Body Temperature (Tbody) was measured by an ear 
thermometer after each ultrasonography. Total peripheral resistance index (TPRI) was 
calculated from MAP, measured by datascope, and cardiac index (CI).  
 
Statistical analysis 
Hemodynamic data are given as mean ± standard deviation. Differences during the 
experiments and between groups were tested with the Analysis of Variance with repeated 
measurements. If significant multiple comparisons were made using the Student Neuman 
Keuls test. The Graphpad Prism software program was used to perform these calculations. A 
p-value of less than 0.05 was assumed to indicate statistical significance.  
 
Results  
Patients 
Six hemodialysis patients, five male and one female participated in the study (Median time on 
dialysis 2.6 years, range 1.5- 4 years; Table 1). The median age of the subjects was 53  11 
years (range; 35-62 years: Table 1). Median residual diuresis was 252 mL/ 24 hr (range 0-950 
mL/ 24 hr ml; Table 1). Three patients had a residual diuresis of less than 5 mL/day, while the 
other three had a rest diuresis of 500 mL/liter or more. One patient with diabetes was 
included, and two patients were hypertensive.  Mean dry weight was 70.6 ± 12.9 kg and 
interdialytic weight gain was comparable in the two sessions (3.6 ± 1.4 kg versus 3.6 ± 2.3 kg; 
n.s.; Table 1).  
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Table 1. Characteristics of the patients    
           
  1 2 3 4 5 6 Mean  SD 
           
M/F  M M M F M M    
age (yr)  57 52 54 36 62 35 49 ± 11 
time on dialysis (yr) 4.0 3.0 1.5 2.5 2.0 2.5 2.6 ± 0.9 
dry weight (kg) 69.0 75.0 69.0 47.5 77.5 85.5 70.6 ± 12.9 
IWG(%) Cont  2.9 2.9 5.1 3,4 1.9 5.4 3.6 ± 1.4 
IWG(%) Nor  2.0 2.8 5.6 2.1 1.2 7.9 3.6 ± 2.3 
residual diuresis 5 825 0 0 950 500 380 ± 440 
           
         Y/N  
Diabetes mellitus - - - + - +  2/4  
hypertension  - - - + + -  2/4  
           
Medication           
beta-adrenergic 
blockers 
- - - - + -  1/5  
ACE-inhibitors  - + - + + +  4/6  
Calcium antagonists - - - + + -  2/4  
Nitrates  - - - - + -  1/5  
IWG, interdialytic weight gain; Cont, control ; Nor, Norepinephrine 
 
 
 
Table 2. Baseline Laboratory data   
  Control                      
Norepinephrine 
             p 
urea (mmol/L) 22.9 ± 6.3 22.2 ± 4.7 n.s. 
osmolarity 
(mosmol/L) 
298 ± 9 299 ± 10 n.s. 
Na (mmol/L) 138 ± 3 138 ± 3 n.s. 
K (mmol/L) 4.8 ± 0.9 4.7 ± 0.5 n.s. 
Ca (mmol/L) 2.38 ± 0.12 2.43 ± 0.08 n.s. 
ionized Ca (mmol/L) 1.24 ± 0.05 1.20 ± 0.07 n.s. 
PO4 (mmol/L) 1.47 ± 0.46 1.51 ± 0.48 n.s. 
Alb (g/L) 38 ± 2 38 ± 2 n.s. 
pH  7.39 ± 0.02 7.40 ± 0.03 n.s. 
pCO2 (kPa) 5.2 ± 0.5 4.8 ± 0.6 n.s. 
HCO3- 22.7 ± 2.4 23.1 ± 3.2 n.s. 
PTH (pmol/L) 93 ± 78 119 ± 74 n.s. 
Hb (mmol/L) 7.4 ± 1.2 7.1 ± 1.0 n.s. 
Ht  (L/L) 0.35 ± 0.06 0.34 ± 0.05 n.s. 
 
Data are ± standard deviation.  Na, sodium; K, potassium;Ca, Calcium; PO4, phosphate; Alb, Albumin, 
pCO2carbon dioxide tension, HCO3-, bicarbonate; PTH, parathormone; Hb, Hemoglobin; Ht, hematocrit  n.s., 
not significant 
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Table 3. Baseline Hemodynamics       
         
  No infusion  Noradrenaline  p 
SAP (mmHg) 165 ± 23  139 ± 35  n.s. 
MAP (mmHg) 113 ± 20  101 ± 20  n.s. 
DAP (mmHg) 84 ± 12  71 ± 13  n.s. 
HR (b.p.m.) 75 ± 17  78 ± 12  n.s. 
CI (ml/m2) 1516 ± 458  1283 ± 541  n.s. 
T body(C) 36,3 ± 1,0  36,9 ± 0,9  n.s. 
n.s., not significant          
 
 
Baseline Values  
At baseline, no differences were found in laboratory data between the Cont and the Nor 
sessions (Table 2).  SAP tended to be lower during the Nor experiment, but this did not reach 
statistical significance (139 ± 35 versus 165 ± 23 mmHg; Table 3). Datascope blood pressure 
measurements were comparable to the Finapres measurements and were  165 ± 24 vs 142 ± 
34 mmHg for Nor and Cont respectively (Table 3). HR, SI, and TPRI were comparable in 
both experiments (75±17 vs 78±12 b.p.m., 20 ± 3 vs 18 ± 6 ml/m2, and 6154 ± 1486 vs 6940 
± 3215 dynes.s m2/cm5 respectively; Table 3) Core Temperature (Tbody) and EF were 
comparable between both groups (36.3 ± 1.0 vs. 36.9 ± 0.9 C, and 47±17 vs. 42±7 %  
respectively; Table 3).  
 
Response to norepinephrine 
The patients tolerated the infusion of Norepinephrine well with minor complaints of anxiety 
and no palpitations. All patients completed the protocol. At 10 minutes SAP tended to 
increase in the Nor group, RBV decreased as compared to baseline (-3 ± 2 %; p< 0.05; Table 
3, Figure 1). HR, MAP, SI and TPRI did not change significantly (Figure 1; Table 4).  
At 30 minutes both SAP and DAP were increased in the Norepinephrine group both compared 
to baseline as compared to the Nor group (SAP; 21±12 %, DAP; 18±12 % by finapres and 
datascope respectively; p< 0.05; Table 4, Figure 1).   
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Table 4. Hemodynamic changes during sessions in the No Infusions and the Norepinephrine group 
 
 Control Norepineprine 
  t= 10 
min 
 t=30 min t= 10 min t=30 min  
RBV(%) 0 ± 1 0 ± 1 -3 ± 2 a -9 ± 3  a,b 
SAP(%) -6 ± 8 -2 ± 14 12 ± 10 a b 24 ± 15 a,b 
MAP(%) 0 ± 12 4 ± 16 13 ± 15 25 ± 17 a,b 
DAP (%) -2 ± 10 4 ± 14 14 ± 5 18 ± 12 a,b 
HR(%) -4 ± 2 -4 ± 5 -6 ± 13 -5 ± 19 
SI(%) 5 ± 18 0 ± 8 1 ± 10 -4 ± 21 
CI(%) 3 ± 19 -3 ± 6 4 ± 18 -10 ± 21 
TPRI (%) 1 ± 16 4 ± 17 6 ± 14 47 ± 47 a 
T body 1 ± 2 0 ± 2 -1 ± 1 -1 ± 1 
EF (%) -5 ± 7 -2 ± 10 3 ± 10 7 ± 14 
 
RBV. Relative blood volume; SAP systolic arterial pressure; MAP, Mean arterial pressur; DAP , diastolic 
arterial pressure; HR, heart rate; SI, Stroke volume Index; CI, Cardiac Index; TPRI, total peripheral resistance 
index , T body, body temperature; EF, ejection fraction  
a significant compared to baseline p< 0.05   b significant compared to control 
 
There was a good agreement between changes in blood pressure by datascope and by finapres. 
No significant change in SI (-4 ± 21 vs 0 ± 8 %; p>0.05), HR (-5 ± 19 versus –4 ± 5; p>0.05), 
EF (7 ± 14 vs –2 ± 10; p>0.05), CI (-10 ± 21 versus –3 ± 6 %; p>0.05) and T body  (-1 ±1 vs 0 
± 2% p>0.05) were observed between both groups  (Table 4, Figure 1). However, in the Nor 
group TPRI increased as compared to baseline (47 ± 47 %; p < 0.05), whereas in the Cont 
group TPRI did not change significantly (4 ± 17 % by finapres; p>0.05) (Table 4).  
This increase in vascular resistance decrease was accompanied by a concomitant decrease in 
RBV (-9±3 vs 0±1 % (p<0.001; Table 4, Figure 1) RBV dropped in all patients and no 
relation was found between the decrease in RBV and the patient characteristics, such as the 
presence of hypertension and/or diabetes and the amount of volume overload.  
was found. The increase in TPRI did not result from Cooling of blood by the extracorporal 
circuit, as BT (-1±1 vs 0±2 C) did not decrease significantly.  
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Discussion  
This study demonstrates that infusion of norepinephrine in patients on dialysis results in a 
direct and substantial  decrease in RBV.  
The observed decrease in RBV during the norepinephrine infusions can be either due to a 
relative increase in the erythrocyte cell mass or to a decrease in the total amount of plasma 
fluid.  
Erythrocyte cell mass could change during vasocontriction, as the erythrocyte cell mass is not 
uniformly mixed and the hematocrit of the peripheral vascular beds is much lower than that of 
the large vessels [20,21].  However, it is unlikely that this mechanism could explain the 
observed decrease in RBV, as during vasoconstriction, blood with a relatively low eryhrocyte 
content is shifted to the large vessels and arterial bloodline, in which RBV is measured. This 
would result in an increase in RBV, rather than a decrease. 
Erythrocyte cell mass could also be increased by splenic contraction. However, previous 
studies showed, that in humans, the spleen does not serve as an important reservoir for red 
blood cells over splenic constraction,  could only account for an increase of 1-2% [22,23].   
Changes in plasma volume can be explained by Starlings law, which determines the fluid shift 
between the vascular and the interstitial compartments and depends on changes in hydrostatic 
and oncotic capillary pressure and on the filtration coefficient of the capillary basement 
membrane [24]. Reduced perfusion of capillary beds during arteriolar constriction leading to a 
decrease of the vascular surface area could explain the norepinephrine-induced decline in 
RBV. A decrease in perfused vascular beds could also increase hydrostatic capillary pressure 
in the remaining vascular beds. This could in turn lead to a decreased vascular refilling and 
hence blood volume. However, there is only a slight relation between the change in peripheral 
resistance and RBV. This can be explained by the fact that total peripheral resistance is 
calculated from blood pressure and cardiac out put. Each of these measurements varies, and 
their summed contribution can lead to considerable variability in the calculated TPR. On the 
other hand, the constriction of the veins could also contribute to the decrease in RBV. When 
vasoconstriction is more pronounced at the venular than at the arteriolar end of the capillaries, 
intracapillary hydrostatic pressure will rise, thereby promoting a shift of fluid from the 
intravasular to the interstitial compartment [25]. Many previous studies lend evidence that 
blood volume increases after a decrease in total peripheral resistance by arterial vasodilatation 
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[26-28]. Moreover, the increase in plasma volume after vasodilatation induced by infusion of 
an alpha-receptor antagonist, was found to be inversely related to the change in CVP [30].  
The results of our study are in accordance with most previous studies in which the effect of 
norepinephrine on plasma volume was studied in non dialysis patients or animals [11-14]. 
In one study, erythrocyte cell mass increased. However, this study was done in dogs in which 
the spleen is a far more important red blood cell reservoir [11]. 
In another study, a norepinephrine-induced increase in peripheral resistance showed no 
significant change in plasma volume, although hematocrit was increased in three out of four 
patients [13]. This experiment differs from ours in the fact that norepinephrine was given for 
six hours, while in our experiment norepinephrine was given for only twenty minutes. It is 
known that in response to prolonged norepinephrine infusions the cardiac output increases 
and consequently peripheral resistance decreases, due to the release of endogenous 
epinephrine [29]. This could diminish the increase in RBV.  
The results of our study have major implications for the interpretation of measurements and 
the applications of a biofeed back control systems in order to prevent dialysis related 
hypotension. When performing maneuvers to improve vascular stability during dialysis, such 
as isolated ultrafiltration, or lowering dialysate temperature, RBV decreases and the critical 
RBV, at which hypotension occurs, will be lowered [17,30]. This can explain the findings of 
Schneditz et al. who describe improved hemodynamic stability, in spite of a greater reduction 
in RBV during cold dialysis. Differences in arteriolar tone may also explain the observed 
variabilility in RBV during hemodialysis and the difficulties to observe a critical  value, at 
which hypotension occurs [31]. Conversely, an increase in RBV does not always lead to an 
increase in effective plasma volume and cardiac filling pressure. Hypertonic glucose infusions 
during dialysis result in a greater increase in RBV than equal volumes of mannitol, which has 
the same osmolarity, molecule mass and charge [16].  
These difference could be related to a decline in vascular tone during the glucose infusion. 
Moreover, during diffusive dialysis, a procedure in which vascular resistance is decreased, we 
observed an increase in RBV [15]. 
We conclude that a norepinephrine induced increase in total peripheral resistance results in a 
decrease in RBV. This indicates that the improved hemodynamic stability during 
hemodialysis through vasoconstriction can be accompanied by a decrease when n RBV, and 
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part of the variability in blood volume may be due to changes in arterial tone. Such changes 
must be taken into account of RBV measurements are used to improve the hemodynamic 
tolerance of dialysis 
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LBNP in Hemodialysis Patients 
 
 
 
Chapter 8: Hemodynamic response to lower body negative pressure in 
hemodialysis patients. 
 143
Chapter 8 
 
Abstract 
Hypovolemia is thought to play an important role in the pathogenesis of dialysis-related 
hypotension. We studied the effect of hypovolemia simulated by lower body negative 
pressure (LBNP) in 11 hypotension prone (HP) and 11 hypotension resistant (HR) 
hemodialysis patients. LBNP was applied step-wise from 0, to -20 to -40 mmHg. Systolic 
arterial pressure, heart rate and central venous pressure (CVP) were recorded continuously 
after canulation of the right jugular vein. Stroke Volume Index (SI) was measured at each step 
echocardiographically. At the end of each level of LBNP, blood samples were taken for 
norepinephrine (NE), epinephrine (E) and atrial natriuretic peptide (ANP) levels. At baseline, 
CVP (12±5 and 16±7 mmHg), heart rate (72±9 and 70±13 bpm), Cardiac index (2.3±0.6 and 
2.5±0.9 l/min), NE (median ,341 pg/mL [range, 198 to 789 pg/mL], and 365 pg/mL [range, 
177 to 675 pg./mL] or 2.02 nmol/L [range, 1.17 to 4.66 nmol/L] and 2.16 nmol/L [range, 
1.05-4.00 nmol/L]), E (median, 46 pg/mL [range, 18 to 339 pg/mL] and 58 pg/mL [range, 21-
122 pg/mL] or 251 pmol/L [range, 98-1951 pmol/L] and 317 pmol/L [range, 115-666 
pmol/L]) were similar, whereas systolic arterial pressure (141±26 vs164±22 mmHg) and ANP 
(441 (152-1330) vs. 804 (517-3560) pg./ml or ng/L) were lower (p<0.05) in HP patients. In 
response to LBNP (-40 mmHg) CVP decreased by 6.5±4.0 mmHg in the HP-group and by 
4.9±4.9 mmHg in the HR-group. In HP patients, this decrease was associated with a greater 
fall in SI (37 ± 16% versus 27 ± 16%) and systolic arterial pressure (19±21% versus 4±14%) 
than HR patients. Plasma ANP levels did not change, whereas the rise in NE and E was 
similar in HP and HR patients. We conclude that patients which frequently experience 
episodes of hypotension during dialysis are also prone to develop hypotension during LBNP, 
which results from reduced myocardial contractile reserve and/or inadequate sympathetic 
tone. 
 
Introduction 
Hypotension is an important cause of morbidity during hemodialysis treatment and occurs in 
approximately 30% of the dialysis sessions. Factors that may contribute to the occurrence of 
hemodialysis-induced hypotension include the reduction in blood volume and the osmotic 
shifts that occur during dialysis [1]. Failure of the heart and/or the autonomous nervous 
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system to respond to the hypovolemia induced by hemodialysis may also result in decreased 
blood pressure preservation [2,3]. The degree in which hypovolemia occurs during dialysis is 
highly variable. We have demonstrated that both intra- and inter-individual variability of 
blood volume changes during dialysis is high and cannot be explained by differences in 
ultrafiltration rate [4]. As these factors may all interact, it is difficult to establish the relative 
importance of each factor during hemodialysis.  
Applying lower body negative pressure (LBNP) allows the isolated manipulation of venous 
return to the heart [5], thereby mimicking controlled hypovolemia. In healthy volunteers, 
LBNP causes a reduction in central venous pressure (CVP) starting at –20 mmHg LBNP 
followed by a reduction in stroke volume index (SI) and cardiac index at higher levels. Blood 
pressure usually remains unchanged due to an increase in total peripheral resistance and heart 
rate, but hypotension may occur at levels of -40 mmHg and higher [5-9]. In healthy 
volunteers, hypovolemia increases the risk for hypotension [8]. 
In order to determine the importance of hypovolemia in the pathogenesis of dialysis related 
hypotension, we studied the cardiovascular response to LBNP in hypotension prone and 
hypotension resistant hemodialysis patients. 
 
Patients and Methods 
Patients 
Twenty-two patients on chronic hemodialysis, 11 hypotension-prone (HP) and 11 
hypotension-resistant (HR), were studied. The ethical committee of the University Hospital 
Rotterdam-Dijkzigt approved the study, and all participants gave written informed consent. 
Criteria for classification as hypotension-prone were: decrease of systolic arterial pressure to 
less then 100 mmHg accompanied by symptoms of hypotension (dizziness and/or syncope) 
occurring in at least one third of dialysis sessions during the last three months prior to 
inclusion in the study. Patients with diabetes mellitus were excluded from the study.  
Age and sex distribution was not different in both groups (Table 1). Time on dialysis was also 
not significantly different in HP and HR patients. The average number of antihypertensive 
drugs was 1.0 in HP patients vs. 1.6 in HR patients (n.s.). All dialysis treatments were 
performed on a trice-weekly basis, using bicarbonate buffered dialysate and biocompatible 
membranes (Hemophane or Polysulphone). Dry weight was considered optimal when patients 
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remained without symptoms of dyspnea or edema during the interdialytic period. Inferior 
caval vein diameter measurement was performed at intervals of one month. Overhydration 
was defined as a caval vein diameter of more than 11.4 and underhydration as a caval vein 
diameter of less than 8 mm/m2 body surface area [10,11]. When inferior caval vein diameter 
before dialysis was outside the normal limits, dry weight was adjusted accordingly.  
 
 
Table 1. Characteristics of the patients      
      
 hypotension prone hypotension resistant  p 
         
n = 11 11    
age (yr) 61.5 ± 15 56.8 ± 9.4  n.s. 
M/F 8/3 8/3    
time on dialysis (yr) 2.82 ± 1.65 1.89 ± 1.9  n.s. 
Interdialytic weight gain (kg) 2.76 ± 0.83 3.36 ± 1.1  n.s. 
        
Medication      
beta-adrenergic blockers 4 7   n.s. 
ACE-inhibitors 2 3   n.s. 
Calcium antagonists 3 5   n.s. 
Nitrates 2 3   n.s. 
      
 
Study design 
All studies were performed in the morning before hemodialysis, in a quiet room with an 
ambient temperature of 24 °C. Smoking and beverages containing alcohol or caffeine were 
avoided for at least 12 hours before the investigation. The patients were placed in a box up to 
the iliac crest, and an airtight connection was attached to the patient’s waist. Evacuating air 
from the box created LBNP. After local anesthesia, catheter with a diameter of 0.6 mm was 
inserted into the right jugular vein for measurement of CVP. Blood pressure and heart rate 
were measured continuously.  
After a 45-minute equilibration period, baseline echocardiography was performed and 
baseline blood samples were collected. Subsequently, LBNP of -20 mmHg was applied for 15 
minutes. At the end of this period, echocardiography and blood sampling were repeated. 
LBNP was subsequently decreased to -40 mmHg for 15 minutes, again followed by 
echocardiography and blood sample collection.  
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Measurements 
Blood pressure and heart rate were registered continuously through finger blood pressure 
measurement by the Finapres device (Ohmeda 2300, Englewood CO, USA). CVP was 
measured continuously using a pressure transducer (Ohmeda single transducer kit) positioned 
at heart level, and a monitor (HP 1290A, Hewlett Packard, California, USA). The average of 
all blood pressure, heart rate and CVP measurements during a one-minute period at the end of 
equilibration, -20 mmHg and -40 mmHg LBNP, were used for analysis. Left ventricular end-
diastolic volume, Stroke volume and cardiac output were assessed in triplicate by 
echocardiography, using the bi-plane discs method. The volume of the ventricle was 
calculated from the apical two- and four chamber views using a modification of Simpson’s 
rule[12]. The principle of Simpson’s rule is to divide the left ventricle into known slices of 
thickness. The volume of the ventricle is then equal to the sum of the volume of the slices. 
Two and four chamber apical views were recorded and stored. The endocardial borders of 
these views were digitally traced at end diastole and end systole. Each projection was divided 
in 20 sections along the long axis. Then the volumes were computed. Stroke volume was 
calculated as the difference between end-diastolic and end-systolic volume. Diastolic left 
ventricular function was assessed by pulse wave Doppler evaluation of left ventricular filling. 
The pulse wave Doppler studies were recorded from the apical four chamber view, with the 
doppler sampler positioned just within the inflow portion of the left ventricle, midway 
between the annular margins of the mitral valve. Mitral velocity profiles were digitized from 
the modal velocity of the Doppler tracings. After measuring early (E) and atrial (A) flow over 
the mitral valve, the E/A ratio was calculated. Total peripheral resistance was calculated from 
mean arterial pressure and cardiac output. Concentrations of plasma epinephrine (E; normal 
limit: < 120 pg/ml (< 655 pmol/L) and norepinephrine (NE; normal limits: 100-600 pg/ml 
(0.59-3.55 nmol/L) were measured by fluorometric detection after high-performance liquid 
chromatography as described previously [13]. Plasma atrial natriuretic peptide levels (ANP; 
normal limits: 60-120ng/L) were measured by means of a commercially available 
radioimmunoassay  (Nichols institute, Wijchen, The Netherlands) [14].  
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Statistics  
Hemodynamic data are given as mean ± standard deviation. Stroke volume, cardiac output, 
and total peripheral resistance are expressed per m2 body surface area and are mentioned SI, 
Cardiac index, and total peripheral resistance index respectively . Differences in the baseline 
data were tested with the unpaired two-tailed Student’s t-test. Changes during LBNP were 
analyzed using Analysis of Variance for repeated measurements, in the case of a significant F-
ratio followed by the Student Neuman Keuls test for multiple comparisons.  
Plasma concentrations of vasoactive hormones are given as median values and range. 
Baseline data were tested with Mann-Whitney’s non-parametric test. Changes during LBNP 
were tested with Friedman P-test, when significant, followed by the Dunn test for multiple 
comparisons.   
Of all parameters, changes at –20 and –40 mmHg LBNP are given as percentages of change 
compared to baseline. However, the changes in CVP are given as absolute values. 
Correlations were assessed by calculating Pearson’s correlation coefficient, in the case of 
vasoactive hormones after log-transformation. A p-value of less than 0.05 was assumed to 
indicate statistical significance.  
 
Results 
Baseline values 
At baseline, CVP tended to be lower in HP patients, but this difference was not significant 
(Table 2). Baseline SAP was significantly lower in the HP-group than in the HR-group. Heart 
rate, SI, cardiac index and total peripheral resistance index were all similar in both groups. 
Diastolic dysfunction (E/A ratio <1.0) was present in 19 out of 22 subjects, with no 
significant differences between both groups. Median values of NE and E were within normal 
limits and were not different in the two groups. However, all patients in both groups had 
elevated ANP-levels. In HR-patients, ANP levels were significantly higher than in HP-
patients.  
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Table 2 Baseline hemodynamic and hormonal data in hypotension-prone (HP) and hypotension-resistant (HR) 
patients 
 HP                   HR  p 
  
 
     
n =  11       11     
        
Hemodynamics        
CVP (mmHg) 12 ± 5  16 ± 7  n.s. 
SAP (mmHg) 141 ± 26  164 ± 22  <0.05 
MAP (mmHg) 95 ± 11  110 ± 15  n.s. 
DAP (mmHg) 73 ± 8  85 ± 14  n.s. 
HR (bpm) 72 ± 9  70 ± 13  n.s. 
SV (ml) 55 ± 11  63 ± 27  n.s. 
CO (l/min) 4.0 ± 1.1  4.3 ± 1.6  n.s. 
TPR (dyne/sec/cm-5) 205
5
± 645  2297 ± 749  n.s. 
E/A ratio 0.85 ± 0.30  0.85 ± 0.44  n.s. 
E/A ratio > 1 2/11     1/11    
        
Vasoactive hormones        
NE (pg/ml) 341 ( 198 - 789 ) 365 ( 177 - 675 )  n.s. 
E (pg/ml) 46 ( 18 - 339 ) 58 ( 21 - 122 )  n.s. 
ANP (pg/ml) 441 ( 152 - 1330 ) 804 ( 517 - 3560 )  <0.05 
         
        
Note. Hemodynamic data are expressed as mean ± SD, hormonal data expressed as median (range). To Convert 
to SI units: for norepinephrine, 1pg/mL = 0.00591 nmol/L; for epinephrine, 1 pg/mL= 5.46 pmol/L; for ANP, 1 
pg/mL = 1 ng/L. Abbreviation: NS, not significant. 
 
 
Hemodynamic and hormonal changes during LBNP 
In HP-patients, -40 mmHg LBNP induced a decrease in CVP of 6.5 ± 4.0 mmHg. Systolic 
arterial pressure decreased significantly by 19 ± 21% at -40 mmHg LBNP. Interestingly, heart 
rate did not change during the investigation. SI decreased by 37 ± 16%, while cardiac index 
decreased by 34 ± 18% at –40 mmHg LBNP. Total peripheral resistance index increased by 
44 ± 47%. Both E and NE levels increased significantly at –40 mmHg LBNP, while ANP did 
not change. 
In HR-patients, CVP decreased by 4.9 ± 4.9 mmHg at –40 mmHg LBNP. Blood pressure and 
heart rate remained constant, while SI and cardiac index decreased by 27 ± 16% and 24 ± 
19% respectively. These changes were accompanied by a 38 ± 25% increase in total
Chapter  8  
 
Table 3. Hemodynamic and hormonal changes during LBNP in hypotension-prone (HP) and hypotension-
resistant (HR) patients 
 HP HR 
LBNP -20 mmHg LBNP   -40 mmHg LBNP -20 mmHg LBNP -40 mmHg LBNP 
           
Hemodynamics  
 
        
CVP (mmHg) -4.0 ± 2.4 c -6.5 ± 4.0 c,e -3.8 ± 3.5 b -4.9 ± 4.9 c 
SAP (%) -3 ± 7 -19 ± 21 b,d 0 ± 6  -4 ± 14  
MAP (%) 1 ± 9 -10 ± 18   3 ± 7  2 ± 13   n.s.
DAP (%) 3 ± 10 -2 ± 18   5 ± 7  6 ± 14   n.s.
HR (%) 0 ± 7 5 ± 14   -1 ± 6  4 ± 15   n.s.
SV (%) -20 ± 13 c -37 ± 16 c,f  -16 ± 18  -27 ± 16 b,d  <0.05 
CO (%) -19 ± 17 b -34 ± 18 c,e -17 ± 17  -24 ± 19 c,d   n.s.
TPR (%) 29 ± 29 44 ± 47 b  27 ± 21  38 ± 25 c  n.s.
              
Neurohormones             
NE (%) 28 (3-61) a 87 (27-182)c 21 (0-73) 53 (15-86)c n.s.
E (%) 33 (0-66) 144 (-4-1030)b 37 (-17-71) 115 (17-625)b,d n.s.
ANP (%) 28 (3-61) -4 (-31-29) 1 (-33-132) -19 (-42-104) n.s.
 
Hemodyamic changes are mean ± SD. LBNP, lower body negative pressure; CVP, central venous pressure; SAP, 
MAP and DAP, systolic, mean and diastolic 
arterial pressure; HR, heart rate; SV, stroke volume; CO, cardiac output; TPR, total peripheral resistance. 
Hormonal changes are given as median and range NE, norepinephrin; E, epinephrin; ANP, atrial natriuretic 
peptide; a p<0.05, b p<0.01 and c p<0.001 vs baseline; d p<0.05, e p<0.01, f p<0.001 vs -20 mmHg LBNP 
 
 
peripheral resistance index. Again E and NE levels increased significantly at –40 mmHg 
LBNP and ANP-levels remained constant.  
The decrease in CVP was comparable in HP and HR-patients. However, this resulted in a 
decrease in systolic arterial pressure in HP-patients, but not in HR patients. At –40 mmHg 
LBNP, the decrease in SI was significantly higher in HP than in HR patients (Table 3; 
p<0.05). Changes in cardiac index, total peripheral resistance index, NE-, E- and ANP-levels 
were not significantly different in both groups. During –40 mmHg of LBNP five patients 
experienced symptomatic hypotension, four of which were classified as hypotension prone. In 
order to study the factors responsible for hypotension in these patients we also presented the 
data in these patients compared to the patients in which hypotension did not occur during 
 150
LBNP in Hemodialysis Patients 
LBNP (Table 4). In the patients in which hypotension occurred during LBNP, the decrease in 
CVP was not significantly diff 
rent from the other patients. There was however a significantly greater reduction in SV and 
cardiac index. Heart rate remained stable, although it decreased in 4 out of 5 hypotensive 
subjects. Plasma E levels increased in both groups, but the magnitude of the increase was 
fourfold higher in the patients that became hypotensive. 
 
 
 
 
Table 4. Hemodynamic and hormonal data in patients who experienced hypotension during -40 mmHg LBNP 
 
 Patients  1  2  3  4  5  
hypotensive 
patients (H) 
 (1-5) 
all other patients  
H 
versus. 
all other 
patients
 Group: HP HP HP HP HR    P 
No. of patients       5      
Haemodynamic  
Changes 
          
17 
    
 CVP (mmHg) -12 -10 -4 -4 -2 -6.4 ± 4.3   -5.5 ± 3.2  n.s. 
 SAP (%) -47 -27 -57 -33 -41 -40.9 ± 11.7   -2.9 ± 12.1   
 MAP (%) -30 -23 -43 -24 -25 -29.0 ± 8.3   3.4 ± 11.4   
 DAP (%) -13 -15 -32 -20 -21 -20.2 ± 7.3   8.5 ± 7.2   
 HR (%) 28 -10 -15 -6 -26 -5.6 ± 20.3   7.5 ± 4.8  n.s. 
 SI (%) -50 -25 -48 -49 -40 -42.6 ± 10.8   -
23.9 
± 9.9  < 0.05 
 CI (%) -36 -32 -56 -52 -56 -46.5 ± 11.4   -
28.9 
± 9.4  < 0.05 
 TPRI (%) 10 14 29 59 68 36.2 ± 26.4   42.4 ± 22.9  n.s. 
Hormonal changes         
 NE (%) 141 84 91 45 21 84 (21 - 141) 62 (15 - 182)  n.s. 
 E (%) 415 147 1030 371 625 415 (147 - 1030) 81 (17 - 625)  < 0.05 
 ANP (%) 3 3 24 -15 -11 3 (-15 - 24) -15 (-42 - 104)  n.s. 
Medication         
 beta-blockers no no yes No no  1/5  10/17  < 0.05 
 
Hemodyamic changes are mean ± SD. LBNP, lower body negative pressure; CVP, central venous pressure; 
SAP, MAP and DAP, systolic, mean and diastolic arterial pressure; HR, heart rate; SV, stroke volume index;  
CO, cardiac  index; TPR, total peripheral resistance index. Hormonal changes are given as median and range  
NE, norepinephrin; E, epinephrin; ANP, atrial natriuretic peptide 
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Discussion 
In the present study we assessed whether the hemodynamic and neurohumoral responses to 
LBNP in HP and HR hemodialysis patients are different. Our findings showed that a 
comparable LBNP-induced decrease in CVP is associated with a greater fall in SI and systolic 
blood pressure in HP than in HR patients, whereas the neurohumoral responses between the 
two groups of patients did not differ. These findings could imply a greater dependency of SI 
on cardiac filling pressure in HP resulting from reduced diastolic function, inadequate 
sympathetic tone or impaired cardiac contractility. 
Baseline values of CVP and ANP were elevated in both groups of patients. Compared to HR 
patients, baseline values of ANP were lower and baseline values of CVP tended to be lower in 
HP patients. These findings strongly suggest that overhydration was less pronounced in the 
HP patients. This contention is supported by the finding that interdialytic weight gain (Table 
1) was lower in HP than in HR patients. 
An explanation why LBNP was associated with a greater decrease in SI in HP than in HR 
patients is not easy to provide. Echocardiographic examination did not reveal the presence of 
valvular, pericardial or pulmonary abnormalities that could cause a decrease in cardiac inflow 
in either HP or HR patients. Left ventricular hypertrophy and uremic myocardial fibrosis are 
commonly observed in hemodialysis patients[15]. These abnormalities impair ventricular 
relaxation and diastolic function, resulting in a decrease in SI when cardiac-filling pressure is 
lowered. Diastolic dysfunction can be diagnosed by considering the ratio of the mitral flow 
velocities of early ventricular filling to atrial assisted ventricular filling (E/A ratio), as 
measured by pulse wave Doppler Echocardiography [16]. An E/A ration below 1.0 indicates 
the presence of diastolic dysfunction. Of the patients participating in the present study almost 
all (19/22) had diastolic dysfunction. No difference in E/A ratios was observed between the 
HP and HR. A caveat for using the E/A ratio as a measure for diastolic function is the 
dependency of this parameter on volume status [17]. Unfortunately E/A ratio’s in the present 
study were only determined before application of LBNP and before hemodialysis. It is 
therefore possible that a difference in the diastolic properties of the left ventricle between the 
groups of subjects has been missed.  
Differences in blood pressure behavior during LBNP could be due changes in sympathetic 
tone and/or systolic function. Of the 22 patients studied five (four of the HP and one of the 
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HR group) developed hypotension during –40 mmHg of LBNP. In all five subjects the 
hypotension was caused by a decrease in cardiac index. Although the decrease in cardiac 
index was predominantly due to a fall in SI, heart rate in all but one of the subjects decreased 
as well.  
A reduction in heart rate during episodes of hypotension has been described by Converse et 
al, who ascribed this response to a paradoxical withdrawal of sympathetic activity [18]. This 
phenomenon, also known as the Bezold-Jarisch reflex, is thought to result from increased 
activity of left ventricular mechanoreceptors as a consequence of a decrease in stroke volume 
and increased cardiac contractility. This form of bradycardia-associated hypotension occurs as 
a result from marked hypovolemia [19].  
However, the results concerning the heart rate response have to be interpreted with care, as  
fluctuations in heart rate normally occur. Mean heart rate remained stable in the HP and a 
severe bradycardia occurred only in one patient, in the HR group. Therefore heart rate was of 
minor importance in the pathogenesis of hypotension during LBNP, although no increase in 
the baroreceptor mediated heart rate response was found. Beta blockade was not likely to be 
responsible for the impairment in the baroreceptor mediated heart rate response, as these were 
mainly used in non hypotensive patients.  It is known that bradycardia can exist independently 
of defects in the autonomic nervous system [20] 
Although plasma norepinephrine almost doubled, we found no differences in norepinephrine 
levels between hypotensive and non-hypotensive subjects. In view of the hypotensive 
response, the increase in plasma norepinephrine concentration in these subjects can be 
considered inappropriate. This would suggest the presence of sympathetic inhibition.  
In patients experiencing hypotension plasma epinephrine concentration was markedly 
increased. As hypotension is a powerful stimulus of epinephrine secretion by the adrenal 
gland and epinephrine concentrations were measured several minutes after the hypotensive 
episode, this could be considered a secondary phenomenon.  
SI was decreased in HP despite comparable filling pressures and sympathetic tone. This 
suggests a reduced sensitivity of  adrenoreceptors. 
The seemingly comparable level of sympathetic drive could also suggest an incapability to 
maintain sympatic tone. The pivotal role of the heart in patients prone to develop hypotension 
during dialysis can be demonstrated by infusion of dobutamine, a -adrenergic receptor 
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agonist. In this group patients, prone to develop hypotension during dialysis, we observed 
impaired myocardial contractile reserve in response to sympathetic stress [21]. These findings 
support the hypothesis of impaired myocardial contractile reserve in the pathogenesis of 
dialysis-induced hypotension. An impaired myocardial contractile reserve could be partly due 
to the fact that patients were by mean five years older and had spent by mean one year more 
on dialysis. 
We conclude that patients that frequently experience episodes of hypotension during dialysis 
are also prone to develop hypotension during LBNP. The hypotension during LBNP results 
from reduced myocardial contractile reserve and/or inadequate sympathetic tone. 
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Summary and Conclusions 
 
Chapter 1 is a brief introduction is to the physical principles and the technical procedure of 
hemodialysis. Factors that can contribute to the occurrence of dialysis related hypotension are 
discussed. We concluded from the available literature that for most factors it is unknown 
whether the most detrimental effect on effective blood volume during hemodialysis is due to a 
decreased plasma refilling or to an inadequate cardiovascular response. Moreover, we 
hypothesized that both mechanisms can affect each other. We concluded that more knowledge 
concerning this relationship is essential before blood volume monitoring and modeling, in 
order to prevent of dialysis related hypotension, can be applied clinically. 
 
In chapter 2, we constructed a mathemathical model of the intercompartmental fluid shifts 
during combined hemodialysis, diffusive hemodialysis, and isolated ultrafiltration (IU). We 
analyzed the relative importance of the factors that govern plasma refilling. We concluded 
that the ultrafiltration rate, the size of sodium gradient between the dialysate and blood side of 
the dialyzer membrane, and the change in regional blood flow are the most important factors 
influencing the magnitude of plasma refilling.  
 
In chapter 3, we analyzed the reproducibility of the decrease in relative blood volume during 
hemodialysis, as it is essential for the application of blood volume modelling that a critical 
level of reduction in relative blood volume can be determined. However, we observed a 
considerable intra- and inter-individual variability and no correlation was observed between 
changes in relative blood volume and either blood pressure or the incidence of hypotension. 
We concluded that the critical level of reduction in relative blood volume, at which 
hypotension occurs, depend more on cardiovascular defence mechanisms, such as 
sympathetic drive.  
 
In chapter 4, we evaluated the effects of diffusive dialysis on the changes in relative blood 
volume during diffusive dialysis without ultrafilitration. During the first and second hour, 
relative blood volume was paradoxically increased. Thus, the detrimental effect of diffusive 
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dialysis may be caused by a decrease in vascular resistance, rather than by reduced plasma 
volume preservation.  
In chapter 5, we have compared  the effect of isotonic saline (0.9 %), glucose (5%), 
hypertonic (3%) saline, mannitol (20%) and glucose (20%) on RBV, as these infusions are 
most frequently used in order to prevent hemodynamic instability during dialysis. We 
observed that hypertonic glucose during dialysis results in a greater increase in relative blood 
volume than equal volumes of other solutions. As mannitol has the same osmolarity, molecule 
mass and charge, the greater increase in RBV following hypertonic glucose appears to be a 
specific effect, possibly related to a decline in vascular tone.  
 
In chapter 6, we studied the pathophysiology of hemodialysis related hypotension. In order to 
distinguish between dialysis related and patient related factors hypotensive dialysis sessions 
were compared with Lower Body Negative Pressure experiments. We observed that dialysis 
related hypotension did not result from an inability to maintain blood volume or from 
decreased cardiac filling. Hypotension appeared to result from the inability to increase 
arteriolar tone adequately and from a reduction in left ventricular function. Both vascular tone 
and left ventricular function appeared to be impaired by the dialysis procedure. 
 
In chapter 7, we observed that an increase in total peripheral resistance resulted in a decrease 
in relative blood volume. This indicates that the improved hemodynamic stability during 
hemodialysis through vasoconstriction can be accompanied by a decrease in relative blood 
volume. Part of the variability in blood volume as described in chapter 4 may be due to 
changes in arterial tone. A diminished vasoconstriction during diffusive dialysis could also 
explain the observed increase in relative blood volume, as observed in chapter 5. Moreover, it 
can be concluded that glucose, which increases relative blood volume more than equal 
amounts of mannitol or sodium, is paradoxically of less benefit in the prevention of dialysis 
hypotension. Therefore, during sodium profiling, the cardiovascular effect of sodium during 
on plasma refilling should be taken into account. 
 159
Chapter 9 
 160
 
In chapter 8 we observed that patients that frequently experience episodes of hypotension 
during dialysis are also prone to develop hypotension during Lower Body Negative Pressure, 
which results from reduced myocardial contractile reserve and/or inadequate sympathetic 
tone. 
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Chapter 10 
 
Samenvatting en Conclusies 
Hoofdstuk 1 is een beknopte inleiding tot de physische aspecten en de technische uitvoering 
van hemodialyse. Factoren die kunnen bijdragen aan bloeddrukverlaging (hypotensie) in 
samenhang tot hemodialyse worden besproken. Uit de beschikbare literatuur konden wij 
vaststellen dat het voor de meeste factoren onbekend is of deze de bloeddruk tijdens 
hemodialyse verlagen via een verminderde vulling vanuit de extravasculaire ruimtes (plasma 
refilling) of door een ontoereikende reactie van het hartvaatstelsel op de door ultrafiltratie 
ontstane hypovolemie. Wij veronderstellen echter dat beide mechanismen elkaar kunnen 
beïnvloeden. Wij kwamen tot de conclusie dat meer kennis betreffende deze relatie absoluut 
noodzakelijk is voordat het kritisch volgen en bewaken van het bloedvolume, ter voorkoming 
van aan dialyse gerelateerde bloeddrukverlaging, klinisch kan worden toegepast. 
 
In hoofdstuk 2 hebben we een rekenkundig model ontworpen van de vloeistofstromen binnen  
de verschillende compartimenten tijdens gecombineerde hemodialyse, hemodialyse zonder 
ultrafiltratie en geïsoleerde ultrafiltratie. Hiermee analyseerden we de relatieve waarde van de 
factoren op de plasma refilling. We kwamen tot de conclusie dat de snelheid van ultrafiltratie, 
de grootte van het natrium gradiënt over de dialyse membraan en de verandering van de 
bloedstroom ter plaatse, de belangrijkste factoren zijn die in hoge mate de plasma refilling 
beïnvloeden. 
 
In hoofdstuk 3 is de reproduceerbaarheid bepaald met betrekking tot de verlaging van het 
relatieve bloedvolume gedurende de hemodialyse sessie. Dit is van wezenlijk belang voor de 
toepassing van bloedvolume regulering, omdat dan bij een eventueel kritisch niveau van de 
verlaging van het relatief bloedvolume de hypotensieve episode kan worden voorspeld. We 
hebben echter aanzienlijke intra-en interindividuele afwijkingen waargenomen. Er is ook geen 
correlatie gevonden tussen veranderingen in het relatieve bloedvolume en bloeddruk of het 
ontstaan van hypotensie. We zijn tot de conclusie gekomen dat het kritisch niveau van 
verlaging in bloedvolume, waarbij hypotensie ontstaat met name afhangt van de reactie van 
het hartvaatstelsel op de door ultrafiltratie ontstane hypovolemie. 
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In hoofdstuk 4 hebben we de effecten geëvalueerd van hemodialyse zonder ultrafiltratie op de  
veranderingen in relatief bloedvolume. Tijdens het eerste en tweede uur was het relatieve 
bloedvolume paradoxaal verhoogd. Dus, het schadelijke effect van diffunderende dialyse zou 
eerder veroorzaakt worden door een verlaging van de vasculaire bescherming dan door het in 
stand houden van een gereduceerd plasma volume. 
 
In hoofdstuk 5 hebben we het effect vergeleken tussen fysiologische zoutoplossing (0,9%), 
glucose (5%), hypertone zoutoplossing (3%), mannitol (20%) en glucose (20%) op het 
relatieve bloedvolume (RBV) omdat deze infusievloeistoffen het meest worden gebruikt om 
hemodynamische instabiliteit tijdens de dialyse te voorkomen. We hebben waargenomen dat 
hypertonisch glucose tijdens de dialyse in een grotere toename van het relatieve bloedvolume 
resulteerde dan een gelijk volume van de andere oplossingen. Alhoewel mannitol dezelfde 
osmolariteit, molecuul massa en elektrische lading heeft, blijkt de toename van het RBV met 
hypertone glucose groter te zijn, welke mogelijkerwijs gerelateerd is aan de verminderde 
capaciteit van glucose om de vaatweerstand te verhogen. 
 
In hoofdstuk 6 wordt de pathosfysiologie van hemodialyse gerelateerde hypotensie 
bestudeerd. Om een onderscheid te maken tussen hemodialyse gerelateerde en patiënt  
gerelateerde factoren, werden hypotensieve dialyse sessies vergeleken met experimentele 
situaties waarbij kunstmatig een hypovolemie werd gecreëerd zonder dat dialyse plaatsvond 
(Lower Body Negative Pressure).  Hypotensie bleek met name te worden veroorzaakt door 
het onvermogen om de arteriële vaatweerstand toereikend te verhogen en door een afname in 
de linker ventrikel functie.  
 
In hoofdstuk 7 hebben we waargenomen dat een verhoging van de totale perifere 
vaatweerstand resulteerde in een verlaging van het relatieve bloedvolume. Dit geeft aan dat de 
verbeterde hemodynamische stabiliteit tijdens de hemodialyse, door vasoconstrictie, gepaard 
kan gaan met een verlaging van het relatieve bloedvolume. Deels kan dus de variatie in 
bloedvolume, zoals beschreven in hoofdstuk 3, veroorzaakt worden door veranderingen in de 
arteriële vaattonus. Een verminderde vasoconstrictie tijdens dialyse zonder ultrafiltratie zou 
ook de waargenomen verhoging in relatieve bloedvolume kunnen verklaren, zoals aangegeven 
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in hoofdstuk 5. Bovendien kan worden vastgesteld dat glucose, dat het relatieve bloedvolume 
meer verhoogd dan gelijke delen mannitol of natrium, paradoxaal minder voordeel laat zien 
ter voorkoming van dialyse hypotensie. Om deze reden zou, tijdens Natrium-profiling 
rekening moeten worden gehouden met het cardiovasculair effect van natrium tijdens de 
plasma refilling.  
 
In hoofdstuk 8 hebben we vastgesteld dat patiënten die regelmatig perioden doormaken van  
hypotensie tijdens de dialyse, tevens neigen naar het ontwikkelen van hypotensie tijdens  
Lower Body Negative Pressure. 
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 Nawoord 
 
De laatste pagina's van een proefschrift zijn altijd voor een dankwoord. Vroeger vond ik dat 
bij het lezen van een proefschrift een beetje onzin, mede door het feit dat het een soort 
formaliteit geworden is, zoals ook de bedankjes bij de oscaruitreiking mij nooit kunnen 
boeien. Nu ik bij het maken van het dankwoord het proefschrift nog eens aanschouw, zie ik 
echter dat ik veel mensen oprecht veel dank verschuldigd ben. Het zijn er zelfs zoveel dat ik 
niet iedereen persoonlijk kan bedanken en daarom beperk ik me tot de meest betrokkenen.  
 Als eerste bedank ik mijn promotor, Willem Weimar, met name voor het gestelde 
vertrouwen  Verder waren zijn commentaren altijd waardevol, waardoor  het proefschrift 
significant verbeterd kon worden. 
 Natuurlijk bedank ik mijn begeleider, Bob Zietse. Ik heb vooral geleerd dat het doen 
van goed onderzoek korte en scherpe vragen en antwoorden vereist. Dit lijkt heel simpel, 
maar het is datgene wat onderzoek juist zo moeilijk, maar ook uitdagend maakt. De in jou 
gewaardeerde scherpe humor zal dan ook niet snel overtroffen worden. Ik wil je echter vooral 
bedanken, omdat je bergen werk verzet hebt en je een sociaal bewogen man bent waarmee het 
plezierig is om mee te werken.  Ik ben er trots op de eerste te zijn die onder jouw begeleiding 
promoveert. Het is ook verheugend te noemen dat de onderzoeksactiviteiten naar de 
hemodynamische stabiliteit van de patiënt tijdens de hemodialyse behandeling in onze 
hemodialyse research unit (HRU) zeker gecontinueerd gaan worden. Hierbij wil ik dan ook 
mijn collega's van de HRU bedanken die mede aan mijn proefschrift gewerkt hebben.  
Harmen Krepel, toen ik in 1998 aan het onderzoek begon was het best eenzaam en verder had 
ik geen idee waar ik moest beginnen. Gelukkig was jij daar op dat moment, jij had al 
onderzoekservaring en was al bijna nefroloog. Jij hebt belangeloos alle energie in mij 
gestoken, en je was mijn mentor op de HRU. Verder hebben we heel wat afgelachen, zeker 
toen Han-Yo Ie onze HRU kwam versterken.   
Han-Yo, ik heb veel steun aan je gehad. Jij weet als geen ander dat promoveren op een dialyse 
onderwerp doorzettingsvermogen vereist, zeker gezien het feit dat uit het grootste deel van 
onze inspanning weinig tot niets concreets is gekomen. Niettemin is mijn proefschrift af en 
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 schrijf jij nu wel hele mooie artikelen voor jou onderzoek. Het feit dat jij er altijd in geloofde, 
stimuleerde mij en ik wil je daar heel erg voor bedanken.  
Rene van den Dorpel wil ik natuurlijk ook bedanken, met name voor hoofdstuk zes en acht, 
waarvan een groot deel zijn inspanning is.  
Verder bedank ik Emin Akcahuseyin, onze klinisch fysicus, voor het doornemen van de vele 
mathematische formules. Je hebt me bijgebracht je door formules niet te laten afschrikken; ze 
helpen juist de huidige inzichten te verduidelijken. Dat is in dit proefschrift ook wel gebleken.  
De leden van de promotiecommissie bedank ik voor hun snelle commentaar op dit 
proefschrift.  
Verder wil ik de dialyseverpleging bedanken, die al die jaren mij hebben geholpen met 
bepaalde dialyseopstellingen en metingen, ook buiten hun werktijd.  
Veel dank ben ik verschuldigd aan de dialysepatiënten, die aan dit onderzoek hebben 
meegewerkt. Niet alle onderzoeken waren voor hen even leuk. Niettemin meldden de 
patiënten zich weer spontaan voor een nieuw onderzoek. Zonder hun bereidheid was dit 
onderzoek natuurlijk nooit tot stand gekomen. Tijdens die vijf jaar heb ik een aantal patiënten 
dan ook beter leren kennen en heb van hen veel geleerd hoe het is om chronisch ziek te zijn. 
Een les die voor een dokter van onschatbare waarde is.  
Als laatste wil ik natuurlijk mijn ouders bedanken. Met hun onvoorwaardelijke steun is het 
begonnen. Jullie hebben in mij geloofd vanaf het moment dat ik de cito toets op de lagere 
school moest doen. Een vak kiezen wat je leuk lijkt en doorzetten dan lukt het wel, was altijd 
jullie devies. Jullie hebben gelijk gehad, maar zonder jullie steun was dit nooit gelukt. 
 
 
Bedankt  
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